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Abstract 
Solvate formation is a phenomenon that has received special attention in solid state chemistry 
over the past few years. This is due to its potential to both improve and impair pharmaceutical 
formulations. The reasons for solvate formation aren’t explicitly known. Therefore, there is 
currently no reliable guide in the literature on what solvents to choose in order to avoid or 
form a solvate when crystallizing an organic material. In this thesis we address the problem by 
trying to find the main reasons of solvate formation. A knowledge-based approach was used to 
link the molecular structure of an organic compound to its ability to form a solvate with five 
different solvents; these are ethanol, methanol, dichloromethane, chloroform and water. The 
Cambridge Structural Database (CSD) was used as a source of information for this study. A 
supervised machine learning method, logistic regression was found to be the optimal method 
for fitting these knowledge-based models. The result was one predictive model per solvent, 
with a success rate of 74-80 %. Each model incorporated two molecular descriptors, 
representing two molecular features of molecules. These are the size and branching in 
addition to hydrogen bonding ability. The models’ predictive ability was validated via 
experimental work, in which slurries of 10 pharmaceutically active ingredients were screened 
for solvate formation with each of the five solvents in the study. During the screening process, 
a new diflunisal dichloromethane solvate, a diflunisal chloroform solvate and a hymercromone 
methanol solvate were found. The PXRD patterns of these forms are reported. The thesis also 
includes SCXRD analysis of a previously known grisoefulvin dichloromethane solvate, a 
previously known fenofibrate polymorph and a new fenofibrate polymorph. 
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Chemical information is growing at exponential rates, as shown by surveys of databases. This 
provides an easy-to-access, reliable source of data. Investigation of such data has the potential 
to help in finding new trends, leading to establishing new relationships that were not 
previously known. The possibility to conduct such investigations has been long recognized, 
where one of the first examples to obtain knowledge from chemical data took place in 1868.1 
Today, the area of chemical information investigation, also known as Cheminformatics, is a 
field that is growing, where the number of publications about chemical information has 
increased lately.2  One area in which cheminformatics research can be applied is solid state 
chemistry, where it is possible to anticipate the physicochemical properties of materials using 
previously obtained knowledge. The information obtained from X-ray diffraction could be 
particularly useful in solid state chemistry. This is due to the large amount of information 
available. Gavezzotti in 1998 stated that “X-ray crystallography is even today a potential source 
of a wealth of physicochemical information which awaits to be tapped.3” However, with 
increased complexity of the problems and extent of the data available, such studies become 
harder. Nowadays, cheminformatics research is a multi-disciplinary area in which 
mathematical, statistical, programming, theoretical and experimental chemistry knowledge is 
required. It is important to mention that the development that is seen in all these fields has 
also facilitated conducting cheminformatics research.  
In solid state chemistry, a phenomenon that is poorly understood today is solvate formation. 
Solvate is a crystalline solid form in which two or more materials constitute the crystal 
structure, where at least one of these materials is in the liquid state at room temperature. This 
form has received special attention in the past few years due to its potential beneficial 
implications, where it could be used to obtain desired properties in a solid. It also has the 
potential to have harmful implications, where its unexpected formation could lead to a change 
in the physicochemical properties of the manufactured material. Additionally, the presence of 
organic solvents as part of the crystal structure could cause toxicity. Despite the large amount 
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of data available on solvate forms, where around one third of organic chemical crystalline 
materials form hydrates,4 the reasons for solvate or hydrate formation are not explicitly 
known. Trial-and-error approaches are nowadays used (in industry for example) in order to 
rule out the ability of a material to form a solvate. In this work, we use a knowledge-based 
approach in an attempt to relate the chemical features of organic compounds to solvate 
formation. This could reveal a connection between the molecular structure and the ability of a 
material to form a solvate. This is achieved by the information from single-crystal X-ray 
diffraction experiments recorded in the Cambridge Structural Database. 
In this thesis, Chapter 2 gives a literature background regarding the areas that are relevant to 
this work, including solid-state chemistry, statistics and experimental methods. The materials 
and the methods used are summarized in Chapter 3. Chapter 4 presents a detailed report on 
how the data of this project was collected from the Cambridge Structural Database, while 
Chapter 5 focuses on the data mining and statistical modelling of the collected data. It also 
shows detailed analysis and criticism of the resulting predictive models. Chapter 6 gives a 
closer look on the factors included in the predictive models and the factors that could probably 
be added to improve the models via examples. 
The applicability of the predictive models in the pharmaceutical industry is tested in Chapter 7, 
where predictions obtained by the models are compared to the results obtained by 
experimental work. This chapter also reports PXRD patterns of new solvate forms and a 
detailed single crystal structural report of a griseofulvin dichloromethane solvate. 
Chapter 8 shows results of a collaborative project with a department colleague, Mr. Pratchaya 
Tipduangta, who studied the heterogeneous crystallization of fenofibrate under different 
conditions. The chapter focuses on the crystal structures of fenofibrate forms IIa and a newly 
found form III.  
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2.1 Solid forms of pharmaceuticals 
Pharmaceutical ingredients are often produced in the solid form. However, solid phases can be 
either single or multi-component. There is a great variety in the possible compositions of 
multi-component organic solids and this situation has caused discussions about feasible 
classification systems of organic solids.1,2 According to the most recently proposed 
classification systems, three main classes of multicomponent solids are distinguished. These 
are salts, cocrystals and solvates.2 Clear definitions of these classes are not available and are 
often interpreted in various ways – this will be further discussed in the following sections. The 
classification systems referred to, however, generally recognize that a salt contains two ions, a 
cocrystal contains two neutral molecules that are solids in their pure form and solvates contain 
neutral molecules one of which is liquid in its pure form at ambient conditions. It is possible 
that a multicomponent solid contains more than two components and therefore subclasses 
are formed. For example, a material containing two ions and a neutral molecule is a cocrystal 
salt and a solid containing three molecules one of which would be a liquid in its pure form is a 
solvate of a cocrystal.2 
Each of the single- or multi-component solids discussed can be either crystalline or 
amorphous: crystalline solids exhibit long range structural order while amorphous materials 
are structurally disordered. Crystalline materials, both single- and multi-component, 
potentially can show polymorphism – different crystal structures with the same composition.  
Research on solid forms of pharmaceutical compounds is of interest for pharmaceutical 
companies because of several reasons. Firstly, each solid form has unique physicochemical 
properties and therefore needs to be studied separately. Secondly, each solid form is also 
subject to intellectual property protection.3 
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2.1.1 Amorphous materials 
The significance of amorphous materials in pharmaceutical solid-state chemistry is related to 
two aspects. Firstly, although the stability of an amorphous form is inferior to that of a 
crystalline form, it is still sometimes selected for production because of better solubility and 
dissolution.4-6 Different techniques are employed by the pharmaceutical industry to stabilize 
amorphous materials. Some examples of medicines containing amorphous API are Lopinavir,7, 8 
Cefuroxime axetil6, 9, 10 and Zafirlukast.6, 11 Secondly, amorphous form can be an intermediate 
phase of solid-state reactions.4 Amorphous materials can be either single-component or 
multicomponent materials.  
Although amorphous materials can have some short-range order (for example, interactions to 
neighbouring molecules), translation or rotational order cannot be identified in these solids.4,12 
This means that there is no three-dimensional long-range order in amorphous materials and 
therefore they are similar to liquids.13 The main tool used to distinguish between amorphous 
and crystalline structures is X-ray diffraction.13  However, it has been noted that a clear 
definition of amorphous does not exist, due to a continuum between amorphous and 
crystalline states.4 Ideal crystalline materials are rare, and real crystals usually show some 
degree of disorder and presence of crystal defects. Furthermore, it is known that the particle 
size can influence properties of a material. For example, a crystalline material with very small 
(Nano sized) particles would behave similarly to amorphous material and care must be taken 
to distinguish between these states.4 
Common methods for preparation of amorphous solids include quench cooling of a melt, 
freeze-drying (lyophilisation), spray-drying and mechanochemical treatment (milling).14,15 
Amorphisation can also be achieved by fast precipitation and by desolvation of solvates.15 In 
the latter case, desolvation of a solvate leads to disintegration of a crystal lattice forming an 
amorphous material.  
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2.1.2 Polymorphism 
Polymorphism is an ability of a compound to crystallize in different arrangements.16 Two 
polymorphs can differ in the conformation of the molecules (conformational polymorphism), 
arrangement of the molecules in space (packing polymorphism) although most commonly both 
these situations are encountered at the same time. Polymorphic forms of a compound 
therefore have different crystal structures and consequently – different stability and 
physicochemical properties.16 This is especially important in the pharmaceutical industry 
because two polymorphs with different properties (for example, solubility) can change the 
efficacy of the drug and lead to inconsistency of dosing. Because of this, polymorphic purity of 
a drug compound is highly important and pharmaceutical companies need to ensure control of 
polymorphism of their API’s. Control of polymorphism is achieved via different methods, such 
as seeding, use of additives, templating, solvent control, use of membranes, confined space.17   
Crystalline phases are always more stable than amorphous phases, however, the stability of 
different polymorphic forms also can vary in a wide range. In order to explore the possible 
polymorphic forms of a compound, crystal energy landscapes can be calculated.18 At given 
conditions one of the polymorphic forms of a compound will be more stable than other forms - 
this form has the lowest free energy with regard to other crystalline forms. All other 
polymorphs are metastable. Every two polymorphic forms can be either monotropically or 
enantiotropically related.16,19 In a monotropic system one of the two polymorphs is more 
stable at temperatures up to its melting point while in enantiotropic system a transition point 
exists. This means that under the transition temperature one of the polymorphic forms is more 
stable than the other and after this point the other form becomes more stable, while at the 
transition temperature both polymorphic forms have equal stability.20, 21 Graphically, this can 
be illustrated by the Gibbs free energy curves as shown in Figure ‎2-1.  
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Figure ‎2-1. Graphical illustration of Gibbs energy in monotriopic polymorph system (A) and in enantiotropic 
polymorph system (B). M.p.is melting point of Form 1 or Form 2 correspondingly and T.p. is polymorph transition 
point in enantiotropic system.
22
 
It is important to distinguish between monotropic and enantiotropic polymorph systems in 
order to prevent undesired polymorph transitions in pharmaceutical products. This is because 
in a monotropic system solid-solid phase transitions are irreversible, while in an enantiotropic 
polymorph system reversible transitions can take place.  
In order to distinguish between monotropic and enantiotropic polymorph systems Burger and 
Lamberger have established several rules.20,23 The Heat of Fusion rule states that “If the higher 
melting form has the lower heat of fusion the two forms are usually enantiotropic, otherwise 
they are monotropic”.20 The heat of transition rule states that “if an endothermal transition is 
observed at some temperature, the two forms are related enantiotropically. If an exothermal 
transition is observed, the two forms are either related monotropically or the transition 
temperature is higher”.20 Additionally, it has also been pointed out that a structure with lower 
density will be less stable at absolute zero and that analysis of absorption bands in IR spectra 
also allows to compare stability of two forms.20  
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2.1.3 Multicomponent crystalline solids 
Alongside the single-component organic solids, multicomponent solids, such as solvates, 
cocrystals and salts, are also possible.  
2.1.3.1 Cocrystals 
According to FDA definition cocrystals are “Crystalline materials composed of two or more 
different molecules within the same crystal lattice that are associated by nonionic and 
noncovalent bonds”.1,24 The scientific literature is not consistent when discussing whether 
solvates (and hydrates) should be classified as cocrystals. It has been pointed out that from 
supramolecular perspective solvates and cocrystals are related.1 From practical perspective, 
however, it is beneficial to differentiate between cocrystals and solvates.25 According to 
Aakeroy,26 reactants making up cocrystals should be solids at ambient conditions. In his 
perspective, cocrystals are structurally homogeneous crystalline materials containing neutral 
molecules in stoichiometric amounts.26 According to these rules, solvates, clathrates and salts 
cannot be seen as cocrystals. Although, the rules set out by Aakeroy26 seem to make a 
distinction between cocrystals and salts, a continuum exists between these species too as 
partial transfer of proton is possible in molecular complexes.27 
Cocrystals are commonly obtained based on knowledge of hydrogen and halogen bonds 
between functional groups of the reacting molecules.28,29,30 Other interactions, such as van der 
Waals forces and π-π interactions can play a role cocrystal formation.31 The necessary 
information can be obtained by analysing the available crystal structure data of other 
cocrystals. Several studies employing Cambridge Structural Database (CSD)32  have shown the 
prevalence of certain supramolecular synthons.33,34,28 This information can be used to design 
new cocrystals.  
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Until recently, the production of pharmaceutical cocrystals was restricted due to FDA 
guidelines. Currently (since 2013) cocrystals have been recognized as drug intermediates and 
the industrial interest about them has increased.  
2.1.3.2 Solvates  
In comparison to cocrystals, in solvates one of the constituents is liquid at ambient 
conditions.25 Solvates of a pharmaceutical compound are sometimes referred to as 
pseudopolymorphs or solvatomorphs although recently the term “solvates” has been 
preferred.25 Solvates can contain either a stoichiometric or a non-stoichiometric amount of 
solvent. These two types of solvates are being referred to as stoichiometric and non-
stoichiometric solvates.35, 36 
In a stoichiometric solvate the solvent molecules are usually a crucial part of the crystal 
structure, being bound to the drug molecule by specific intermolecular interactions. 
Incorporation of a solvent molecule in such a structure leads to a more stable crystalline form 
therefore stoichiometric solvates can be chosen as a final drug product to be marketed.37, 38 In 
non-stoichiometric solvates, on the other hand, the solvent molecules usually do not form 
strong interactions to the host molecules.  
An alternative way to classify solvates (this classification system is typically used for hydrates) 
is with regard to their structure: isolated site solvates, channel-type solvates and ion-
associated solvates can be distinguished.39 In isolated-site solvates, solvent (water) molecules 
are separated from each other and connected to API molecules by hydrogen bonds. Isolated-
site solvates are usually stoichiometric. Some examples of stoichiometric isolated-site solvates 
are cephradine dihydrate, cefaclor dehydrate40 and siramesine hydrochloride monohydrate.41 
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In channel-type solvates the solvent (water) molecules are accommodated in channels or 
between layers of the host molecules (API)37 (these can be both stoichiometric and no-
stoichiometric).  Channel and layer type structures can often accommodate a range of various 
solvents resulting in series of isostructural solvates. These solvates are often non-
stoichiometric and easily undergo desolvation. In case of isostructural solvates, desolvation 
commonly leads to isostructural (isomorphic) desolvates with the same structure of the host 
molecules and empty voids that used to accommodate solvent molecules.42 Some compounds 
known to form isostructural solvates are tenofovir disoproxil fumarate43 and sulfathiazole.44 
In ion-associated solvates solvent/water molecules are coordinated around an ion.  This type 
of solvate is not the scope of this study, as we focus on organic solvates. 
It is possible for a solvate (with the same stoichiometry) to have several crystalline forms – 
polymorphs.  
Manufacturing solvated forms of API’s is limited by the toxicity of the solvent present in the 
material. Hydrates, that is solvates of water, however, are free from this concern and 
therefore are the most commonly used solvates. Additionally, the water molecule because of 
its small size can easily fill structural voids. Moreover, its hydrogen bond donor and acceptor 
properties ensure efficient bonding to API molecules resulting in a stable crystal lattice.36 It has 
been estimated that at least one third of pharmaceutical compounds can form hydrates.45 
Furthermore, water is present in the atmosphere and can come into contact with the drug 
compound during processing of the solid.46 Many hydrate forms have been commercialized, 
for example, amoxicillin trihydrate,47 darunavir ethanolate48 and dasatinib monohydrate.49 
Solvates containing multiple solvents are much more rare among the manufactured products. 
An example on the latter is indinavir sulfate ethanolate.50 
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While cocrystals and salts are usually prepared intentionally, solvates can form unexpectedly. 
Since it is important to obtain a pure solid form as a final product of manufacturing, 
information on possible solvation of a compound is crucial.  
2.2 Identification of the solid form 
Most of newly discovered Active Pharmaceutical Ingredients (API) do not reach the market, 
where it is reported that 89 % of these APIs fail before being marketed.51 The main reasons for 
this failure is their poor biopharmaceutical properties, low efficacy and toxicity, where these 
account for 41 %, 31 % and 22 % of total failure in development, respectively.52 Therefore, the 
sooner the properties of an API are known, the less time and money is spent on their 
development. In order to achieve this early judgement of which medical candidates are going 
to be useful, two main approaches are available, these are an in vitro (experimental) and in 
silico (theoretical) approaches, which are going to be discussed in sections ‎2.2.1 and ‎2.2.2. 
2.2.1 Experimental identification of solid form 
Historically, screening experiments in biological and pharmaceutical areas were slow processes 
that used to consume a considerable amount of materials.53 A report in 2007 was published by 
Pereira and William who worked in Pfizer. This report mentions that each biological or 
pharmaceutical assay required to be 1ml in volume, required an amount of the compounds 
being investigated and a separate test tube for each experiment.54  This resulted in testing 20-
50 compounds in a laboratory per week. In the past two decades, it was possible to automate 
and speed up the process using computers and robotics. Currently, it is possible to use pico-
litres of liquid and conduct over 100,000 assays per day via Ultra High-throughput screening 
(uHTS), resulting in reduced time and expenses of a study.55,56 Note that the process of 
screening can be used in various areas such as conducting biological, toxicological and 
pharmacokinetic assays.55  
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In this work, we highlight the application of high-throughput techniques in solid form 
selection. A solid form is normally obtained by crystallization, as the final step of synthesis. 
Multiple crystallization methods are known, such as evaporative, cooling and anti-solvent 
crystallizations. For the same compound, using a different crystallization method can result in 
a different solid from. Additionally, in any of these crystallization processes it is possible to 
change the form of the solid obtained by manipulating factors such as the composition of the 
crystallization medium, concentration and additives. These factors are summarized in a review 
that was published by Sherry L. Morissette et al in 2004.53 The variety of methods of 
crystallization and the number of factors to adjust in each result in a large number of 
experiments that need to be conducted to cover the possible solid forms of an API. For this 
reason, high-throughput has become one of the standard techniques that companies use for 
discovering solid form diversity. Although this is a popular method nowadays, it still has its 
disadvantages when applied in solid state chemistry. For example, it can require large amounts 
of material, especially when crystallizations are conducted. This is because crystallization 
experiments cannot be done at the pico-scale these methods offer. Additionally, if 
experiments did not cover absolutely all possible materials/ratios of materials in a 
crystallization experiment, unexpected solid forms could arise.57 
2.2.2 Theoretical prediction of possible solid forms 
2.2.2.1 Crystal Structure Prediction (CSP) 
Crystal structure prediction is a computational chemistry method, aiming to find the crystal 
structure of a molecule given its chemical structure and in some cases, crystallization 
conditions.58  
For a specific organic structure, current CSP methods work by looking for the structure with 
the lowest lattice energy (also known as global minimum) among all possible structural 
arrangements. This means the found structure is likely to have high thermodynamic stability. 
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Note that it is not the absolute most stable form because the entropy is ignored here.59 The 
energy of these structures is mainly calculated using empirical models or ab initio calculations 
or a mixture of both. 
Although this might sound straightforward, different challenges are faced; most notably the 
number of possible structures (largely depends on the space group choice and the number of 
independent molecules in the space group), the phenomenon of polymorphism and the choice 
of the model to perform the calculations.60,61 For example sometimes the structure that has 
the lowest lattice energy is not experimentally observed. Sometimes one polymorph is the 
most stable under certain temperature, but as this temperature changes, a different 
polymorph becomes more stable.61 
In order to evaluate the different methods available and the progress in improving the 
predictability of crystal structures, the Cambridge Crystallographic Data Centre (CCDC) 
periodically organizes international blind tests of crystal structure predictions. In this test, 
research groups that are interested in developing crystal structure predictive methods are 
given a set of organic structures with unknown crystal structures. The groups are then asked to 
report their predictions regarding the space group, cell dimensions and atomic coordinates of 
the given structures.61 Six of these tests have been conducted so far, with the latest of them 
being in late 2015. The details about the first five of these tests can be found in the references 
provided.58, 62-65 
It is worth noting that the fourth CSP blind test has introduced multi-component solids as a 
new class to be part of the blind test.58  This emphasizes the growing importance of multi-
components in solids state chemistry. Specifically, predicting the crystal structure of a cocrystal 
was attempted. Determination of the cocrystal structure was the hardest among all others, as 
the report of the test states: 
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“As expected, the cocrystal was the main problem – the increased search space was the main 
reason for including the new category of two-component crystals in this blind test and seven 
of the 12 groups who attempted predictions for this system did not locate the observed 
crystal structure in their search.”58 
Few years later, multi-components still showed a big challenge to the process of CSP, where 
the report of the fifth bind test states: 
“Hydrate (XXI) proved to be one of the most challenging systems in the blind test”65 
Most recently, the report on the sixth blind test included a prediction of a crystal structure of a 
chloride salt hydrate. One of the participating groups was able to predict the experimentally 
known structure, where they ranked it as the second most stable structure in their submitted 
prediction. Although this prediction doesn’t directly fall into the scope of this thesis, a correct 
prediction of the experimental structure of a 3-component system including a solvent is 
important to note. Despite these improvements, some issues remain the limiting factors of 
CSP. An example is the complexity of this method; where it requires an expert in the field to 
generate and assess the possible structures. Additionally, it has a high computational cost, 
where a landscape calculation of a molecule can take months.57 Therefore, at current times 
CSP is used as a complementary method with experimental work and high throughput 
crystallizations, where it helps highlighting the possibility for undiscovered polymorphic 
forms.59 
2.2.2.2 Cheminformatics 
Cheminformatics (also known as chemoinformatics, chemical informatics and molecular 
informatics) can be defined as the science in which information technology is employed in 
order to help making better and faster decisions in the fields of drug discovery and 
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development.66,67 This is a multi-disciplinary science that employs the fields of chemistry 
(chemical information) of structures, mathematics, statistics and computer programming.66 
Chemometrics, a sub-field of cheminformatics is a field that is concerned with deriving 
chemical information from experimental data.68 In biology, two parallel sciences that are 
heavily used nowadays are Bioinformatics and Biometrics. As the name implies, they are 
similar to cheminformatics but they use data derived from biology.69 
One of the main concepts in cheminformatics is Quantitative Structure-Activity Relationship 
(QSAR). This term describes a process in which the structure of a chemical is mapped to the 
biological activity. A closely related term is Quantitative Structure-Property Relationship 
(QSPR). This is a process that tries to find an association between the structure of a chemical 
and a physicochemical property of this structure.70  
The basis of this field could probably be assigned to Crum-Brown in 1861, where he suggested 
the possibility of finding mathematical model that would explain chemical theories.71 He was 
able to reveal the association between the water solubility of primary alcohols and their 
toxicity.70 Few years after that, he supported this opinion in a publication with Fraser, where 
their publication focused on the possibility of linking a physicochemical property of a chemical 
to its physiological action of a chemical.72 Several studies on QSAR/QSPR followed after that, as 
given by review articles.70 Currently, knowledge-based cheminformatics approaches play a 
significant role in lead discovery and optimization, where it assesses the toxicity, permeability 
and other properties of drug candidates. It is also used in early selection of drug candidates 
that are going to be tested experimentally using high-throughput techniques.73,51 
In order to establish a quantitative structure-activity or structure-property relationship, a few 
elements are required. Firstly, it is important to have a reliable source of data regarding the 
chemical structures from which information and later on, knowledge can be obtained. In this 
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work, we obtain our data from the Cambridge Structural Database (CSD).32 Secondly, a 
numerical description of the chemical structures is required.70 Such description is often known 
as molecular descriptors (sometimes referred to as “descriptors” alone). More formally, 
molecular descriptors have been defined by Todeschini and Consonni to be “The final result of 
a logic and mathematical procedure which transforms chemical information encoded within a 
symbolic representation of a molecule into a useful number or the result of some standardized 
experiment.”74 In this thesis, the molecular descriptors are obtained using a software called 
Dragon.75 The details about the descriptors that are calculated by this software are given in 
section ‎3.2.1. 
The third step in finding a QSAR/QSPR would be the conduction of statistical tests and machine 
learning methods in order to fit models that can best describe the data provided and make 
predictions of future data points. It is also important to evaluate these models to ensure they 
are not biased.70 The statistical part is going to be discussed in details in section ‎2.3. 
2.2.3 Previous CSD investigations on hydrate and solvate formation 
Considering the significance of solvates, especially in pharmaceutical science, several attempts 
to develop approaches for predicting solvate formation have been made. Alongside studies 
that have investigated the behaviour of compounds that readily form large number of 
solvates,76-78 A number of studies have been conducted using large datasets obtained from 
CSD.32 CSD offers valuable information of crystal structures and therefore allows studying 
various structural aspects that are expected to facilitate hydrate formation.   
It was noticed, however, that most if not all of the studies conducted were at least partially 
based on the consideration that formation of hydrogen bonds are the main governing force of 
solvate (hydrate) formation. For example, a study conducted by Desiraju investigated the 
formation of hydrates in relation to hydrogen acceptor and donor properties.143 The inspection 
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of hydrate structures of organic compounds revealed that almost all of these compounds did 
contain hydrogen bond donor and acceptor groups. The results of this work implied that most 
of hydrate-forming compounds have larger number of hydrogen acceptor groups than 
hydrogen donor groups. Regardless, actual hydrogen bonding between the compound and 
water did not always take place. In some cases (no estimate given) the water only acted as 
space-filler.  
The conclusion made by Desiraju regarding the effect of hydrogen donor/acceptor ratio was 
countered by another study based on CSD data, performed by Infantes et al79 who investigated 
hydrate formation in relation to the count of hydrogen bond donors and acceptors in the 
compound. In this work, several parameters describing formation of donor-acceptor bonds 
were derived and calculated for molecules of interest. A number of molecular parameters, 
such as atom count and dipole moment were also calculated. This study concluded that 
donor/acceptor ratio does not have effect on probability of hydrate formation. However, this 
work showed that higher sum of all donor and acceptor groups in the compound facilitate 
hydrate formation. More polar surface of molecule also was found to facilitate hydrate 
formation.  
Another study, performed by Nangia and Desiraju,80 inspected solvates with the 10 most 
common solvents in the database. The results showed that solvates are more often formed 
with solvents (1,4-dioxane, DMSO and DMF) that have high probability to participate in multi-
point hydrogen bonded recognition schemes between solvent and solute molecules. Hydrogen 
bonding between solvent molecules was also common.80 On the other hand, solvents that 
have comparatively poor multi-point hydrogen bonding ability (ethanol, ethyl acetate and 
diethyl ether) were found to rarely form solvates (the occurrence of solvates was calculated 
considering how often the solvent is used for recrystallization). They also recognized that 
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solvents such as benzene, p-xylene and CCl4 are included mostly in rigid framework-type 
structures as guest molecules.   
The crystallographic information available in the CSD has been used to thoroughly characterize 
the molecular environment of the two most common solvent molecules found in solvate 
crystal structures – water81 and methanol.82 It was found that the most common environment 
for water is such that it allows formation of three hydrogen bonds – two involving its hydrogen 
atoms and one with its oxygen atom. No correlations between the environment and the 
hydrogen bond strength were found. The inspection of the environment of methanol 
molecules in solvate crystal structures showed that in 305 of 375 methanol solvate examples 
one of five molecular environments could be identified. In the most common environment, the 
hydroxyl oxygen acted both as hydrogen donor and acceptor. 
A significant contribution to analysis of solvate crystal structure data has been given by van de 
Streek and Moteherwell83 who developed a software for CSD data analysis to find sets of 
structures containing both solvated and non-solvated forms of any compound. They used this 
in-house software to analyse such aspects as packing density, flexibility of the compound, 
chirality, number of possible donors and acceptors etc. The study showed that larger 
molecules commonly include larger number of water molecules (higher stoichiometry). They 
also found that certain groups (R2PO2
-, Cl- and NH3+) are considerably more common in 
hydrates than in anhydrates.  Some other groups (CF3, CCl and OCONH), however, were 
preferred in anhydrates. A comparison of contacts formed by the same compound in hydrated 
and anhydrate structures showed that for most of the functional groups the count is higher in 
hydrates. This was most obvious for Cl-, COO- and NH3R
+ groups. This study did not find 
correlation between flexibility of molecules and tendency to form hydrates. Chirality, on the 
other hand, had a positive effect on hydrate formation. In a subsequent study, van de Streek 
developed a program that screens the CSD structures to find solvates based on topological 
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indices.84 This program allowed obtaining lists of solvates for compounds with the 51 most 
common solvents. Closer inspection of the extracted lists showed that promising solvate 
formers are molecules with non-coplanar aromatic rings, cholic acid derivatives and 
calixarene/cyclodextrin type molecules. The solvate lists generated by this program allow 
preparing a correlation matrix that can be useful to predict solvation of a compound in certain 
solvents based on knowledge about similar cases.  
The reports reviewed in this section show that although invaluable work has already been 
performed to understand the structural reasons of solvate formation, more investigations are 
needed in this area. For example, although it has been extensively shown that intermolecular 
interactions, especially hydrogen bonds often facilitate solvate formation, some significant 
factors such as flexibility of molecules, their size, steric hindering and other have not been 
properly challenged.  Moreover, it is expected that most of organic structures present in CSD 
would contain heteroatoms, therefore presence of hydrogen bond donors and acceptors is 
unavoidable, and it is not surprising to find that most of the compounds forming solvates 
would also have some hydrogen bond donors and acceptors. Regardless, only a fraction of all 
heteroatomic molecules actually does form solvates. Therefore, it would be useful identify the 
factors governing solvate formation and quantify them. This would provide a tool that would 
be able to predict the formation of solvate. In order to develop a comprehensive approach 
that would be able to predict solvate formation, as many aspects as possible should be 
objectively evaluated. 
2.3 Statistics 
In this section, statistical methods that were used in the thesis are going to be presented. 
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2.3.1 Hypothesis testing 
In its simplest form, this process compares two contradicting hypotheses about a data set, in 
terms of a variable. The result of the test is the decision of accepting one hypothesis and 
rejecting the other. This decision is based on the value of a statistic that is calculated through 
the values of the variables of the data set.85 In this thesis, a comparison between two 
distributions, whether they come from the same population or not is required. the Wilcoxon 
signed-rank test.86 The choice of this test was based on its properties, where it does not 
assume a normal distribution of the data (non-parametric).87 Additionally, this test is ordinal 
which means it is not going to be affected largely by outliers.88 Such properties are suitable for 
the type of data in the problem being solved in this thesis. The study being conducted is for 
thousands of molecules, a normal distribution cannot be guaranteed and the amount of 
outliers will differ depending how each molecule is described.  
This test, developed in 1947, works by comparing two samples in order to know if they come 
from the same population. The test is closely related to the Wilcoxon rank-sum test which was 
developed earlier in 1945.89 The Wilcoxon signed-rank test works with paired samples, while 
the Mann Whitney test was designed to work when the two samples being tested are of 
different sizes.86 
The null hypothesis (Ho) is that the two samples come from the same population against an 
alternative hypothesis (H1) that the two samples come from different populations. One 
commonly used method for accepting or rejecting the null hypothesis is comparing a chosen 
alpha (α) level to the p-value obtained by the test.90 Alpha is simply the significance level that 
is chosen by the test conductor. The p-value is a probability of obtaining a statistic value that is 
as extreme or more extreme to the specified boundary value.91 It is important to note that the 
p-value is calculated based on the sample being tested, assuming the null hypothesis is true.92 
The convention is to use a p-value 0.05 as recommended by Fisher.93 When a p-value is below 
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the significance level, the null hypothesis (Ho) is rejected and the alternative hypothesis (H1) is 
accepted. It is worth noting that the alpha value can be on the positive and/or the negative 
end of the distribution giving three types of test, a left-tailed, a right-tailed and a two-tailed 
test, as illustrated by Figure ‎2-2. 
 
Figure ‎2-2. (a) A distribution with a left-tailed alpha value and an equivalent |p-value|. (b) A distribution with a 
right-tailed alpha value and an equivalent |p-value|. (c) A distribution with a two-tailed alpha value and a |p-
value| equivalent to alpha/2. 
The choice of the tailing of the test is set by the user. It is important to notice that in one tailed 
tests the absolute values of the alpha and the p remain similar, but when the a two-tailed test 
is chosen the p-value is split between the positive and the negative end, causing it to be half of 
the magnitude of the alpha level, as illustrated in Figure ‎2-2. 
2.3.2 Data mining and machine learning 
Data mining can be defined as the process of learning from large amount of input data.94 
Machine learning, a closely related term, is the use of computers in order to learn from these 
large amounts of data.95 The aim of machine learning can be predictive (to know what future 
data would look like) and/or descriptive (to know more about existing data).95 
Typically, machine learning algorithms can be classified into two types, these are the 
supervised methods, which require previously known outcome of the data (labelled data) and 
the unsupervised methods, which don’t require previously labelled data.96 More details about 
these methods are given in sections ‎2.3.2.1 and ‎2.3.2.2. 
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2.3.2.1 Unsupervised learning: Principal component analysis (PCA) 
As presented earlier, this type of learning works with unlabelled data. One of the most 
commonly used unsupervised techniques, and the one used for this project is Principal 
Component Analysis (PCA).97 It was introduced by K. Pearson back in 1901.97 It works by 
projecting the data to a new set of dimensions (variables), which are essentially linear 
transformations of existing dimensions.99 The new imaginary variables (known as principal 
components) maximize the variance in the dataset in terms of the variables provided. The first 
principal component accounts for the largest possible variance, and each succeeding variable 
accounts for the highest possible variance, on the condition that each new of these principal 
component has to be orthogonal (uncorrelated) to the rest of the principal components. Such 
properties make it an ideal way for visualizing the data in a low-dimensional space (for 
example in 2D or 3D plots).100 
The technique is used for several purposes, but one of the most popular reasons to apply this 
method is data exploration and dimensionality reduction. Additionally, it is used as a 
preparatory method before applying other classification techniques.101 In simpler terms, it 
could be used to summarize the data and omit repetitive information from the dataset.100 An 
example of a transformation of data in terms of 4 variables to 2 principal components is shown 
in Figure ‎2-3. 
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Figure ‎2-3. An illustration of 4 variables that point in different directions (have some correlation) in terms of 
principal components 1 and 2. 
Principal components can be calculated via singular matrix decomposition or by eigenvalue 
decomposition of the covariance matrix. The software used in this thesis offers both 
calculation methods but recommends the latter method as for better numerical accuracy in 
the documentation of the “prcomp()” and “princomp()” functions.102 
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2.3.2.2 Supervised learning 
In supervised machine learning, we try to find a model that would classify the supplied labelled 
data correctly in using the predictors (variables) provided in the dataset. The model that is 
established is then used to make future predictions.103 Several supervised machine learning 
algorithms exist. Some of the popular algorithms are artificial neural networks,104 logistic 
regression,105 and support vector machines.106 In this thesis, logistic regression, and to a lesser 
extent, support vector machine are going to be used. An introduction to these methods is 
provided. 
Logistic regression (LR) 
To present the idea of logistic regression, a comparison with linear regression could be 
established. Linear regression is used for finding a relationship between variables. However, in 
the case of data that belong to two classes (binary outcomes), it is not suitable to fit a linear 
regression model. For example if the relationship between an independent, continuous 
variable X and a binary dependent variable Y was to be plotted, the outcome will be data 
points on two straight lines, with a y value of either 0 or 1, as presented in Figure ‎2-4. 
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Figure ‎2-4 Values of Y (on the y-axis) vs the values of the continuous variable X (on the x axis). 
It is clear that the relationship between X and Y isn’t linear. The logistic regression, a binary 
classifier that was developed by D. Cox in 1958 proposes a solution to this problem.107   The 
idea is to transform the dependent, binary variable Y so that it becomes a linear function of 
the predictor X.108 More specifically, it expresses the probability of obtaining the binary 
response of (Y) depending on the values of the predictor variable (X) using a logistic function as 
shown in Equation (‎2-1): 
 
𝑝 =
1
1 + 𝑒−(𝛽0+𝛽1𝑥1+𝛽2𝑥2+⋯+𝛽𝑖𝑥𝑖)
 
(‎2-1) 
where 𝑝 is the probability of an event to happen, 𝛽0is the intercept, 𝛽𝑖is the coefficient of the 
variable 𝑥i. Note that the value of the probability p ranges from 0 to 1 while the value of the 
term in the exponent ranges from -∞ to ∞.109 The relationship between p and x is not linear, 
plotting their relationship results in a sigmoidal curve as illustrated in Figure ‎2-5. On the other 
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hand, this form means that the logarithm of the odds-ratio becomes a linear function of x, as 
presented in Equation (‎2-2). 
 𝑙 𝑛 (
𝑝
1 − 𝑝
) = 𝛽0 + 𝛽1𝑥1 + 𝛽2𝑥2 + ⋯ +𝛽𝑖𝑥𝑖 
(‎2-2) 
 
Figure ‎2-5. Fitted probabilities (Y axis) vs the values of X (X axis). Red and black points correspond to two classes, 
representing a case of binary data. 
The parameters of the function (𝛽, 𝑥) in Equation (‎2-1) are found using a maximum likelihood 
estimation (MLE) function. Specifically, the software used in this thesis utilizes the iteratively 
reweighted least squares (IRLS) algorithm, as given by the software documentation.102 
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Support vector machines (SVM) 
Support Vector Machines is a supervised machine learning technique that has been introduced 
by Vapkin in the 1990s.106 Similar to logistic regression, this algorithm requires labelled data. In 
its simplest form, the support vector machine algorithm assumes that the given data can be 
separated linearly in the space of the provided variables (input space),110 as illustrated in 
Figure ‎2-6. 
 
Figure ‎2-6. An illustration of support vector machine linearly separating binary data. 
The hyperplanes are the dotted lines passing through the nearest points from each group; 
these are known as the support vectors. The middle dotted line is known as the decision 
boundary.  
In support vector machines, the algorithm tries to maximize the margin separating the two 
classes.111 In the case of non-linearly separable data, the same data can be mapped into a 
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higher dimensional space, known as the feature space 𝐹 in which the data is linearly separable. 
Nevertheless, performing this mapping step explicitly could be practically impossible as the 
dimensions of the new feature space can be infinite in number. Alternatively, a kernel function 
can be introduced to the SVM algorithm, where it allows us to find a separating hyperplane in 
feature space 𝐹 without mapping the data into the feature space.112,113 An illustration of non-
linear SVM, projected back to the input space is shown in Figure ‎2-7. 
 
Figure ‎2-7. An illustration of non-linear vector machine with separating binary data. 
Multiple kernels such as the Radial Basis Function (RBF) and the Polynomial Kernel can be used 
with SVM.104 The choice of a kernel is normally based on prior knowledge of the data being 
analysed. Generally, an RBF kernel is used for preliminary testing of SVM.105 But what if the 
data is not perfectly separable by SVM? An illustration of such case is shown in Figure ‎2-8. 
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Figure ‎2-8. An illustration of non-linear support vector machine with soft margins, note that the algorithm 
converged despite the misclassification of one black point. 
In such a case, it is possible to allow a certain number of incorrect classifications by the model, 
also known as soft margins. This helps increasing the simplicity but reduces the accuracy of the 
established hypothesis.106  
In comparison to logistic regression, it is possible for SVM to separate non-linear problems, 
which could be an advantage above logistic regression. On the parameter optimization of 
Support Vector Machines for binary classification] Additionally, unlike the methods optimized 
through maximum likelihood estimation, SVM is optimized by structural risk minimization 
(SRM), which has no prior assumptions regarding the data used (non-parametric).110 This offers 
SVM another advantage above logistic regression. 
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2.3.3 Model selection 
After machine learning methods are used to fit statistical models, the best performing models 
need to be selected. The techniques that are used for selecting these are discussed in this 
section. 
2.3.3.1 Cross-validation (CV) 
This is a statistical method that estimates the error associated with a model trained on a 
dataset to predict a different, independent dataset.117 Technically, a dataset is randomly split 
into 𝑘 number of partitions, where one or more partitions are used for fitting a model and the 
remaining partitions are used for testing the model. A loop of training and testing is repeated 𝑘 
number of times, until all of the data points have been used for training and for testing the 
model. Such a procedure helps avoiding overfitting, where the test set is completely different 
from the training set.108  An illustrative example of how this method works is given in 
Figure ‎2-9. 
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Figure ‎2-9. An illustration of how a 5-fold cross-validation works. 
The fundamentals of Cross validation were introduced by Mosier in 1951.119The importance of 
this method in model selection in machine learning has been recognized since the 1970s.120 
Multiple variations have been applied to this method over time.121 In this thesis, 10 fold cross-
validation is going to be used as a standard method for evaluation of model performance. 
Although more intense cross validation, such as the leave-one-out method can be performed, 
researchers argue that it is more reliable to use a moderate number of folds (10-20), not to 
mention how computationally expensive it is to run a leave-one-out method when the dataset 
–as it is in the case of this work- is thousands of data points.122  
2.3.3.2 Mean squared error (MSE) 
Another method for model selection is MSE. This is simply the mean value of the squared loss 
error of each prediction made by a model. This error estimator takes into account the variance 
and the bias terms in its calculation, leading to a precise model.123 In this thesis, MSE was the 
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principal method for model evaluation, where it was obtained for each cross-validation loop, 
weighted by the sample size of each fold. This is calculated using the formula shown in 
Equation (‎2-3): 
 
𝑀𝑆𝐸 =  
1
𝑛
∑(ŷ𝑖 − 𝑦𝑖)
2
𝑛
𝑖=1
 
(‎2-3) 
where ŷ𝑖  is the estimated value from the model, 𝑦𝑖  is the real value (0 for solvates or 1 for 
non-solvates) and 𝑛 is the number of data points. The average weighted MSE of the 10-fold 
cross-validation can be calculated using Equation (‎2-4): 
 
 
𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑤𝑒𝑖𝑔ℎ𝑡𝑒𝑑 𝑀𝑆𝐸 =  ∑
𝑁𝑘
𝑁
𝑀𝑆𝐸𝑘
𝑛
𝑘=1
 
(‎2-4) 
where 𝑛 is the number of folds (10), 𝑁𝑘  is the sample size in the 𝑘th fold, 𝑁 is the total number 
of molecules, and 𝑀𝑆𝐸𝑘 is the 𝑀𝑆𝐸 value of the 𝑘th fold.  Due to the large sample sizes used 
in the analysis, the weighting has minimal effect on the results. The factor 
𝑁𝑘
𝑁
 will have a value 
very close to 0.1 for each fold, even if the number of molecules is not divisible by 10. For 
simplicity, the average weighted MSE calculated by the software is going to be referred to as 
MSE from this point onward.  
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2.3.3.3 The area under the curve (AUC) 
The area under the Receiver operating characteristic (ROC) curve, (see section ‎2.3.4.1 for more 
about ROC curve) also known as AUC is a popular estimate that can be used to compare the 
quality of models.124, 125 The AUC represents the probability that a randomly selected positive 
instance will be ranked more positive than a randomly selected negative one.125 
2.3.3.4 Akaike information criterion (AIC) 
Another method for selection of a model among others is the Akaike information criterion. 
This criterion measures the relative quality of the fitted models.126 Specifically, it helps the 
decision of how many descriptors to include in a model by introducing a penalty for adding 
variables to the model. This helps avoiding the problem of overfitting in the model. It is 
calculated using Equation (‎2-5): 
 𝐴𝐼𝐶 =  2𝑘 − 2𝑙𝑛 (𝐿) (‎2-5) 
where 𝑘 is the number of variables in the model and  𝐿 is the maximized value of the likelihood 
function of the fitted model.127 
2.3.4 Graphical illustrations 
Some figures in this work are presented in non-conventional plots. An example of these plots 
and what they mean is going to be shown in this section. 
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2.3.4.1 Receiver operating characteristic (ROC) curve 
This curve was introduced by the British Royal Airforce back in World War II as a means of 
signal detection. Currently, it is being used in multiple fields of science.128 In this thesis, we use 
the ROC curve for visualizing the performance of a binary classifier (logistic regression). This 
curve plots the false positive rate (fall-out) on the and x- axis against the true positive rate 
(sensitivity) on y-axis at threshold levels between 0 and 1129 as illustrated in Figure ‎2-10. 
 
Figure ‎2-10. An example of the ROC curve of the chloroform model presented in this thesis. 
Note that the diagonal line shown in the Figure ‎2-10 represents the random guess. Any model 
showing results above this line indicates a better performance. In the same graph it is possible 
to overlay the true positive rate (sensitivity) with the false positive rate (specificity). As seen in 
Figure ‎2-11. 
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Figure ‎2-11. Sensitivity and specificity curves, with the optimal threshold level shown in the dotted line. 
The threshold level that maximises both the sensitivity and specificity is the ideal point at 
which the model gives a non-biased prediction towards the positive or negative outcome.128 
2.3.4.2 Boxplots 
Boxplots, also known as box and whiskers plot was introduced by Tukey.130 This type of 
illustration visualizes variables values in terms of their quartiles. An example of this boxplot is 
shown in Figure ‎2-12. 
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Figure ‎2-12. An example of a boxplot, obtained as a comparison between the solvate and the non-solvate groups 
in this thesis. 
The lower side of the box represents the lower quartile. The middle of the box represents the 
median. The higher side of the box represents the upper quartile. The whiskers that extend 
outside the box represents a maximum of 1.5 of the interquartile range or a minimum of the 
most extreme point, whichever is closer to the median.131 outliers can be easily seen in this 
type of figure as they just sit outside the whiskers range. 
2.4 Non-covalent interactions 
In order to describe the structures that are included in this thesis, an insight into a few types of 
intermolecular interactions needs will be provided in sections ‎2.4.1 to ‎2.4.3.  
2.4.1 Hydrogen bond 
Hydrogen bonding is an attractive interaction between an electron-depleted hydrogen atom 
and an electron rich site, which can be represented by the scheme of X-H···Y, where X,Y are 
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two atoms with greater electronegativity than the hydrogen atom H.132  The X-H part of the 
bond is known as the proton donor while the Y is known as the proton acceptor. The proton 
donor (also known as “donor” alone) can interact with multiple acceptors. Examples of atoms 
with greater electron density than hydrogen include C, O, N, F, P, Cl, Br, I, in addition to regions 
of high electron density such as double and triple bonds.132 
The first recognition of hydrogen bonding was in 1912 by T.S.Moore and T.F.Winmill133 as 
mentioned by L. Pauling’s book in 1960.134 Currently, the literature regarding hydrogen 
bonding is vast.135,136 However in this section we will focus on the aspects of hydrogen bond 
that have significant impact on the work conducted in this thesis. 
In 2011, the IUPAC has released a document listing criteria for a bond to qualify as a hydrogen 
bond.137 These criteria include almost linear (180 °) X–H···Y angle, prolonged X–H distance 
(evident from shifts of absorption bands as well as formation of new bands in IR spectra), 
deshielding of H (involved in the X–H bond) in NMR spectra. Additionally, the Gibbs energy 
related to the formation of the bond should be detectable experimentally. 
The strength of a hydrogen bond can range from a 0.2 to 40 kcal/mol, making it second to ionic 
interactions.136 In this wide energy range, hydrogen bonding can be broken down into 3 types: 
weak (1-5 kcal/mol), intermediate (5-15 kcal/mol) and strong hydrogen bonding (15-40 
kcal/mol). The strength of the hydrogen bond can be estimated from its geometrical 
information (distances between atoms and angles between bonds).138 Several reports have 
correlated the strength of hydrogen bonds to bond length and angle values acquired from 
large amount of spectroscopic or crystallographic data.138,139,140 These studies have allowed 
establishing guidelines of hydrogen bond distances and angles. Indicative distances138 of some 
of the most common medium strong hydrogen bonds are given in Table 2-1. These are the 
main hydrogen bonds that have also been identified in the structures described in this work.  
40 
 
Table ‎2-1. Distances of some common hydrogen bonds 
Bond type H…A bond length Sum of Wan der Waals 
radiia (H···A) 
O–H···O 1.215 to 1.230 Å (linear, strong bonds) to 
2-3 Å (multi-centre bonds) 
2.72 
 
N–H···O 1.58 to 2.59 Å. 2.72 
N–H···N 1.75–2.33 Å 2.75 
O–H···N 1.59–2.19 Å 2.75 
a According to Bondi, taken from Mercury manual 
From the examples demonstrated in Table 2-1, it can be seen that each hydrogen bond 
distance for medium strong bonds is shorter than the sum of van der Waals radii by at least ca. 
0.1 Å. This was therefore selected as a limit for detecting hydrogen bonding during hydrogen 
bond analysis. However, it should be noted that hydrogen bonds are predominantly 
electrostatic interactions,141,142 therefore their angles and distances can vary in a long range. 
IUPAC in their recommendations have pointed out that the distances of strong hydrogen 
bonds would be shorter than the sum of van der Waals radii.137 The angle should preferably be 
above 110 °, however, weak and multi-centre bonds can have smaller angles.  
Alongside the medium strong hydrogen bonds given in Table 2-1, weak bonds such as C–H···O 
can also contribute to the stability of a crystal structure.138,143 The C···O separation for these 
bonds can be up to 4 Å and the energy of C–H···O hydrogen bonds is usually below 2 
kcal/mol.143 
Hydrogen bonds contribute to the stability of crystalline structures and therefore are highly 
significant in solid-state chemistry. For example, hydrogen bonding is considered with regard 
to polymorphism of pharmaceutical ingredients.28 Hydrogen bonds are also important in 
biochemistry as they ensure binding of ligands to the proteins.144 Additionally, hydrogen 
bonding can direct chemical reactions145 and impact physical properties of a solid.  
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2.4.2 Halogen bond 
A halogen bond is an attractive interaction that forms between a halogen atom (e.g. F, Cl, Br, I) 
and an electron-rich site. It can be represented with the scheme R–X···Y, where the X a halogen 
atom, Y is the electron rich site and R is a group that is covalently attached to the halogen X. 
Similar to hydrogen bonding, the electron-deficient site is known as the halogen bond donor 
(the R-X in the scheme) and the electron rich site is known as the halogen bond acceptor (the 
symbol Y in the scheme). This can get confusing because the former is sometimes referred to 
as the electron density acceptor and the latter is referred to as electron density donor. Note 
that a halogen atom X can form more than one halogen bond at the same time.146,147 
Halogen bond has been known since the late 19th century, where it was described by F. Guthrie 
as sticky electrophilic sites.148 Later on, this type of bonding started receiving more 
attention.149 The energy of this bond can range from 1.4 to 10 kcal/mol, as shown in an 
extensive study by S. Kozuch et al.150 Due to this significant bond energy, it plays an important 
role structurally and biologically151,152 The length of this bond is typically shorter than the sum 
of the van der Waals radii of the two interacting atoms.153 In terms of its properties, this bond 
shares some properties with hydrogen bonding. For example, the driving force of the 
interaction is electrostatic. It is also a directional bond, where the interaction occurs at an 
angle of almost 180 ° considering the R–X···Y scheme. In fact, the Y approaches the X along the 
axis of the R-X bond. The interaction is thought to form following the σ-hole model, in which 
static charges plays a significant role.154 Therefore, the more electron-deficient the halogen 
bond donor X is, the stronger the halogen bond would be.146,152 
2.4.3 Interactions of aromatic rings 
In their simplest form, this type of interaction takes place between two unfunctionalized 
benzene rings, adopting one of three common arrangements known as sandwich (parallel), 
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offset-parallel and T-shaped (face-to-edge) interactions.154  An illustration of these interactions 
is shown in Figure ‎2-13. 
 
Figure ‎2-13. Graphic representation of ring interaction types. 
The first observations of the (offset) parallel π-π interactions were made around 1930-1950 by 
Robertson and Lonsdale after analysing crystal structures of aromatic compounds.155  Initially, 
π-π interactions were explained by formation of a charge transfer complex, but later 
experimental findings have shown that this explanation is unlikely.155 The energy associated 
with π-π interactions is low and therefore difficult to determine. Several theoretical studies 
have been conducted to calculate the binding energy in benzene dimers, however, the method 
of calculation and the basis set can significantly affect the result. Sinnokrot et al.154 compared 
the effect of different basis sets and concluded that aug-cc-pVDZ or larger basis set is 
necessary to obtain reliable results. The results obtained in their study are presented in 
Table 2-2. The authors have confirmed the correspondence of the geometry of benzene dimers 
obtained in their calculations to crystallographic observations.  
  
43 
 
Table ‎2-2. The distances and binding energy in the different π-π interactions 
Interaction type Distance between centroids, Å 
Binding energy, 
kcal/mol 
Sandwich 3.7 1.8 
T-shaped 4.9 2.7 
Parallel displaced 3.76a 2.8 
a The reported distance is 3.6 vertically 1.6 horizontally (displacement), the value given is 
obtained by applying Pythagorean theorem. 
The values reported in Table 2-2 shows the binding energies of the benzene dimer. Note that 
these conformations can have higher binding energies when the rings are subistituted.156 Ring 
interactions are known to contribute to the stability of biological systems, for example, the 
structure of DNA is supported by ring interactions.157 These interactions also contribute to 
stability of crystal structures containing aromatic groups, such as pyrene.158 Aromatic 
interactions also participate in binding ligands to proteins and therefore are a significant 
aspect of pharmaceutical compounds. For example, the complexation of the anaesthetic 
bupivacaine to receptors has been shown to rely on ring interactions.159 In this work, we will 
focus on the role ring interactions play in solvate formation. 
2.5 Characterization 
2.5.1 X-ray diffraction techniques 
In order understand solid-state materials it is crucial to obtain information about their 
structure. The most advantageous method in terms of information obtained is single crystal X-
ray diffractometry. This method allows to obtain detailed information on the 3D structure of a 
material as well as to characterize its intermolecular interactions.160, 136 However, it is not 
always possible to use single-crystal X-ray diffractometry as it requires having single crystals of 
the material of appropriately large size.  If use of single-crystal X-ray diffraction is not possible, 
crystal structure solution can be attempted from powder X-ray diffraction data. This method 
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gives less information where two dimensions of data are merged into one dimension. 
However, if sufficient information about the molecules in the crystal is available, it can be used 
for crystal structure determination. Powder X-ray diffraction is commonly used as a routine 
technique for identifying crystalline phases bases on a “fingerprint” of peak positions.  
Both diffraction methods are based on Bragg’s law which states that the distance d between 
Miller planes (planes in crystal structure formed by atoms or molecules) can be calculated 
from the 2θ position at which a reflection has been observed if the wavelength of radiation λ is 
known using Equation (‎2-6):  
 
𝑑 =
𝜆
2𝑠𝑖𝑛𝜃
 
(‎2-6) 
2.5.1.1 Single crystal X-ray diffraction 
In single crystal X-ray diffractometry a single crystal of the compound is analysed. X-ray 
diffraction patterns for this crystal are recorded depending on its angular position with regard 
to the source of radiation and detector. The intensity and position of diffraction peaks in these 
patterns contain information on atom positions and symmetry operations in the crystal lattice. 
The first step in extracting this information is indexing the diffraction pattern. Indexing assigns 
Miller indices to the diffraction peaks. This leads to characterizing the Miller planes orientation 
in the unit cell and allowing to calculate unit cell parameters.161 In further steps, the reflection 
intensities (corresponding to amplitude of the radiation wave) are used to calculate structure 
factor Fhkl, which contains information of the electron density in each point (x,y,z) of the unit 
cell. Fhkl can be calculated using Equation (‎2-7): 
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𝐹ℎ𝑘𝑙 = ∫ 𝜌(𝑥, 𝑦, 𝑧)𝑒
2𝜋𝑖(ℎ𝑥+𝑘𝑦+𝑙𝑧)𝑑𝑉
𝑉
 
(‎2-7) 
where ℎ, 𝑘, 𝑙 are Miller indices, 𝑥, 𝑦, 𝑧 are fractional coordinates and V is volume of the unit 
cell. Fourier synthesis can be applied to calculate electron density,162 as presented in Equation 
(‎2-8):  
 
𝜌(𝑥, 𝑦, 𝑧) =
1
𝑉
∑ ∑ ∑|𝐹ℎ𝑘𝑙|𝑒
𝑖𝜑ℎ𝑘𝑙𝑒−𝑖2𝜋(ℎ𝑘+𝑘𝑦+𝑙𝑧)
𝑙𝑘ℎ
 
(‎2-8) 
This equation also contains a phase angle φhkl of the waves  - this information is lost in the 
experiment causing the “phase problem”.162,163 Generally phase problem is solved by using the 
previous knowledge that crystals consist from discrete units – atoms – arranged in three-
dimensional structures.  
Several approaches have been developed to address the phase problem: direct methods,163 
charge flipping,164 molecular replacement, VLD (Viva la difference)165  etc. The most commonly 
used of these are direct methods, which employs structure invariants to link normalized 
structure factors to phase angles.163 These algorithms are integrated in crystal structure 
determination and analysis packages such as SHELX, SIR, OLEX and other software 
packages.160,166 
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2.5.1.2 Powder X-ray diffraction 
Although crystal structure determination using powder X-ray diffraction data is considerably 
more complicated compared to single crystal X-ray diffraction, recent advances in computation 
techniques together with development of powerful algorithms have facilitated the use of this 
method.167,168 The first step in the crystal structure solution from powder data is generation of 
random trial structures, followed by simulation of their powder diffractograms and 
comparison of these with the experimental diffractogram. Subsequently, global optimum is 
found. The most commonly employed approach to find the global minimum is “Simulated 
Annealing” which is based on Monte Carlo method.169  
Other more common uses of X-ray powder diffraction include qualitative and quantitative 
analysis of solid phase mixtures. The distinctive property of X-ray powder diffraction is that it 
allows obtaining information about the structure of the material to be analysed, but not about 
its chemical composition therefore it is irreplaceable technique in polymorph screening.170,171 
Nowadays, X-ray diffractometry is a fast method used in high-throughput solid form screening 
analysis. The data analysis is often conducted using statistical analysis – clustering and 
multivariate data analysis.172 
X-ray diffraction data can be used not only to identify solid phases present in a sample but also 
to quantitatively determine their amount. For quantitative analysis of X-ray diffraction data 
two approaches can be distinguished – individual reflection analysis and full pattern analysis. 
The first one is based on measuring the intensities of individual reflections with regard to a 
reference.173 The full pattern analysis, on the other hand, is based on finding the best possible 
agreement between experimental and simulated X-ray diffraction patterns. The simulated 
pattern is calculated either from crystal structures (Rietveld method)174 or from reference 
patterns of the components present in the sample.175,176,177  
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2.5.2 Thermal analysis 
Thermal methods such as thermogravimetry (TG), differential thermal analysis (DTA) and 
differential scanning calorimetry (DSC) are used to investigate the thermal behaviour of 
organic solids. Thermogravimetry is especially advantageous in identifying solvates, as this 
technique allows observing weight changes upon heating, which are often related to 
desolvation of solvates or decomposition of the material.170 In order to analyse the by-
products of decomposition, systems combining TG with evolved gas analysis have been 
developed. These systems commonly use mass spectrometry to analyse the products of 
decomposition.178 DTA method is often used together with TG and allows identifying thermal 
events taking place upon heating the sample.179  
Thermogravimetry is extensively used in this work to identify solvate formation. A typical 
thermogravimeter consists from a programmable furnace and a balance.180 Thermogravimetric 
measurement provides information on the temperature of the thermal event and the amount 
of lost weight.181 In addition, it is also often possible to differentiate between stoichiometric 
and nonstoichiometric solvates as the nature of the weight loss step is different for both of 
these. The stoichiometric solvates usually have well-defined weight loss steps in a narrow 
temperature range, while non-stoichiometric solvates lose weight in a wide temperature range 
and the weight loss may also vary for the same species.170, 182 A comparison of TG graphs 
comparing desolvation events of stoichiometric and non-stoichiometric solvates is shown in 
Figure ‎2-14.  
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Figure ‎2-14. A comparison of desolvation events in TG thermograms for stoichiometric and non-stoichiometric 
solvates. 
Although DSC is not going to be used in this work, it is worth highlighting the principles and 
uses of this method, as DSC and TG are considered two complementary methods. DSC detects 
the physical and chemical changes in a sample by measuring heat flow against a reference as a 
function of temperature and time. The output from DSC gives information about endo- and 
exothermic events, such as glass transition, crystallization and melting.183,184 Such properties 
make it especially useful in detection and characterization of a wide range of solid forms, 
including polymorphs, amorphous forms, multi-component solids as well as complete 
formulations. Due to its wide range of applications, it is reportedly one of the most heavily 
used methods in solids state characterization.183 Temperature-modulated DSC (MTDSC), a 
relatively recent improvement to this method,185 enables DSC to separate overlapping 
thermodynamic (irreversible) and kinetic (reversible) events.186 
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  Materials and methods Chapter 3:
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3.1 Materials 
The solvents used in this work were ethanol (C2H6O, Sigma Aldrich, UK, purity: ≥ 99 % (GC)), 
methanol (CH3O, Fisher Scientific, UK, purity: HPLC grade), dichloromethane (CH2Cl2, Sigma 
Aldrich, UK, purity: ≥ 99 % (GC)), chloroform (CHCl3, Fisher Scientific, UK, purity: laboratory 
reagent grade) as well as Milli-Q water that is prepared on site in the School of Pharmacy at 
the University of East Anglia. 
The pharmaceutically active ingredients that were used were Theophylline anhydrous 
(C7H8N4O2, Sigma Aldrich, UK), 4-Methylumbellferone (Hymecromone) (C10H8O3, Sigma Aldrich, 
UK), Isoniazid (isonicotinohydrazide) (C6H7N3O, Fluka, ≥99 %, India), Ethenzamide (2-
ethoxybenzamide) (C9H11NO2, Alfa Aeser, Germany), Carbamazepine (C15H12N2O, Sigma Aldrich, 
UK), Diflunisal (C13H8F2O3, Sigma Aldrich UK), Fenofibrate (C20H21ClO4, generously donated by 
Merck Serono (Germany)), Felodipine (C18H19NO4Cl2, Afine Chemicals Limited, Hangzhou, 
China)). Ketoconazole (C26H28Cl2N4O4, Alfa Aeser, Germany), Griseofulvin (C17H17ClO6, Alfa 
Aeser, Germany). 
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3.2 Methods 
3.2.1 Descriptor calculation 
Descriptor calculation was conducted using the Dragon software. Relevant technical details of 
calculation process are given below. 
3.2.1.1 Main descriptors calculated by Dragon 
The Dragon software that was used in this thesis calculates 29 families of descriptors, known 
as blocks. These blocks are presented in Table ‎3-1. 
Table ‎3-1. The 29 main blocks of descriptors calculated by Dragon. Details explaining the calculation of each 
descriptor can be found in the Dragon software documentation
1
 
Block 
number Block name 
Examples (Name in Dragon) 
1 Constitutional descriptors 
Molecular weight (MW), 
number of non-H atoms 
(nSK), percentage of O 
atoms (O %) 
2 Ring descriptors 
Number of rings (nCIC), 
number of 6-membered 
rings (nR06),  total ring size 
(TRS) 
3 Topological indices 
First Zagreb index (ZM1)2, 
all path Wiener index 
(Wap)3  
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Table 3-1. Continued 
4 Walk and path counts 
Molecular path count of 
order 1 (MPC01, nr. of 
bonds between non-H 
atoms); self-returning walk 
count of order 4 (SRW04, 
nr. of possible 4-bond walks 
that return to the same 
atom) 
5 Connectivity indices 
Randic connectivity index 
(X1)4, solvation connectivity 
index of order 0 (X0sol) 5 
6 Information indices 
The information index on 
molecular size (ISIZ)6, Kier 
symmetry index (S0K)4 
7 2D matrix-based descriptors 
Average vertex sum from 
reciprocal squared distance 
matrix (AVS_H2), third 
order spectral moment of 
the topological distance 
matrix (SM3_D) 
8 2D autocorrelations 
Moran autocorrelation of 
lag 1 weighted by mass 
(MATS1m) 7 
9 Burden matrix eigenvalues8 
Largest eigenvalue of 
Burden matrix weighted by 
mass (SpMax1_Bhm)  
10 P_VSA-like descriptors9 
P_VSA-like descriptor on 
LogP, 1st bin  
(P_VSA_LogP_1)  
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Table 3-1. Continued 
11 ETA indices10 
Eta core count (Eta_alpha), 
eta p shape index 
(Eta_sh_p) 
12 Edge adjacency indices 
Leading eigenvalue from 
the edge adjacency matrix 
of the H-depleted molecular 
graph (SpMax_EA) 
13 Geometrical descriptors 
radius of gyration (Rgyr), 
gravitational index G1 (G1)11 
14 3D matrix-based descriptors 
Wiener-like index from 
distance/distance matrix 
(Wi_G/D) 12 13 
15 3D autocorrelations 
3D Topological distance 
based autocorrelation with 
lag 1, unweighted 
(TDB01u)14 
16 RDF descriptors 
Value of the Radial 
Distribution Function 
weighted by atomic mass at 
1.5 Å (RDF015m)15 
17 3D-MoRSE descriptors16  
Unweighted scattered 
intensity at a scattering 
ratio of 1 (Mor01u)  
18 WHIM descriptors17 
Unweighted variance of 
atomic coordinates along 
the 1st principal axis of the 
molecule (L1u) 
19 GETAWAY descriptors18, 19 
Atomic leverage weighted 
autocorrelation of lag 0 
(H0u) 
20 Randic molecular profiles20 
Molecular profile 1 (sum of 
all interatomic distances, 
divided by the number of 
atoms, DP01) 
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Table 3-1. Continued 
21 Functional group counts 
Number of aliphatic 
carboxyl groups (nRCOOH) 
22 Atom-centred fragments21 
Number of CH2R2 
fragments in the molecule 
(C-002) 
23 Atom-type E-state indices22 
Sum of the 
electrotopoligical states of 
all methyl carbon atoms in 
the molecule (SsCH3) 
24 CATS 2D23, 24 
Number of donor-donor 
atom pairs at a separation 
of 3 bond (CATS2D_03_DD) 
25 2D Atom Pairs25 
Sum of topological 
distances between N..N 
atom pairs (T(N..N)) 
26 3D Atom Pairs 
Sum of geometrical 
distances between N..N 
atom pairs (G(N..N)) 
27 Charge descriptors 
The maximum positive 
atomic charge (qpmax) 
28 Molecular properties 
The hydrophilic factor 
(Hy)26, total surface area of 
acceptor atoms (SAacc) 
29 Drug-like indices 
Complementary Lipinski 
Alert index (cRo5, 0 or 1 
indicating whether the 
molecule violates at least 
two criteria from Lipinski’s 
rule of five)27, 28 
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3.2.1.2 The reciprocal squared topological distance matrix (H2) 
This matrix is mentioned when the ethanol solvate formation model is presented. The process 
of calculating topological distance matrix (H2) will be described using a commonly used drug; 
aspirin (2-(acetoxy)benzoic acid). Calculations for other compounds are conducted similarly.  
 
Figure ‎3-1. Molecular graph of the aspirin molecule. 
The topological distance matrix is calculated from the molecular graph. The topological 
distance between atoms i and j (dij) is defined as the number of bonds in the shortest path 
connecting them in the molecular graph. The diagonal elements of the topological distance 
matrix are zero, while the off-diagonals give the topological distance between non-hydrogen 
atoms. An example for aspirin is shown in Table ‎3-2 (refer to Figure ‎3-1 for atom numbering). 
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Table ‎3-2. Topological distance matrix of aspirin 
- 1 2 3 4 5 6 7 8 9 10 11 12 13 
1 0 1 2 3 2 1 1 2 2 2 3 4 4 
2 1 0 1 2 3 2 2 3 3 1 2 3 3 
3 2 1 0 1 2 3 3 4 4 2 3 4 4 
4 3 2 1 0 1 2 4 5 5 3 4 5 5 
5 2 3 2 1 0 1 3 4 4 4 5 6 6 
6 1 2 3 2 1 0 2 3 3 3 4 5 5 
7 1 2 3 4 3 2 0 1 1 3 4 5 5 
8 2 3 4 5 4 3 1 0 2 4 5 6 6 
9 2 3 4 5 4 3 1 2 0 4 5 6 6 
10 2 1 2 3 4 3 3 4 4 0 1 2 2 
11 3 2 3 4 5 4 4 5 5 1 0 1 1 
12 4 3 4 5 6 5 5 6 6 2 1 0 2 
13 4 3 4 5 6 5 5 6 6 2 1 2 0 
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Squaring each element in the matrix gives the squared topological distance matrix, shown in 
Table ‎3-3.  
Table ‎3-3. Squared topological distance matrix of aspirin 
- 1 4 9 16 25 36 49 64 81 100 121 144 169 
1 0 1 4 9 4 1 1 4 4 4 9 16 16 
4 1 0 1 4 9 4 4 9 9 1 4 9 9 
9 4 1 0 1 4 9 9 16 16 4 9 16 16 
16 9 4 1 0 1 4 16 25 25 9 16 25 25 
25 4 9 4 1 0 1 9 16 16 16 25 36 36 
36 1 4 9 4 1 0 4 9 9 9 16 25 25 
49 1 4 9 16 9 4 0 1 1 9 16 25 25 
64 4 9 16 25 16 9 1 0 4 16 25 36 36 
81 4 9 16 25 16 9 1 4 0 16 25 36 36 
100 4 1 4 9 16 9 9 16 16 0 1 4 4 
121 9 4 9 16 25 16 16 25 25 1 0 1 1 
144 16 9 16 25 36 25 25 36 36 4 1 0 4 
169 16 9 16 25 36 25 25 36 36 4 1 4 0 
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By taking the reciprocal of each element in the squared matrix, the reciprocal squared 
topological distance matrix (H2) is obtained as shown in Table ‎3-4. 
Table ‎3-4. Reciprocal squared topological distance matrix (H2) of aspirin 
0.00 1.00 0.25 0.11 0.06 0.04 0.03 0.02 0.02 0.01 0.01 0.01 0.01 0.01 
1.00 0.00 1.00 0.25 0.11 0.25 1.00 1.00 0.25 0.25 0.25 0.11 0.06 0.06 
0.25 1.00 0.00 1.00 0.25 0.11 0.25 0.25 0.11 0.11 1.00 0.25 0.11 0.11 
0.11 0.25 1.00 0.00 1.00 0.25 0.11 0.11 0.06 0.06 0.25 0.11 0.06 0.06 
0.06 0.11 0.25 1.00 0.00 1.00 0.25 0.06 0.04 0.04 0.11 0.06 0.04 0.04 
0.04 0.25 0.11 0.25 1.00 0.00 1.00 0.11 0.06 0.06 0.06 0.04 0.03 0.03 
0.03 1.00 0.25 0.11 0.25 1.00 0.00 0.25 0.11 0.11 0.11 0.06 0.04 0.04 
0.02 1.00 0.25 0.11 0.06 0.11 0.25 0.00 1.00 1.00 0.11 0.06 0.04 0.04 
0.02 0.25 0.11 0.06 0.04 0.06 0.11 1.00 0.00 0.25 0.06 0.04 0.03 0.03 
0.01 0.25 0.11 0.06 0.04 0.06 0.11 1.00 0.25 0.00 0.06 0.04 0.03 0.03 
0.01 0.25 1.00 0.25 0.11 0.06 0.11 0.11 0.06 0.06 0.00 1.00 0.25 0.25 
0.01 0.11 0.25 0.11 0.06 0.04 0.06 0.06 0.04 0.04 1.00 0.00 1.00 1.00 
0.01 0.06 0.11 0.06 0.04 0.03 0.04 0.04 0.03 0.03 0.25 1.00 0.00 0.25 
0.01 0.06 0.11 0.06 0.04 0.03 0.04 0.04 0.03 0.03 0.25 1.00 0.25 0.00 
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3.2.1.3 Main descriptors used in thesis 
The values of these descriptors for two common drugs are illustrated in Table ‎3-5. The 
descriptors that require previous knowledge of the 3D structure of a molecule were not 
included. 
Table ‎3-5. Values of the descriptors mentioned in the thesis calculated for carbamazepine and acetaminophen 
molecules 
Descriptor Brief explanation 
of the descriptor 
  
AVS_H2 
The log 
transformation of 
the average of the 
sum of the entries 
in each row of the 
reciprocal squared 
topological 
distance matrix. 3.783 3.016 
TRS 
The number of 
atoms in each 
independent ring 
in the molecule. 19 6 
SM3_H2 
The log 
transformation of 
the third order 
spectral moment 
of the reciprocal 
squared distance 
matrix. 4.168 3.358 
𝜋ID 
The logarithmic 
transform of the 
conventional bond 
order ID number. 9.776 6.033 
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Table 3-5. Continued 
nHDon 
The number of 
hydrogen bond 
donors. 2 2 
Hy 
The hydrophilic 
factor 0.32 0.66 
H-050 
The number of 
hydrogen atoms 
attached to a 
heteroatom 2 2 
nH 
The number of 
hydrogen atoms. 12 9 
nCIC 
The number of 
rings in the 
molecule. 3 1 
MPC01 
The log 
transformation of 
the count of paths 
of length 1 in the 
H-depleted 
molecular graph. 3.045 2.485 
3.2.2 Slurry preparation 
Chapter 7 of this thesis incorporated screening of materials for solvate and hydrate formation. 
All slurries were prepared using one general procedure, that is, the addition of an amount of 
the solid material into a 1-1.5 ml of the solvent until slurry is formed.  Five slurries were 
prepared per candidate, each of them being with a different solvent (ethanol, methanol, 
water, chloroform, dichloromethane), resulting in a total of 50 slurries. After these slurries 
were prepared, they were left to shake at 25 °C and 250 rpm for 20 days.The details of each 
sample preparation are shown in Table 3-6. 
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Table ‎3-6. A summary of the preparation of each slurry used in the screening experiments 
Drug candidate Solvent 
Volume of 
solvent added 
(ml) 
Amount of 
drug added 
(mg) 
Drying time 
(minutes) 
Theophylline Ethanol 1.5 50 20 
Theophylline Methanol 1.5 50 20 
Theophylline Dichloromethane 1 50 10 
Theophylline Chloroform 1 50 10 
Theophylline Water 1.5 50 60 
Hymecromone Ethanol 1.5 50 20 
Hymecromone Methanol 1.5 50 20 
Hymecromone Dichloromethane 1 50 10 
Hymecromone Chloroform 1 50 10 
Hymecromone Water 1.5 50 60 
Griseofulvin Ethanol 1.5 50 20 
Griseofulvin Methanol 1.5 50 20 
Griseofulvin Dichloromethane 1 250 10 
Griseofulvin Chloroform 1 100 10 
Griseofulvin Water 1.5 50 60 
Isoniazid Ethanol 1.5 100 20 
Isoniazid Methanol 1.5 100 20 
Isoniazid Dichloromethane 1 100 10 
Isoniazid Chloroform 1 100 10 
Isoniazid Water 1.5 200 60 
Ethenzamide Ethanol 1.5 100 20 
Ethenzamide Methanol 1.5 150 20 
Ethenzamide Dichloromethane 1 200 10 
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Table 3-6. Continued 
Ethenzamide Chloroform 1 200 10 
Ethenzamide Water 1.5 50 60 
Carbamazepine Ethanol 1.5 100 20 
Carbamazepine Methanol 1.5 150 20 
Carbamazepine Dichloromethane 1 250 10 
Carbamazepine Chloroform 1 250 10 
Carbamazepine Water 1.5 50 60 
Diflunisal Ethanol 1.5 300 20 
Diflunisal Methanol 1.5 250 20 
Diflunisal Dichloromethane 1 50 10 
Diflunisal Chloroform 1 50 10 
Diflunisal Water 1.5 100 60 
Fenofibrate Ethanol 1.5 100 20 
Fenofibrate Methanol 1.5 100 20 
Fenofibrate Dichloromethane 1 750 10 
Fenofibrate Chloroform 1 750 10 
Fenofibrate Water 1.5 50 60 
Felodipine Ethanol 1.5 150 20 
Felodipine Methanol 1.5 180 20 
Felodipine Dichloromethane 0.5 650 10 
Felodipine Chloroform 0.5 600 10 
Felodipine Water 1.5 50 60 
Ketoconazole Ethanol 1.5 80 20 
Ketoconazole Methanol 1.5 150 20 
Ketoconazole Dichloromethane 1 500 10 
Ketoconazole Chloroform 1 500 10 
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Table 3-6. Continued 
Ketoconazole Water 1.5 50 60 
3.2.3 Thermogravimetric analysis 
In this work, the thermogravimetric analysis was conducted to detect the solvate formation. 
TGA Q5000 (TA instruments, Newcastle, USA) was used for this purpose. The samples were 
prepared from slurry then dried at room temperature. After drying they were heated from 
40 °C up to 250 °C at a rate of 10 °C min-1. The nitrogen gas purge rate was set to 100 ml min-1. 
3.2.4 Single crystal X-ray diffraction. 
The single crystal X-ray diffraction experiments in this thesis were performed using an Oxford 
Diffraction Xcalibur-3/Sapphire3-CCD diffractometer (Oxford diffraction Ltd., Oxford, UK) 
equipped with a graphite monochromator. The diffractometer uses a Mo-Kα radiation of 
wavelength 0.71073 Å.  Intensity data was measured by thin-slice ω- and φ-scans. All 
experiments were conducted at 140(1) K. The programs CrysAlisPro-CCD and -RED were used 
to process the diffraction data.29,30 The structures were solved in SHELXT31 via the dual-space 
approach. SHELXL and the user interface ShelXle were used to refine the structures.32,33 All 
non-hydrogen atoms were located from electron density maps. The thermal displacement 
parameters of these atoms were refined anisotropically. Hydrogen atoms were added in 
geometrically idealized positions and their coordinates were refined in riding mode, while 
allowing rigid rotations of the methyl groups. All hydrogen atoms were refined with isotropic 
displacement parameters. 
Crystal structure analysis and geometric measurements were carried out using the programs 
PLATON and OLEX2.34, 35 The graphical illustrations were created using Mercury.36 
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3.2.5 PXRD 
Powder X-ray Diffraction experiments were conducted using a Thermo-ARL X’tra 
diffractometer (Ecublens, Switzerland). Cu Kα1 radiation source was used with 45 kV voltage 
and a current of 40 mA. All experiments were conducted at room temperature and humidity. 
PXRD patterns of hymecromone, diflunisal and fenofibrate were obtained in this work. All 
samples were prepared by gentle crushing of the crystals using a metal spatula or a mortar and 
pestle and transferring the crushed material into the sample holder. The diffraction data was 
recorded in 2θ-rage from 3 ° to 50 °. The measurement was carried out at a rate of one second 
per step and the step size of 0.01 °. Note that the solvate samples were measured immediately 
after crushing, to avoid possible solvent loss. 
3.2.6 Microscopy 
The hot-stage microscopy experiments in reflective mode were carried out using 
LinkamMDSG600 automated hot stage and Linkam imaging station that was attached to a 
microscope with LED light source and ×10 magnification lens.  
The polarised light microscopy experiments were conducted using Leica DM LS2 polarised light 
microscope (Wetzlar GmbH, Germany) connected to a video capture system and equipped 
with the Mettler Toledo FP 82 HT hot stage and FP 90 temperature controller.  
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  Data acquisition and descriptor calculation  Chapter 4:
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4.1 Overview of the research steps 
The introduction in Chapter 1 has given a background on how the work in this thesis is 
designed to predict the hydrate and solvate formation in organic compounds. An overview of 
the technical steps that need to be taken to achieve the desired predictions is summarized in 
Figure ‎4-1. 
 
Figure ‎4-1. Main steps of analysis of solvate formation. 
4.2 Data collection 
In this section, technical details on how the data was collected, the challenges faced and how 
each issue was treated will be discussed. 
4.2.1 Solvent selection rationale 
The steps presented in Figure ‎4-1 seems to be in a logical order, but the question remains what 
solvents should be studied for their solvate formation ability? Over 300 recrystallization 
solvents are recorded in the CSD, as shown by a study conducted in 2000.1 Studying this large 
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number would not be feasible due to the time limit. Additionally, it would not be possible to 
draw reliable conclusions for solvents having small number of hits in the database. For these 
reasons, few solvents had to be selected. Solvents with the largest number of hits in the 
database would be a rational choice, as this is a knowledge based approach, where the larger 
amount of information could lead to more robust results. 
The same study that reported the 300+ solvents has also shown the top 50 solvents ranked by 
number of solvates they formed with organic compounds in the CSD.1 Note that the word 
solvate here means solvate that is formed by a single solvent, for example a dichloromethane 
solvate. The information in this article was published based on the CSD version of October 
1998. To check if these numbers are still valid at this time, the top 10 solvents addressed in the 
article were checked using the CSD November 2013 version. The comparison can be seen in 
Figure ‎4-2. 
 
Figure ‎4-2. The number of solvates recorded in CSD for the 10 most commonly used organic recrystallization 
solvents. 
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The top 5 solvate-forming organic solvents (with organic materials) in 1998 remained as the 
top forming ones in 2013, these solvents are methanol, dichloromethane, benzene, ethanol 
and chloroform. With exception to benzene, all of these solvents are reported to be commonly 
used solvents in pharmaceutical industry.2 Additionally, ethanol and methanol belong to the 
same family of hydroxyl group-containing solvents, similarly, dichloromethane and chloroform 
are also closely related chlorinated solvents. Comparing the hydroxylated to the chlorinated 
solvents could have several benefits on the study. For example, solvents of the same group are 
expected to have similar behaviour. Benzene did not show the same potential as it stands in a 
different group. For these reasons, ethanol, methanol, dichloromethane and chloroform were 
selected. Water, being the most commonly used solvent and the largest solvate former, where 
hydrates represent around 33 % of entries in the CSD was also included in this study.3 Although 
dichloromethane and chloroform have well recognized high toxicity4,5, a large increase (around 
4-folds) in the number of dichloromethane and chloroform solvates among organic crystals 
was observed, relative to the year 1998. This shows the increasing usage of these solvents in 
crystallization; therefore the importance of studying them. 
4.2.2 Entries selection rationale 
Identification of the factors that contribute to solvate formation in the five chosen solvents is 
possible through comparing the molecules which were able to form a solvate to those that 
were not able to form a solvate, both being crystallized from the same solvent. In order to do 
this comparison, two groups of molecules per solvent need to be extracted from the database, 
these are: a solvate forming and a non-solvate forming group. In order to keep the study in a 
defined shape, it was necessary to apply restrictions on the selected molecules. For example, 
formally charged molecules are expected to form an ionic bond, which is significantly stronger 
than any other non-covalent interaction.6 This shows that the inclusion of such entries would 
cause an increase in the number of outliers in the data. The ConQuest software was used to 
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make a custom search in the database. The solvate-forming entries for each solvent were 
selected based on the following criteria: 
 Each entry should have 2 chemical entities that are not covalently bonded. 
 One of these 2 entities is the solvent of interest. 
 Only organic structures were considered, no organometallic structures were searched.  
 Structures that are ionic (salts) or polymeric were also excluded from the search. 
 
To extract the non-solvate entries that were recrystallized from a certain solvent, the search 
criteria were set to: 
 Each entry should have 1 molecule only.  
 The recrystallization solvent should only be the solvent of interest.  
 Only organic structures were considered, no organometallic structures were searched.  
 Structures that are ionic (salts) or polymeric were excluded from the search. 
Note that in both groups, only organic structures were selected. This is due to the fact that the 
reason for solvent inclusion (esp. water) changes with the presence of metal ions. This is 
reported to occur due to the entry of water atoms into the coordination sphere of metal 
atoms.7 
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A total of 54,653 CSD entries were exported using the search criteria explained. The extracted 
data consisted of 15,082 solvate-forming (S) and 39,571 non-solvate-forming (NS) structures. 
The breakdown of these entries between the 5 solvents is shown in Table ‎4-1. 
Table ‎4-1. The breakdown of the number of solvate and non-solvate entries by solvent 
Solvent NS S Total 
Ethanol 17,958 855 18,813 
Methanol 7,862 1,942 9,804 
Dichloromethane 7,149 1,767 8,916 
Chloroform 4,382 1,676 6,058 
Water 2,220 8,842 11,062 
Total 39,571 15,082 54,653 
4.2.3 Refinement of the non-solvate/solvate forming groups 
Random samples of the non-solvate and solvate groups were visually examined in each solvent 
to ensure they meet the desired criteria mentioned above. Five types of unexpected entries 
were encountered.  
(1) When the non-solvate forming groups were searched for, ConQuest text search was used. 
It was intended that entries recrystallized from the solvent of interest only would be selected 
from the database. When the entries were investigated, it was seen that many of them had a 
combination of recrystallization solvents. Additionally, entries having the solvent as part of 
their name were also within the results of text search. An example of that is 2-(Boranyl(t-
butyl)methylphosphoranyl)-1,1-diphenylethanol (CSD refcode: BETMAQ)8 which was listed as a 
result for the search, although it doesn’t have ethanol as the recrystallization solvent. 
Moreover, an overlap in the names of the solvents was observed. For example, the string 
“ethanol” was used to search the recrystallization solvent of each entry in the database. 
Results for molecules that were recrystallized from methanol also turned up. This explains the 
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large number of entries under the ethanol non-solvate group compared to the other organic 
solvents’ groups. It is notable that some of these issues could have been avoided if the 
recrystallization solvent search was used instead of the text search in the first place. However, 
these issues were fixed by processing the non-solvate lists through a Linux command line script 
that strictly looks for the recrystallization solvent of interest in each dataset. 
(2) Upon examining the solvate-forming groups, it was noticed that some of the entries had no 
recrystallization solvent recorded. These entries were part of the results of the search because 
the search criteria for solvate-forming entries did not include a criterion to look in the 
recrystallization solvent tab in the database. The percentage of entries with unknown 
recrystallization solvent versus the complete solvate dataset is shown in Figure ‎4-3. 
 
Figure ‎4-3. Percentages of entries with unknown recrystallization solvent among the solvate-forming entries in 
each solvent dataset. 
The large percentage of empty recrystallization solvent entries raises the question whether to 
include these entries in the analysis or to exclude them. Since the solvent exists as a part of the 
structure in the solvate-forming group, this means that the solvent was used in the 
preparation of the sample. Solvate entries with unknown recrystallization solvents were 
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considered as part of the dataset. For the non-solvate-forming group, the recrystallization 
solvent cannot be known without having it mentioned in the database. For this reason, we 
excluded any non-solvate molecule with an unknown recrystallization solvent. This issue of an 
unknown recrystallization solvent did not happen in the non-solvate groups as the string of the 
solvent (for example “dichloromethane”) was searched for. 
(3) Some solvate entries had a solvent in the crystal structure that was not included as a 
recrystallization solvent in the database. An example is the CSD reference code: ZEQPUI entry.9 
This entry is an ethanol solvate in which the recrystallization solvent was recorded as a mixture 
of petroleum ether and ethyl acetate. Few entries (less than 10) of this type were present in 
each dataset. Since the solvent cannot just show up in the crystal, it must have been used 
although it might not be recorded. For this reason, these entries were accepted in the solvate 
dataset. They were rejected in the non-solvate datasets. 
(4) Another issue that affected the accuracy of the solvate-forming lists was the inconsistency 
in the solvents nomenclature in the CSD, which made the collection of a complete dataset 
harder. For example, ethanol was recorded in the database under different names, including 
alcohol, ethyl alcohol, abs. alcohol, 96 % alcohol. The proportion of structures crystallized from 
ethanol that were saved using these names was below 0.5 %. In water datasets on the other 
hand, more than 13 % of the total non-hydrates had their recrystallization solvent recorded as 
“aqueous” instead of “water”, which can cause a significant change in the information 
obtained. These different solvent names were searched and the results were considered part 
of the dataset. 
(5) It is important to mention that by applying the mentioned criteria in ConQuest, hydrate and 
solvate structures of different stoichiometric ratios (disolvates/ dihydrates/ hemisolvates etc.) 
were all considered to be a hydrate or a solvate form. An example of that is the carbamazepine 
dihydrate (CSD reference code: FEFNOT02)10 which contains two water moieties, yet was still 
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present in the datasets of hydrate although the criterion of the number of chemical units was 
set to two. This is because the search option used in ConQuest treats every molecule in the 
asymmetric unit as one chemical entity regardless of the number of times that this unit is 
present in the unit cell. On the other hand, entries that contained molecules with more than 
one type of solvent in the crystal structure were excluded from this search because they are 
considered to have three chemical units. An example is 2-ethoxy-1,3-bis(3-
(trifluoromethyl)phenyl)-1,3-dihydro-1H-imidazo(4,5-b)quinoxaline methanol ethanol solvate, 
(CSD reference code: CAWREY).11 This entry contains ethanol and methanol moieties as can be 
seen in Figure ‎4-4. 
 
Figure ‎4-4. The CSD entry CAWREY showing more than one solvent in the crystal structure. 
Entries with more than one type of solvent in the structure were excluded in order to reduce 
the number of variables in the investigation and to keep it as simple as possible. The count of 
the solvate and non-solvate forming entries after corrections are shown in Table 4-2. 
.  
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Table ‎4-2. The count of solvate and non-solvate entries after refinement 
 
NS S Total 
Ethanol 6,745 855 7,600 
Methanol 4,065 1,942 6,007 
Dichloromethane 1,520 1,767 3,287 
Chloroform 1,449 1,676 3,125 
Water 443 7,086 7,529 
Total 14,222 13,326 27,548 
4.2.4 Further partitioning of the solvate group 
Including the solvate entries with unknown recrystallization solvent to the solvate-forming 
entries gave the question whether the entries recrystallized from a known source would show 
a different behaviour from the ones with no recrystallization solvent mentioned. It would also 
be advantageous to know if entries recrystallized from one solvent would show a different 
behaviour from the entries recrystallized from a combination of solvents. Note that the latter 
comparison is valid only if the two groups had a solvent in common. For these purposes, the 
data of each solvent was further partitioned as illustrated in Figure ‎4-5. 
 
Figure ‎4-5. An illustration of the four individual groups of each solvent. 
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At this point, the solvate data consisted of three groups, the main group that includes all 
solvate entries, a sub-group that consists of entries recrystallized from a mixture of solvents 
and a sub-group that consists of entries recrystallized from the solvent of interest only. The 
non-solvate group was not partitioned; simply because the group did not have entries with 
blank recrystallization solvent tab in the database. The detailed number of entries in each of 
the solvate group and sub-groups are given in Figure ‎4-6. 
 
Figure ‎4-6. The number of entries that were recrystallized from the solvent of interest and the number of entries 
recrystallized from a mixture as obtained from the database. Note: numbers were rounded to the nearest integer 
this is why they do not all sum precisely to 100 %. 
Based on the partitioning seen in Figure ‎4-5, a total of 20 groups (4 groups per solvent) were 
exported from the database as (gcd) lists. These are text files that include the CSD reference 
codes of the entries. They can be read in ConQuest to recall the hits from the database. After 
that, the entries were finally exported in the (mol2) file format, which contains the structural 
information and is suitable for descriptor calculation. 
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4.2.5 Preparing the data for descriptor calculation 
The purpose of calculating molecular descriptors is to be able to represent the molecular 
features, such as the size of a molecule in a numerical value and later, compare those using 
statistical methods. The Dragon software was used for the molecular descriptor calculation. As 
the name “molecular descriptor” implies, Dragon strictly works with molecules. That means 
any entries that have more than one molecule in the asymmetric unit would give an error and 
no descriptors for this entry would be calculated. Based on that, all solvate entries are going to 
show an error. Non-solvate entries with more than one molecule in the asymmetric unit are 
also going to fail the descriptor calculation. Moreover, any entries with disorders would also 
cause an error. In order to resolve this issue, every extracted structure had to go under a 
“splitting step”. This means the mol2 files were processed to obtain one molecule in 
asymmetric unit before the descriptor calculation can take place. An example of each case 
above is shown in Figure ‎4-7. 
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  (a)
                    (b) 
Figure ‎4-7. The splitting step of the AFEYOA
12
 (a) and the COHLOC
13
 (b) entries. 
The splitting step was performed using in-house software, developed by my PhD advisor, 
Dr. László Fábián (written in Perl language). This small program splits a mol2 file into a number 
of mol2 files equal to the number of molecules in the asymmetric unit. Each of the newly 
generated mol2 files has one molecule in it with the first file generated always having the 
molecule with the largest molecular weight.  
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4.3 Descriptor calculation 
After all non-solvate and solvate molecules were extracted, refined and split, the 20 lists of 
entries were fed into Dragon, where 4,885 molecular descriptors were calculated per 
molecule. 20 tables, corresponding to the 20 lists of molecules were obtained. Each row in 
these tables represents a molecule (identified by its CSD reference code), while each column 
represents a molecular descriptor. A sample of the Dragon software output can be seen in 
Table ‎4-3. 
Table ‎4-3. A sample from the Dragon software’s output. Specifically, the sample was taken from the 
dichloromethane non-solvate entries dataset.  NA values represent an error in the calculation 
Refcode MW AMW nH nAT nSK nHAcc qpmax 
MUKBUQ 354.650 15.420 6 23 17 2 NA 
FUGYAH 344.440 7.488 20 46 26 4 NA 
BILCUU11 NA NA NA NA NA NA NA 
LOVBON 212.280 9.230 8 23 15 1 NA 
DUWBUT01 306.490 6.255 26 49 23 2 NA 
DUWBUT02 306.490 6.2550 26 49 23 2 NA 
QUPKIV 260.320 16.270 0 16 16 2 NA 
WIZMAU 287.200 11.046 6 26 20 6 1 
In this table, MW is a the molecular weight, AMW is the average molecular weight, nAT is the 
number of atoms in the molecule, nH is the number of hydrogen atoms in the molecule, nSK is 
the number of the non-hydrogen atoms in the molecule, nHAcc is the number of hydrogen 
bond acceptors carbon atoms and qpmax is the maximum positive charge in each molecule. 
As it can be seen in the Table ‎4-3 few errors occurred during the calculation of the molecular 
descriptors. Three types of molecules causing errors were identified. The cause of these errors 
and how they were treated is discussed in section ‎4.3.1. 
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4.3.1 Entries with calculation problems 
(1) For some molecules, the calculation of all 4,885 descriptors failed although no errors, 
disorders or other problems could be seen in the structure/entry. An example is the entry S-(4-
Chlorophenyl) (4-chlorophenyl)thiosulfonate, CSD reference code: BILCUU11.14 Molecules 
giving this type of error were not traced back and fixed as this would be a time-consuming 
procedure. Alternatively, these faulty molecules were omitted from the datasets. 
(2) Another example of molecules that caused trouble during descriptor calculation are 
molecules with no hydrogen atoms. These were mostly old entries with no H coordinates 
determined. This causes mistakes in the calculation of some descriptors. The simplest example 
on a descriptor that can be miscalculated due to this missing information is the nH descriptor, 
which counts of the number of H atoms. Other descriptors such as nAT, the number of atoms 
in a molecule, were affected by this error. An example of a molecule showing this error is 
shown in Table ‎4-3, entry CSD reference code: QUPKIV,15 which is illustrated in Figure ‎4-8. 
(b) 
Figure ‎4-8. QUPKIV molecule and how it is recorded in the CSD (left) and the auto-edited structure by Mercury 
(right). 
Molecules with no hydrogen atoms were also removed from all datasets using a script in R.  
(3) Entries having polymorphs were prevalent in the extracted datasets. Since the original 
claim was to predict hydrate and solvate formation using the molecular graph (only 2-D 
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descriptors), polymorphs in the datasets cause a redundancy of the information. This can have 
large influence on the outcome of the data analysis. A script in R was developed to keep one of 
the polymorphs. The selection of a polymorph was based on keeping one entry with a unique 
molecular weight and the same first six letters of the CSD reference code. 
The removal of faulty molecules, molecules with no hydrogens and polymorphs has reduced 
the number of molecules in the dataset. The new number of molecules in each dataset is 
shown in Table 4-4.  
Table ‎4-4.  The count of solvate and non-solvate entries left after removing the errors 
Solvent Number of structures Solvates Non-solvates 
Ethanol 4,895 689 4,206 
Methanol 4,366 1,518 2,848 
Dichloromethane 2,761 1464 1,297 
Chloroform 2,556 1,363 1,193 
Water 4,432 4,128 304 
Total 19,010 9,162 9,848 
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4.3.2 Descriptors with calculation problems 
The mol2 files that were extracted from the CSD do not contain information about partial 
charges of molecules. For this reason, any charge-related descriptors showed NA values across 
the dataset. An exception was zwitterionic molecules, which had an overall charge of zero but 
contained formal charges in the molecule. An example of these descriptors is qpmax, which is 
shown in Table ‎4-3. The WIZMAU16 molecule (for which the descriptors were calculated in 
Table ‎4-3) is shown in Figure ‎4-9. 
 
Figure ‎4-9. A zwitterionic molecule from the dichloromethane non-solvate dataset. The WIZMAU molecule. 
 These descriptors showed an NA value for more than 99 % of the data in each dataset. They 
were removed from the dataset because they were not meaningful at this point. The 
molecules that were zwitterionic were kept as part of the dataset. 
4.4 Summary of data  
Before starting the statistical analysis, it is a good idea to investigate the structure of the data 
that is going to be analysed. Every solvent had a different number of entries in its dataset. An 
illustration of the relative number of these entries is shown in Figure ‎4-10. 
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Figure ‎4-10. Percentage of solvate and non-solvate forming molecules in each solvent's dataset. Total number of 
entries is 19,010. 
The number of entries in the ethanol set was the largest (26 %) followed by water (23 %), 
methanol (23 %), dichloromethane (15 %) and chloroform (13 %). In terms of solvate- and non-
solvate groups, the hydrate and ethanol non-solvate were the largest among them. Ironically, 
the groups that corresponds to these two (the non-hydrate and ethanol solvate, respectively) 
were the smallest. Methanol has shown a more balanced dataset with a non-solvate group 
that is twice the size of the solvate group. Dichloromethane and chloroform have shown 
datasets that are almost perfectly balanced (nearly half-split of solvate and non-solvate). 
After the structure of the data was seen, it was important to consider the range of data 
covered in these datasets. For example, what is the chemical space that is covered by these 
datasets? How hydrophilic are these compounds? Each solvent’s dataset was plotted in terms 
of chemical space, Log P value, number of hydrogen bond acceptors and number of hydrogen 
bond donors, as illustrated in Figures 4-11 to 4-14. The column colours in these figures are just 
for a more clear illustration. 
4 % 
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8 % 
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8 % 
7 % 
7 % 
6 % 
22 % 
1 % 
Ethanol solvate
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Methanol solvate
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Figure ‎4-11. The chemical space covered by each solvent dataset (units in Da (g/mol)). Y axis shows the frequency 
of occurrences. 
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Figure ‎4-12. Log P values for each solvent dataset. Y axis shows the frequency of occurrences. 
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Figure ‎4-13. The number of hydrogen bond donors in each solvent's dataset. Y axis shows the frequency of 
occurrences. 
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Figure ‎4-14. The number of hydrogen bond acceptors in each solvent's dataset. Y axis shows the frequency of 
occurrences. 
As can be seen in Figure ‎4-11 the molecular weight of the entries in different datasets was 
similar, where most of the data was concentrated in the region of 100-600 Da (g/mol). The 
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chlorinated solvents have shown a larger number of high molecular weight entries compared 
to the other solvents. Water on the other hand has shown a slight shift towards lower 
molecular weight. 
With exception of water, the Log P values of most entries ranged between -1 and 6 
(Figure ‎4-12), showing a more hydrophobic nature of data for these 4 solvents. The chlorinated 
solvents have shown a tail towards higher values. The Log P values in most water entries 
ranged between -5 and 6, showing a more balanced hydrophilicity in its dataset. 
As illustrated by Figure ‎4-13, most of the entries in the dataset possessed no hydrogen bond 
donors. In ethanol and methanol, the non-solvate entries largely outnumber the solvate ones, 
therefore a majority of entries with no hydrogen bond donors is a logical outcome. Chlorinated 
solvents are unable to form hydrogen bonds, so a majority of entries with no hydrogen bond 
donors can also be understood. On the hand, over 90 % of the water dataset were solvate 
entries, yet it had a majority of entries with no hydrogen bond donors. This is a rather 
interesting observation, as hydrogen bonding is reportedly one of the most important features 
that make hydrates more common than other solvate forms. For the number of hydrogen 
bond acceptors, solvents with hydrogen bond ability (ethanol, methanol and water) have 
shown a normal-like distribution (Figure ‎4-14) with the largest frequency being entries with 3 
acceptors. Chlorinated solvents on the other hand, have shown fuzzy distribution, which does 
not show a clear pattern. 
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 Statistical analysis Chapter 5:
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5.1 Overview 
The think process of this chapter is outlined in Figure ‎5-1. 
 
Figure ‎5-1. The thinking process throughout Chapter 5 
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5.2 Dimensionality reduction  
The datasets obtained in Chapter 4 were now ready to start the analysis. Each dataset was 
described by about 5000 variables. The question here would be: are all these descriptors 
useful for predicting solvate formation? In order to answer this question, a significance test 
between each pair of solvate and non-solvate dataset was conducted. Such test would be able 
to tell which descriptors showed difference between the two groups, indicating the descriptors 
that are useful for solvate prediction. Ideally, it would also quantify that difference, indicating 
which variables show the largest discriminating ability between the two groups of interest. The 
Wilcoxon rank-sum test (also known as Mann–Whitney U test) was chosen to carry out this 
comparison. 
5.2.1 The Wilcoxon rank sum test 
This test works by testing a null hypothesis that the two samples being tested come from the 
same population. In this study, the null hypothesis would be that the solvate and the non-
solvate groups come from the same population. In this comparison, the p-value was set to 
0.05. This value is the conventional value that has been used for significance testing by Fisher 1. 
It corresponds to an α (alpha) level of 5 %, which means there is a 5 % risk of omitting a good 
descriptor. On the other hand, this also means that there is 95 % chance that the rejected 
descriptor is not useful. Since the values of descriptors can take any value, a two-tailed test 
was necessary. Because this is a two-tailed test, any descriptor with a p value above 0.025 was 
rejected.  
The non-parametric nature of this test means it doesn’t have any underlying assumptions 
about the distribution of the parent data. This was important as the datasets of the five 
solvents are not guaranteed to have a normal distribution. Moreover, the dataset is described 
by the molecular descriptors, where each of them represents the data differently. This renders 
the data not feasible for optimal transformation of each descriptor. Another property that was 
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important in choosing the Wilcoxon rank-sum test was its ability to rank the data, therefore, it 
is not largely affected by outliers. For these reasons, the Wilcoxon test was suitable for the 
data in question. A deeper insight of the characteristics of this test are given in the literature 
review (Section 2.3.1). 
At this point, it is useful to remember the structure of the data. It consists of 5 datasets 
corresponding to the 5 solvents being tested. Each of these 5 datasets is partitioned into 4 
groups. Each group consists of a number of molecules that are described by 4885 descriptors. 
The general structure of the data was illustrated in section ‎4.2.4. 
As mentioned earlier, the Wilcoxon rank-sum test compares two samples of a population, in 
terms of one variable. In this sense, two aspects had to be adjusted for each solvent’s dataset 
in order to run the significance. These are the number of samples (i.e. groups) and the number 
of variables (i.e. descriptors). In order to adjust the number of samples, the test was applied to 
the two major groups only, that is; the group consisting of all non-solvate forming molecules 
(NS) and the solvate-forming molecules (S). The other groups, i.e. the solvate from a mixture of 
solvents (S-M) and the solvate entries from the solvent of interest alone (S-O), where just 
included in the visualization of the results. In order to compare one descriptor at a time, the 
test took place on a descriptor-by-descriptor basis. This means every descriptor from the non-
solvate-forming molecules (NS) dataset was compared with the same descriptor from the 
corresponding solvate-forming molecules (S) dataset at a time. An automated loop was 
scripted in R to perform the analysis over the 4885 descriptors. The p-value for each 
comparison in the loop was recorded, and the descriptors that show a p-value larger than 
0.025 were omitted from the dataset. Figure ‎5-2 shows an illustration of the comparison 
between the four groups in the ethanol dataset. 
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Figure ‎5-2. Boxplot of the nAT descriptor value in the ethanol dataset (Y axis). The circles represent the outliers in 
the dataset. 
The boxplot shows a clear difference between the solvate-forming group and the non-solvate 
forming group in this descriptor, but the variation among the solvate sub-groups was minimal. 
This trend of the S-O and S-M groups to have similar descriptor values to the larger S group 
was observed for all descriptors. Despite the known effect of having a mixture of solvents on 
the recrystallization process (by changing solvent activity), this phenomenon cannot be 
observed using the descriptors and datasets included. 
Descriptors that did not show a significant difference between the two groups were omitted 
from the datasets as these descriptors do not give information about what features might be 
important for solvate formation. This omission leaves us a smaller dataset to investigate for 
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each solvent. An example of a descriptor that did not show a significant difference between 
the two groups is shown in Figure ‎5-3.  
 
Figure ‎5-3. Insignificant difference between the groups in the O % descriptor. Such descriptors were omitted from 
the dataset. 
Over 2850 out of 4885 descriptors turned out to have a significant difference between the 
solvate and the non-solvate group in each solvent’s dataset. An illustration of the amount of 
remaining and omitted descriptors is shown in Figure ‎5-4. 
 
120 
 
 
Figure ‎5-4. An illustration of the number of the variables that were omitted due to insignificance between the 
solvate-forming and the non-solvate forming groups. Total number of descriptors in each circle is 4885. 
Although the test reduced the datasets to the descriptors with significant difference between 
the NS and the S groups, the reduction was not enough. 2850 descriptors in each dataset do 
not give a clear idea about the features that influence hydrate/solvate formation. 
5.2.2 Principal component analysis 
The main concern at this point was the large number of descriptors in each dataset. A method 
that can select the most meaningful descriptors in each dataset was required. This means a 
further reduction in the number of descriptors. It is important to remember that all these 
descriptors have shown significant difference between the groups and omitting them means 
the loss of part of the information they might contain. An unsupervised machine learning 
technique, principal component analysis (PCA) was the method chosen to solve the issue.  
PCA reduces the dimensionality of a problem by creating new variables from existing 
descriptors. The PCA method has the advantage of combining the available variables 
(descriptors) rather than selecting the best ones in the dataset (See section ‎2.3.2.1). This 
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reduces the number of variables being studied without losing the information the descriptors 
might contain. 
The principal component analysis procedure was applied to each solvent dataset individually. 
The principal component algorithm has given rise to a large number of principal components, 
equal to the number of datapoints in each dataset. For example, over 1300 PCs were given in 
the ethanol dataset. 
The large number of PCs obtained were ordered by the amount of variance explained by each 
of them. The first principal component accounts for the highest variability in a dataset and the 
succeeding components account for lower variability. An illustration of the variance explained 
by the first 100 principal components in the ethanol dataset is shown in Figure ‎5-5. 
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Figure ‎5-5. The percentage of Variance explained by the top 100 principal components in the ethanol dataset. 
Each bar represents a principal component, ordered. 
The variability explained by principal components dramatically drops after the first few ones. 
For example, in the ethanol dataset, the top three principal components accounted for 54 %, 
while the top 5 accounted for 61 % and top ten principal components accounted for 68 % of 
the total variance. In order to see how well the PCA algorithm works in the different solvents 
datasets, the variance explained by the top three, five and ten principal components in each 
dataset was observed. 
 
Although the percentage of variance explained by them isn’t extremely high, the first 3 
principal components seem a good choice to have an initial look at the data, as they explain a 
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variability equal to the rest of the variables in the dataset. Additionally, visualizing data in 
space with more than 3 variables would not be an easy task. For these reasons, only the first 
three principal components were selected. A scatterplot of the data points in terms of the 
principal components would show the spread of these points across the imaginary axes with 
the highest variability. It might as well show a trend of the solvate-forming and the non-
solvate-forming molecules along the principal components. The spread of data points of the 
ethanol dataset in terms of PCA is shown in Figure ‎5-6. 
 
Figure ‎5-6. The ethanol data points in terms of the first three principal components. The solvate-forming 
molecules are shown in blue and the non-solvate forming molecules are shown in red. 
A 3D plot from a 2D perspective isn’t the best way to precisely see the effect of the principal 
components, but it can certainly show the combined effect of the three dimensions (principal 
components). For more clear representation of the spread of the data points in terms of the 
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first three principal components, pairs plot was used.  An example of pairs plot of PC1, PC2 and 
PC3 of the same ethanol dataset is shown in Figure ‎5-7. 
 
Figure ‎5-7. Pairs plot of ethanol data points in terms of PC1, PC2 and PC3. The solvate-forming molecules are 
shown in blue and the non-solvate forming molecules are shown in red. 
The principal component analysis showed a good spread of the data points across the axes. 
Additionally, they showed a fairly good separation of the solvate-forming and non-solvate 
forming molecules along the top three PCs.  
As it has been previously pointed out, the principal components are essentially combinations 
of the existing descriptors. Since these components showed some splitting of the data, the 
knowledge of which descriptors mainly account for these principal components might give an 
indication of the most important descriptors involved in solvate formation. In order to know 
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which descriptors affect the first three principal components, the loadings (rotations) of these 
principal components should be calculated. The loadings of a principal component show the 
contribution of each descriptor to this principal component 2. This means that if a certain 
descriptor had a high rotation value of PC1 (e.g. 0.7), then it is an important determinant in the 
classification of the data points into solvate and non-solvate forming molecules. 
A list of the rotation values of all descriptors was obtained in each solvent. An illustration of 
the distribution of the rotation values of PC1, PC2 and PC3 in the ethanol dataset is given in 
Figure ‎5-8. 
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(a)
(b) 
 
 
Figure 5-8. Histograms of the rotation values of the first (a), second (b) and third (c) principal components in the 
ethanol’s dataset. Total number of variables is 2647. The colours of the bars have no indication, they are used for 
a better illustration. 
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(c) 
Figure ‎5-8. Histograms of the rotation values of the first (a), second (b) and third (c) principal components in the 
ethanol’s dataset. Total number of variables is 2647. The colours of the bars have no indication, they are used for 
a better illustration. 
Although the shape of the histogram shown in Figure ‎5-8 (a) looks promising (as there seem to 
be some high values at the positive end of the x-axis), the actual values on the x-axis are very 
small. Small rotation values were obtained for the first three principal components in all 
solvents datasets. The details of the maximum rotations of the first 3 PCs in each solvent are 
shown in Table ‎5-1. 
Table ‎5-1. The maximum rotation value in the first three components in each solvent dataset 
Solvent Max rotation in PC1 Max rotation in PC2 Max rotation in PC3 
Ethanol 0.028 0.047 0.068 
Methanol 0.027 0.052 0.067 
Dichloromethane 0.027 0.044 0.068 
Chloroform 0.028 0.046 0.066 
Water 0.027 0.039 0.076 
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This means that these principal components do not mainly depend on one or even on a few 
descriptors, which makes it hard to conclude which molecular features would affect the 
solvate formation with any solvent. 
5.3 Supervised machine learning 
Since PCA did not help in concluding what molecular features affect solvate formation, the 
direction of thinking has changed from dimensionality reduction to using a learning method in 
an attempt to find a pattern in the data. One special feature about this type of data is that it 
already has a known outcome, that is, each molecule is labelled as a solvate or a non-solvate. 
When this is the case, the supervised machine learning techniques can be used. (see 
section ‎2.3.2.2) Several machine learning algorithms are available. The question is which of 
these methods would be the most suitable in this case? 
5.3.1 Selection of the machine learning algorithm 
Tens of machine learning algorithms are available, and trying each for solving the solvation 
problem wouldn’t be feasible. In order to select the most suitable machine learning algorithm, 
it is important to know the underlying concepts of the algorithms. Machine learning algorithms 
can be broadly classified into linear and non-linear classifiers. For example logistic regression 
(LR) is a linear classifier, while neural networks and support vector machines can perform as 
nonlinear classifiers. The ultimate way to know whether the problem of solvate formation is 
linear or non-linear (in terms of the molecular descriptors available) would be a preliminary 
testing of a linear and a non-linear classifier. Logistic regression was used as a representative 
of the former family while SVM (with an RBF kernel) was chosen as a representative of the 
latter family.  The selection rationale of these methods was their simplicity and the previous 
evidence of their usefulness in classification problems. The RBF kernel is a reasonable choice 
for preliminary testing of SVM. It offers several advantages over other kernels, most notably 
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the small number of parameters that require adjustment compared to other kernels.3 The 
KNIME software was used to perform preliminary testing and comparison of these methods.4 
This program provides a user-friendly interface and offers different machine learning 
algorithms, among which SVM and logistic regression are available. Note that the measure 
used for choosing the better method was the accuracy, which means the number of correctly 
predicted instances over the total number of instances. This is the method that is mostly used 
in supervised learning algorithm selection. 5 
Before the testing started, three “concerns” had to be adjusted, these are the number of 
descriptors, the number of molecules and the parameters of the machine learning methods, as 
explained by sections ‎5.3.2 to 5.2.4. 
5.3.2 Choosing descriptors to decide the linearity of the problem 
At this point, around 3,000 descriptors have shown to be useful to discriminate between the 
solvate and non-solvate groups in each dataset. It was not possible to use all these descriptors 
at once to fit a predictive model, helping to show the performance of LR and SVM. The large 
number of variables and the multicollinearity among the descriptors have caused errors and 
prevented the algorithm from converging. Alternatively, three variables were selected based 
on the p-value in the Wilcoxon rank sum test. The first variable to be selected was the one 
with the lowest p-value. The second variable shouldn’t be selected directly to have the second 
lowest p-value. This is due to the possible high correlation between the first and the second 
two variables with the lowest p-values. Therefore, any variable showing a correlation above 
0.5 to the first variable was removed from the dataset, and the variable with the lowest p-
value among the remaining ones was selected. The third variable was selected in a similar 
manner to the second where any variable correlated more than 0.5 to the second variable was 
omitted from the dataset and the variable with the lowest p-value among the remaining ones 
was selected. 
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5.3.3 Equal size sampling 
Datasets such as the ethanol and water datasets showed a high imbalance between the 
number of solvate and nonsolvate entries. If a logistic regression or a support vector machine 
model was to be fitted with any of the variables in these two datasets, the outcome of the 
prediction would be 100 % of the larger group. For example, a water model was fitted to the 
descriptor with the lowest p-value, which is the number of carbon atoms in the molecule (nC). 
The prediction results of this model are show in Table ‎5-2. 
Table ‎5-2. The confusion matrix and overall prediction accuracy of the water logistic regression model, fitted to 
the nC descriptor 
 
Predicted as 
non-hydrate 
Predicted 
as hydrate 
Non-hydrate 0 273 
Hydrate 0 3714 
Overall correct prediction 93 % 
The overall accuracy looks very promising, where 93 % of the data was correctly classified. On 
the other hand, the confusion matrix shows that none of the hydrate entries was predicted 
correctly. This leads to a completely useless model. A more reasonable representation would 
be using samples of equal sizes from both the solvate and the non-solvate datasets. This 
causes the total number of molecules (rows) in each dataset to drop. The total count of 
molecules was kept as large as possible by reducing the number of data-points in the group 
with the larger number just enough to meet the number of the data-points in the smaller 
group. 
The random selection of the instances for equal size sampling could lead to the inaccuracy of 
conclusions, since not all molecules were used for fitting the models or even for testing them. 
This can be referred to as sampling error. To minimize this error, 3 equal size, random samples 
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were withdrawn from the complete dataset.6 Each of these equal size samples was treated as 
a separate dataset, where logistic regression and support vector machine models were fitted 
and the error rates were recorded. The steps of analysis are illustrated in Figure ‎5-9.  
 
Figure ‎5-9. An example of a KNIME workflow illustrating the steps of analysis that were taken to compare SVM to 
LR. The CSV Reader node reads the data. The Column Filter node selects what variables will be included in the 
model fitting. The Equal Size Sampling node takes a sample of the data in which the two classes (solvate and 
nonsolvate) are equal in number. The Partitioning data node splits the data into a training set (10 % of the data) 
and a test set (90 % of the data). The Learner and Predictor nodes fits the model and performs the prediction, 
respectively. The Scorer node gives the % accuracy (percentage of correct predictions). 
For each solvent’s dataset, 3 types of models were fitted, these are models with the first 
variable (lowest p-value), a model with the first two variables and a model with the first three 
variables. With each of these, 3 equal size samples were used for training and testing the 
models. In other words, if we consider Figure ‎5-9 to show one workflow, 3 workflows were 
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conducted per solvent. For the logistic regression models, this was straightforward, as no 
parameters require adjustment. The performance of the logistic regression models with these 
three types of model was recorded. 
5.3.4 Parameter adjustment of the RBF kernel 
The last adjustment required before the analysis can take place is the parameters of the RBF 
kernel. The main two parameters to adjust are the sigma and the C parameter 7. The sigma 
parameter specifies the limit of the influence of one training point on the model (as given by 
the formula of the radial basis function), while the C parameter is a penalty term that specifies 
the softness of the margins of the SVM model.7 (See section ‎2.3.2.2). These parameters have 
no pre-determined value, where the optimal value is different for each training data. 
Moreover, their optimal value would change with the sample provided for the training dataset. 
For these reasons, these parameters are classically adjusted via grid search, although other 
faster methods are being suggested.8 Therefore; after the data was split into a training and a 
test set, a grid search was performed using an “optimization loop” in KNIME.  
As has been shown in section ‎5.3.3, each solvent had 9 equal size samples taken from the 
parent data. Each of these equal size samples was partitioned into a training and a test set 
under a specific static seed (randomization seed). The sigma and C parameters were adjusted 
for each of these partitions, simply because the optimized parameters would not be ideal for 
other equal size samples or a differently partitioned sample. For this reason, the same dataset, 
equal size sampling and partitioning was used to fit the SVM and logistic regression model in 
each trial, as illustrated in Figure ‎5-10. 
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Figure ‎5-10. KNIME workflow for optimizing SVM parameters, testing an SVM model and testing a logistic 
regression model. This was done for 3 samples per variable which gives 9 trials for each of the solvents, resulting 
45 similar workflows. 
The workflow illustrated in Figure ‎5-10 represents the test that was done for 1 sample, where 
the results from the optimization loop (the first line in the work flow, which adjusted the sigma 
and the C parameter value) were used to fit the SVM model and compare it to the LR model. 
There are 5 solvents being tested, each of them had 3 types of models being tested, the 1 
Variable, 2 Variable and 3 Variable models. In order to avoid the sampling error, each of these 
was tested 3 times, summing the total number of samples to 45.  
5.3.5 SVM vs LR 
The results of the 45 workflow are presented in bar plots in Figure ‎5-11 to Figure ‎5-15. Note that 
45 workflow means 45 SVM and 45 LR model, resulting in 90 bars in total to compare. 
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Figure ‎5-11. The percentage of correct predictions from the ethanol dataset made by the logistic regression and 
the support vector machine models that were fitted to the same samples. The test set is more than 1200 
molecules. 
 
Figure ‎5-12. The percentage of correct predictions from the methanol dataset made by the logistic regression and 
the support vector machine models that were fitted to the same samples. The test set is more than 2700 
molecules. 
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Figure ‎5-13. The percentage of correct predictions from the dichloromethane dataset made by the logistic 
regression and the support vector machine models that were fitted to the same samples. Test set is more than 
2300 molecules. 
 
Figure ‎5-14. The percentage of correct predictions from the chloroform dataset made by the logistic regression 
and the support vector machine models that were fitted to the same samples. Test set is more than 2100 
molecules. 
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Figure ‎5-15. The percentage of correct predictions from the water dataset made by the logistic regression and the 
support vector machine models that were fitted to the same samples. Test set is more than 500 molecules. 
Overall, LR has performed better than SVM in all solvents, where it showed higher prediction 
accuracy in most samples. SVM has topped LR in some cases, most notably the water 2 
Variable model, Sample 3. Nevertheless, this is a small difference.  
The fact that that LR mostly topped SVM as the number of dimension increased, signals that 
this problem is better classified using a linear classifier, or at the very least, it can be 
confidently said that there’s no reason to use a more complex, non-linear method. 
5.4 Principal components as logistic regression variables 
Logistic regression turned out to be a good method of classification for the datasets under test, 
as non-linear SVM method showed no advantage over it. The question remains on what 
descriptors to include in this method to make predictions. Instead of looking for the descriptor 
that would give a good prediction, one idea was to start with what is already available. The 
PCA in section 5.1.2 has shown the ability to split the data into a solvate and a non-solvate 
forming groups (Figure ‎5-6). Although the main descriptors contributing to the formation of 
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these principal components were not found, the first three principal components were able to 
aggregate the data in what looked like two large clusters. This means these uncorrelated 
components could be used to make predictions if they were used as variables in a logistic 
regression function. The logistic regression function was applied in R, with the first three 
principal components being the variables used by the algorithm. The error rate associated with 
every model was estimated via cross-validation, where the cross-validation estimate of 
prediction error was used to decide the performance of the resulting models. 9, 10 
5.4.1 Models with one principal component 
The PCA applied to the datasets here used equally sized samples for all solvent’s datasets. For 
example in the ethanol dataset the total number of molecules approaches 5000, but only 1364 
were used to perform the PCA to ensure that the principal components obtained explain the 
variability in the dataset of both the solvate and the non-solvate group. To estimate the 
sampling error, 10 equally sized samples were tested. Additionally, each model was cross-
validated 10 times. 
It is important to mention that all of these sampling procedures took place based on fixed seed 
values. This means the algorithm for randomly choosing these molecules is saved in the R 
script. This helps getting reproducible results when the script is run again. 
 The estimate through which the performance of the logistic regression model was measured 
was the Average Mean Squared Error of the 10-fold cross validation (MSE). Other estimates, 
such as the Akaike Information Criterion (AIC) and the Area Under the receiver operator curve 
ROC (AUC) were calculated. The analysis was started with the simplest possible form of the 
models; that is a logistic regression model that takes only the first principal component into 
account, denoted as model 1. The results of the models with the lowest MSE (best 
performance) and the models with the highest MSE (worst performance) among the 10 equal 
size samples for each solvent are shown in Table ‎5-3.  
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Table ‎5-3. Details of the logistic regression models taking into account the first principle component (model 1) in 
different solvents. The models with the lowest MSE (best performance) and the models with the highest MSE 
(worst performance) among the 10 equal size samples for each solvent are shown 
Solvent Performance Number of datapoints  Mean squared error 
Ethanol Best 4893 0.187 
Ethanol Worst 4893 0.198 
Methanol Best 4364 0.213 
Methanol Worst 4364 0.217 
Dichloromethane Best 2759 0.156 
Dichloromethane Worst 2759 0.159 
Chloroform Best 2554 0.157 
Chloroform Worst 2554 0.160 
Water Best 4427 0.161 
Water Worst 4427 0.177 
The models utilizing the first principal component only have shown a good separation ability of 
the data into the solvate and the non-solvate groups. This can also be noticed as the highest 
MSE value across all solvents was below 0.22. The inter-sample variation of the models is also 
little, where the largest difference in MSE between the 10 equal-size-samples was in ethanol, 
with a difference of 0.03. It is also notable that the AUC and the AIC always agree with the MSE 
value, indicating these terms can be used interchangeably for the estimation of the goodness 
of the fit. The AUC value can actually be visualized through a ROC curve. An example of the 
ROC curve of the ethanol model is shown in Figure ‎5-16.  
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Figure ‎5-16. Receiver operative curve (ROC) of the ethanol model 1. The area under the curve is approx. 0.72. The 
dotted line, with the 45 ° angle represents the random guess (50 % correct prediction). 
5.4.2 Models with two and three principal components 
In order to see the improvement in the performance of the model upon the addition of next 
principal components, logistic regression models taking into account the first two and the first 
three variables (model3) were fitted. The results are given in Table 5-4 and Table 5-5, 
respectively. 
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Table ‎5-4. Details of the logistic regression models taking into account the first two principal components (Model 
2) in different solvents. The models with the lowest MSE (best performance) and the models with the highest 
MSE (worst performance) among the 10 equal size samples for each solvent are shown 
Solvent Performance 
Number of data 
points  Mean squared error 
Ethanol Best 4893 0.184 
Ethanol Worst 4893 0.194 
Methanol Best 4364 0.213 
Methanol Worst 4364 0.217 
Dichloromethane Best 2759 0.151 
Dichloromethane Worst 2759 0.154 
Chloroform Best 2554 0.153 
Chloroform Worst 2554 0.156 
Water Best 4427 0.161 
Water Worst 4427 0.178 
 
Table ‎5-5. Details of the logistic regression models taking into account the first three principal components 
(Model 3) in different solvents. The models with the lowest MSE (best performance) and the models with the 
highest MSE (worst performance) among the 10 equal size samples for each solvent are shown 
Solvent Performance Number of datapoints  Mean squared error 
Ethanol Best 4893 0.181 
Ethanol Worst 4893 0.192 
Methanol Best 4364 0.211 
Methanol Worst 4364 0.217 
Dichloromethane Best 2759 0.150 
Dichloromethane Worst 2759 0.153 
Chloroform Best 2554 0.153 
Chloroform Worst 2554 0.157 
Water Best 4427 0.161 
Water Worst 4427 0.177 
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Although the second and the third principal components accounted for part of the variability in 
the dataset (see section 5.1.2), they did not show much improvement to the predictive 
models. The addition of each principal component to the models has even shown an increase 
to the MSE value in some cases. For example looking at the water models, it can be seen that 
the MSE for the best model 1 has a lower MSE value than the best model 2 and model 3 all 
equal to 0.161. This shows that they do not add any advantage to the models based on 
model 1. This inability to show an improvement can be better illustrated through an overlay of 
the ROC curves, as shown in Figure ‎5-17. 
 
Figure ‎5-17. ROC curves of the water models taking into account 1, 2 and 3 principal components. The curves 
almost overlap, showing the insignificance of the addition of the second and the third principal components. 
Bearing in mind that the MSE values shown in Table ‎5-3 to Table ‎5-5 are for best and worst 
models, which have the biggest difference among all 10 samples, the models prove to have a 
robust behaviour regardless of the subset that was taken from the original dataset.  
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5.5 Systematic variable selection using logistic regression 
The first three PCs, each consisting of a combination of a few thousand descriptors, were able 
to give good classification ability with an MSE value between 0.150-0.217 in all solvents. 
Although this is a very good predictive ability, the principal components still do not give an 
idea on which of the descriptors actually contribute to the solvate formation. This is due to the 
low rotation values that were shown in Figure ‎5-8. 
In order to see if there is a single, or a few descriptors that can classify the solvate and the 
non-solvate groups correctly, another approach was used. In this approach, only the 
descriptors that showed a significant difference between the solvate and the non-solvate 
groups in the Wilcoxon rank sum test were investigated. These descriptors were used in 
conjunction with the best machine learning algorithm found for this problem; that is the 
logistic regression. 
5.5.1 Single-variable models 
It is well known by now that about 3000 descriptors had significant effect on solvate 
formation. In order to select which among these give the logistic regression model that split 
the data best, a trial and error approach was used. Similar to the analysis conducted in 
section ‎5.4, the dataset of each solvent was split into 10 random equal size samples. For each 
of these samples, a number of models equal to the number of variables in each dataset were 
fitted. Each of these models was tested via a 10-fold cross validation and the MSE of the cross-
validation was calculated. The variable that showed the lowest MSE was chosen as the best 
variable to describe the dataset. The performance of the models containing the best variable 
in each solvent is shown in Table ‎5-6. 
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Table ‎5-6. Single-variable models: details and performance. The models noted as “best” are the ones with the 
lowest MSE out of the 10 random samples. Similarly, the ones marked as “worst” have the highest MSE. This 
applies to Table ‎5-6, Table ‎5-9 and Table 5-10. 
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It is notable that all descriptors in these single-variable models were derived from the spectral 
moments of topological matrices. These are complex descriptors that represent the size and 
branching of molecules. Spectral moments are discussed in detail later (see section ‎5.6.2) 
5.5.2 Two variable models 
The single-variable models showed a surprisingly good ability to predict solvate formation. This 
lead to the anticipation that using a model that takes two variables into account rather than 
one would improve the predictive ability even further. The question was on how to select the 
best model that takes two variables into account? The ultimate answer to this question would 
be a trial-and-error approach. This means all possible two-variable models would be fitted, 
tested and compared. Logically, the descriptors that showed a significant difference between 
the solvate and the non-solvate groups in section ‎5.2.1 were used for this analysis. Fitting a 
model to every possible combination of length two for these ~3000 descriptors means that for 
each solvent, over 4 million models were fitted. In order to obtain unbiased models, ten equal 
size samples were used again here. This means that a total of more than 200 million models 
were fitted. A 10-fold cross validation was applied to each of these models, where the average 
MSE of these 10-folds was calculated. The combination of variables with the lowest MSE in 
each of the 10 subsets were recorded, as seen in Table 5-7. 
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Table ‎5-7. The 10 descriptor combinations with the lowest MSE in the dichloromethane data set – sample 1 
Combination MSE 
SM3_H2 + Hy 0.14569 
SM3_H2 + H.050 0.14588 
EE_H2 + Hy 0.14596 
SM3_H2 + nHDon 0.14597 
SM4_H2 + Hy 0.14607 
EE_H2 + H.050 0.14614 
SM3_H2 + BLTD48 0.14619 
SM3_H2 + MLOGP 0.14619 
SM3_H2 + BLTA96 0.14619 
SM3_H2 + BLTF96 0.14619 
Doing this type of testing is CPU intensive. For this reason, these analyses were executed using 
the High Performance Computing Cluster at the University of East Anglia, where the analyses 
were parallelized between 160 dedicated cores with 64 GB of RAM. The script to perform the 
analyses was programmed in R, with the parallelization conducted using the “dopar” package 
11. The time required for the analyses was between 3 and 5 days per dataset, depending on the 
number of data points. The models with the lowest errors among the 4 million were selected. 
Due to the fact that 10 subsets were withdrawn from the complete dataset in each solvent, 
the best model obtained from each sample was different. For example, the best model might 
not necessarily utilize the same descriptors in each subset, as shown in Table 5-8. 
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Table ‎5-8. The descriptor combinations with the lowest MSE in each of the 10 subsets in the dichloromethane 
data 
Sample No. Combination MSE 
1 SM3_H2 + Hy 0.14569 
2 SM3_H2 + Hy 0.14593 
3 SM3_H2 + Hy 0.14585 
4 SM3_H2 + Hy 0.14578 
5 SM3_H2 + MLOGP 0.14565 
6 SM3_H2 + Hy 0.14699 
7 SM3_H2 + Hy 0.14694 
8 SM3_H2 + Hy 0.14705 
9 SM3_H2 + MLOGP 0.14699 
10 SM3_H2 + MLOGP 0.14692 
Although the 10 subsets of the Dichloromethane dataset resulted in different best models, 
only one combination should be chosen for the final models. Therefore the best combination 
was selected based on a voting system, where the pair of descriptors that gave the lowest MSE 
in most of the 10 samples were chosen. The resulting models are shown in Table 5-9. 
  
147 
 
Table ‎5-9. Two-variable models: details and performance  
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Compared to the single-variable models, the addition of the second variable has improved the 
predictive ability of the models in some but not all solvents. The MSE values were reduced into 
the range of 0.145 to 0.184. The variable that was added to the single-variable models of 
ethanol and methanol was related to hydrogen bond donation. These variables have 
contributed to the MSE reduction of the models. In dichloromethane and chloroform, the new 
variable was related to hydrophilicity and heteroatoms connected to hydrogens, all of which 
are correlated to hydrogen bonding (correlation between these variables is above 0.95 in all 
datasets). In water on the other hand the variable was related to the 3D structure of the 
compound.  The second variable in dichloromethane, chloroform and water, did not result in a 
large model improvement, an illustration of the MSE value of the single- and the two-variable 
descriptors is shown in Figure ‎5-18. 
 
Figure ‎5-18. Reduction of the MSE by the addition of the second descriptor in each solvent. 
5.5.3 Three-variable models 
The two variable models have shown a large improvement over the single-variable models of 
ethanol and methanol in addition to a slight improvement in the predictive ability of the 
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dichloromethane, chloroform and water models. In order to improve the models even further, 
another descriptor was planned to be added. 
The same exhaustive approach that was used to add the second descriptor (where all possible 
models of length two were tested), cannot be applied to the three-variable models. The 
number of possible models increases exponentially with the number of descriptors included. 
For example in the single variable models, around 3000 models were possible per solvent.  
Upon the addition of the second descriptor, the number of possible models increased to 
approximately 4.5 million per solvent. This required parallelization and the use of a cluster to 
perform this calculation. Using the same approach with three variables would increase the 
number of possible models to about 4.5 billion. Such a calculation would require a lot of 
computing power and it is not feasible to perform it within a reasonable timeframe. For this 
reason, the three-variable models were fitted based on the two-variable models via forward 
selection. The addition of a third variable to the two-variable models was performed using the 
“stats” package in R. This package offers the function “add1()” that fits models by adding one 
extra variable at a time to an existing model. Again here, since the datasets are not balanced in 
number between the solvate and the non-solvate groups, 10 equal size samples were used, 
resulting in a reasonable number (~30,000) of models per solvent. The “add1()” function 
evaluates the best model using the AIC value. But would our judgment be consistent if the AIC 
was used as a performance measure?  
In order to answer this, Table ‎5-6 and Table ‎5-9 were checked again. In these tables, it can be 
seen that the AIC value always agreed with the MSE. Although these two estimates seem to 
generally agree on the performance of different models, a closer look is required to see how 
closely related they are. These two estimators are unit less and they use different approaches 
to be calculated. See section ‎2.3.3 for details on how the AUC and the MSE are calculated.  
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AIC values in the two-variable models fell between 565 and 3333 while the MSE values fell 
between 0.145 and 0.184. This means the former values is around 10000 times larger than the 
latter for the same model. In order to compare these two estimators, their values were 
normalized to their means, the comparison is shown in Figure ‎5-19. 
 
Figure ‎5-19. A plot of the normalized AIC and MSE value for the best and the worst two-variable models. The 
details of these models were shown in Table ‎5-9. 
Figure ‎5-19 shows that the MSE and the AIC are very close estimates, supporting the idea that 
the AIC is as efficient as the MSE in these models. Therefore, the models with the lowest AIC 
values were selected after the “add1()” function was applied. The best and the worst model of 
these 10 samples in each solvent, along with the AIC, MSE and the AUC values are shown in 
Table 5-10.  
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Table ‎5-10. Three-variable models: details and performance 
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While the AIC values of some solvents slightly decreased (such as dichloromethane), others 
have shown a slight increase in this value (e.g. ethanol). The AIC values of the new models 
were generally similar to those of the two-variable models. This leads to the conclusion that 
the addition of the third variable increased the complexity of the model without giving extra 
information that is good enough to outperform the complexity. The MSE values were similarly 
affected. As the MSE was used to evaluate previous models, a comparison of the MSE values in 
the two- and the three-variable models is shown in Figure ‎5-20.  
 
Figure ‎5-20. The change in MSE between the two-variable and the three-variable models. For each solvent, the 
models with the lowest and the highest MSE of the 10 equally sized samples is shown. 
The addition of more descriptors to the current models does not seem to improve their 
predictive ability any further. For this reason, the two-variable models are going to be used. 
5.6 A closer look on the two-variable models 
After all the investigations were conducted in section 5.4., the two-variable models turned out 
to give the most reasonable predictions for solvate formation, both in terms of complexity and 
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
0.18
0.2
Two-variable Three-variable
153 
 
performance. Therefore, these models are going to be used to make predictions. In this 
section, the two-variable models are going to be presented, discussed and analysed. 
5.6.1 The models 
The general formula for the predictive models is given in Equation (‎5-1). 
 
𝑃𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦 =
1
1 + 𝑒−(𝐼𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡 +𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑒𝑖𝑛𝑡1∗𝐷𝑒𝑠𝑐𝑟𝑖𝑝𝑡𝑜𝑟1+𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑒𝑖𝑛𝑡2∗𝐷𝑒𝑠𝑐𝑟𝑖𝑝𝑡𝑜𝑟2)
 
(‎5-1) 
Each model contains two types of parameters, the constants, which only change when 
predicting a different solvent’s behaviour and the descriptors, whose values change depending 
on the molecule to be predicted. For the constants part, the intercept showed nonnegative 
values in all models. On the other hand, the coefficients of all descriptors had negative values 
except for one descriptor in the water model. It is important to keep in mind that the 
descriptor values themselves can be positive or negative. Each descriptor is multiplied by its 
coefficient. In logistic regression, if the product of the descriptor and its coefficient gives a 
negative term, it pushes the probability value towards zero (0), while a positive one pushes the 
prediction towards one (1). In these models, solvate formation is more likely when the 
probability is closer to zero, while non-solvate formation is more likely when the prediction is 
closer to one.  
Although the descriptors to include in the model of each solvent are known at this point, the 
coefficients of these models would slightly differ depending on the sample used for training 
the algorithm. In order to obtain models that are fair, 10 models were obtained for 10 random 
subsets per solvent (these are the same 10 subsets used earlier in cross-validation). The 
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models were then averaged in terms of the intercept, descriptor 1 coefficient and descriptor 2 
coefficient. These models are given in Equations (‎5-2) to (‎5-6). 
 
𝑝𝑒𝑡ℎ𝑎𝑛𝑜𝑙 =
1
1 + 𝑒−(15.939 −3.817AVS_H2−0.861nHDon)
 
(‎5-2) 
 
𝑝𝑚𝑒𝑡ℎ𝑎𝑛𝑜𝑙 =
1
1 + 𝑒−(2.8−0.085TRS−0.612nHDon)
 
(‎5-3) 
 
𝑝𝑑𝑖𝑐ℎ𝑙𝑜𝑟𝑜𝑚𝑒𝑡ℎ𝑎𝑛𝑒 =
1
1 + 𝑒−(15.459−3.314SM3_H2−0.664Hy)
 
(‎5-4) 
 
𝑝𝑐ℎ𝑙𝑜𝑟𝑜𝑓𝑜𝑟𝑚 =
1
1 + 𝑒−(14.744−3.05SM3_H2−0.384H050)
 
(‎5-5) 
 
𝑝𝑤𝑎𝑡𝑒𝑟 =
1
1 + 𝑒−(4.672−0.424πID+0.327Mor05u)
 
(‎5-6) 
 
where 𝑝𝑒𝑡ℎ𝑎𝑛𝑜𝑙, 𝑝𝑚𝑒𝑡ℎ𝑎𝑛𝑜𝑙, 𝑝𝑒𝑡ℎ𝑑𝑖𝑐ℎ𝑙𝑜𝑟𝑜𝑚𝑒𝑡ℎ𝑎𝑛𝑒, 𝑝𝑐ℎ𝑙𝑜𝑟𝑜𝑓𝑜𝑟𝑚 and 𝑝𝑤𝑎𝑡𝑒𝑟 are the probability of 
a molecule to stay in the non-solvated form when crystallised from the corresponding solvent. 
The result is a value between 0 and 1, where 0 represents a solvate and 1 represents a non-
solvate. 
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Since these models, along with the coefficients they contain, were averaged over multiple 
datasets, a reasonable question would be how much confidence is associated with each of 
these coefficients. In other words, what was the deviation of each sample from the mean value 
of the coefficient that is shown in the Equations (‎5-2) to (‎5-6)? The confidence of the intercept, 
the first and the second coefficient in each model can be represented by finding the standard 
deviation of the 10 models, fitted to the subsets of the complete data. Comparing the absolute 
standard deviations won’t give an intuitive value. This is because some coefficients have large 
and others have small values for standard deviations. In order to make the values comparable, 
the relative standard deviation (also known as the coefficient of variation) can be used instead, 
that is the standard deviation divided by the mean.12 The relative standard deviations are 
shown in Table ‎5-11. 
Table ‎5-11. Relative standard deviation of the intercept, first coefficient and second coefficient over 10 models in 
each solvent 
Solvent Intercept Coefficient 1 Coefficient 2 
Ethanol 0.04 0.05 0.05 
Methanol 0.03 0.03 0.04 
Dichloromethane 0.01 0.01 0.04 
Chloroform 0.01 0.01 0.02 
Water 0.08 0.13 0.08 
As it can be noticed, the deviation among the 10 samples was minimal. The largest deviation 
that can be seen is the first coefficient of the water model. This is expected, as the water had 
the most imbalanced sample, leading to almost completely different subsets that were used to 
fit the model, when equal size sampling was used. 
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5.6.2 The meaning of the descriptors 
In this section, the descriptors that are utilized in each of the two-variable models are going to 
be discussed in details. For the ethanol model, the predictive model utilizes the AVS_H2 and 
nHDon descriptors. AVS_H2 is a descriptor that is determined based on the reciprocal squared 
topological distance matrix, and it is calculated by taking the natural logarithm of the average 
of the sum of the entries in each row of the matrix. The details of calculating this descriptor 
are provided in section ‎3.2.1.2. The AVS_H2 descriptor value is linked to molecular size and 
branching in a molecular graph. A molecule that is large and highly branched is expected to 
have a large AVS_H2 value. The second descriptor in the best ethanol two-variable model was 
a simple count descriptor, nHDon. This descriptor simply counts number of hydrogen bond 
donors via the molecular graph. These are hydrogen atoms that are bound to a nitrogen or an 
oxygen atom, according to the Dragon software documentation. 
In the methanol two-variable model, the first descriptor was TRS (Total Ring Size). This is the 
total number of atoms in each independent ring in the molecule (e.g. TRS value of benzene is 6 
and of naphthalene is 12). The fact of having this descriptor as part of the best methanol 
model could indicate the role of the hydrophobic ring interactions in the stabilization of 
solvate crystals. The second descriptor in the methanol model was the same as the second 
descriptor in the ethanol model (nHDon: the number of hydrogen bond donors). 
The dichloromethane model had the SM3_H2 and the Hy descriptors. The former refers to the 
third order spectral moment of the reciprocal squared distance matrix (H2).13 The third 
spectral moment is calculated as the trace of the third power of the matrix. 14 844−849. Since this 
descriptor is calculated from the H2 matrix, it is closely related to the AVS_H2 descriptor 
observed in the ethanol model, where it also incorporates information about the size and 
branching of molecules. In fact, SM3_H2 is obtained by the logarithmic transformation 
[x’ = ln (1+x)] of the spectral moment. This is due to the exponential increase in its value with 
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the molecular size. The second descriptor in the dichloromethane model was Hy; the 
hydrophilic factor. This factor is calculated using the formula presented in Equation (‎5-7): 
 
𝐻𝑦 =
(1+𝑁𝐻𝑦)∙𝑙𝑜𝑔2(1+𝑁𝐻𝑦)+𝑛𝐶∙(
1
𝑛𝑆𝐾
.𝑙𝑜𝑔2
1
𝑛𝑆𝐾
)+ √
𝑁𝐻𝑦
𝑛𝑆𝐾2
𝑙𝑜𝑔2(1+𝑛𝑆𝐾)
  
(‎5-7) 
𝑁𝐻𝑦 is the number of hydroxyl, amine or thiol groups, 𝑛𝐶 is the number of carbon atoms and 
𝑛𝑆𝐾 is the number of non-hydrogen atoms.15 
The chloroform model shares the same first descriptor with the dichloromethane model; that 
is SM3_H2. This descriptor, combined with H-050 resulted in the chloroform model with the 
lowest MSE. The descriptor H-050 is calculated by counting the number of hydrogen atoms 
attached to a heteroatom.16, 17 This descriptor is highly correlated to Hy (r > 0.95). This suggests 
a proximity in behaviour between dichloromethane and chloroform in terms of solvate 
formation, where they have the first descriptor in common and have a near-identical second 
descriptor.  
The best water two-variable model, included the πID and the Mor05u descriptors. The former 
is based on the conventional bond order ID number.18 It is calculated using the formula in 
Equation (‎5-8): 
 𝜋𝐼𝐷 = ln (1 + 𝑛𝑆𝐾 + ∑ 𝑤𝑝)𝑝   (‎5-8) 
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were 𝑛𝑆𝐾 is the number of non-hydrogen atoms and 𝑤𝑝is the weight of molecular path 𝑝. The 
index 𝑝 runs over all bond paths in the hydrogen-depleted molecular graph, where the length 
of the path ranges from 1 bond to the longest path possible. Each path 𝑝 is weighted by 
conventional bond orders of the bonds in this path, resulting in  𝑤𝑝 ;the weight of molecular 
path. The conventional bond order of single bonds is 1, 1.5, 2 and 3 for single bonds, aromatic 
bonds, double bonds and triple bonds, respectively. By incorporating this information, the 𝜋𝐼𝐷 
descriptor value doesn not only incorporate information regarding the complexity (size and 
branching) of a molecule. It also indicates the rigidity of a molecule. Note that the descriptor 
was subject to logarithmic transformation [see Equation (‎5-8)]. The second descriptor in the 
water model was a 3D-MoRSE (3D-Molecule Representation of Structures based on Electron 
diffraction) descriptor; that is Mor05u. This family of descriptors are calculated from the 
atomic 3D coordinates obtained by a molecular transform that is similar to the electron 
diffraction formulae,19 the formula to calculate the Mor05u descriptor is presented in Equation 
(‎5-9): 
 𝑀𝑜𝑟05𝑢 = ∑ ∑
sin(5𝑟𝑖𝑗)
5𝑟𝑖𝑗
𝑛𝐴𝑇
𝑗=𝑖+1
𝑛𝐴𝑇−1
𝑖=1   
(‎5-9) 
where rij is the topological distance between atoms i and j in the molecule and nAT is the total 
number of atoms in a molecule. 
The 3D-MoRSE descriptors require the previous knowledge of the 3D coordinates of atoms in a 
molecular before conducting the descriptor calculation. This is not always applicable, 
especially that this model aims at predicting solvate formation at early development stages. 
For this reason, the Mor05u in the water model can be replaced with a 2D descriptor, 
providing the ability to predict solvate formation using the molecular graph only. A highly 
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correlated, easy-to-calculate descriptor can be used instead. Fortunately, two simple 
descriptors showed high correlation (r =0.94) with Mor05u; these are the number of hydrogen 
atoms (nH) and the number of atoms of molecule (nAT). A water model based on the 𝜋𝐼𝐷 and 
𝑛𝐻 descriptors gives an average MSE of 0.161 compared to an average MSE of 0.159 of the 
original hydrate model. The alternative water model is given in Equation (‎5-10). 
 
𝑝𝑤𝑎𝑡𝑒𝑟−𝑎𝑙𝑡𝑒𝑟𝑛𝑎𝑡𝑖𝑣𝑒 =
1
1 + 𝑒−(4.756−0.434πID−0.089nH)
 
(‎5-10) 
With exception to water, all two-variable models consisted one descriptor that related to the 
size and branching of a molecule and another one that is related the heteroatoms in the 
molecules. The water model on the other hand has possessed one variable related to size and 
branching in addition to rigidity, while the second variable focused on the count of hydrogen 
atoms in a molecule. 
5.6.3 The descriptor values and their coefficients 
The models of the different solvents include descriptors that are identical or highly correlated, 
as has been shown in section 5.5.1, Equations (‎5-2) to (‎5-6). In the first instance, this could 
imply that the models are similar. In fact, it shows that the models are conceptually, but not 
numerically similar. The value of parameters in the logistic function (i.e. intercepts and 
coefficients) vary widely between the different models. This difference can be demonstrated 
using the ethanol and methanol models, where the relative importance of a shared descriptor 
(nHDon) is roughly 1.5 times higher in the ethanol model than it is in methanol model. 
Each descriptor that is included in the logistic regression equation has a different impact on 
the overall result. The influence of each descriptor on the total model can be estimated by 
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looking at two properties: the coefficient of each descriptor and the value of the descriptor 
itself. Looking at the general logistic regression formula [Equation (‎5-1)], the value of each 
descriptor is multiplied by the coefficient found by the model. For example: in the ethanol 
model, for a given molecule, the value of the AVS_H2 descriptor is multiplied by -3.817. The 
mean value of this descriptor across the dataset is 3.728. Their multiplication gives a value of -
14.23.  The product of the descriptor value and its coefficient also has to be compared to the 
product of the other descriptor and its coefficient. The coefficient of the number of hydrogen 
bond donors (nHDon) descriptor is -0.861 and the mean value of this descriptor across the 
dataset is 1.113. The effect of the mean value multiplied by the coefficient gives a value of -
0.958. This means that for an “average” molecule, the value of the AVS_H2 descriptor has an 
effect on the model around 15 times the value of the number of hydrogen bond donors 
(nHDon). This clearly shows that the importance of the size, complexity and branching exceeds 
the importance of the hydrogen bonding ability of a molecule in forming ethanol solvates. The 
negative sign in both descriptors indicates that larger values of the descriptors push the 
prediction value closer to zero i.e. towards solvate formation. 
The value of a coefficient alone in the model is not enough to imply the importance of a 
descriptor as the value of the descriptor itself might be small or large. For example in the 
methanol model, the coefficients of the TRS and the nHDon descriptors are -0.084 and -0.612, 
respectively. In the first instance one might think that the hydrogen bonding is more important 
than the size for determining the methanol solvate formation ability. However, the mean value 
of the methanol model descriptors was 22.328 for the TRS descriptor and 1.497 for the nHDon. 
The product of the multiplication of the mean values with the coefficients is -1.876 for TRS and 
-0.916 for nHDon.  This leads to the conclusion that the size and branching of a molecule is still 
the most important factor in comparison to the hydrogen bonding in methanol. Care must be 
taken not to take the coefficient or the descriptor value as an indicator of the final probability 
as it might cause misinterpretation of the results.  
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5.6.4 Visual representation 
Since each solvent’s model equation contains two variables, it is possible to represent these 
models in a 2D plot. An illustration of the dichloromethane model, its decision boundary and a 
sample’s prediction is shown in Figure ‎5-21. 
 
Figure ‎5-21. A plot of 2600 datapoints from the dichloromethane dataset in terms of the 2 descriptors that give 
the best linear separation, these are the SM3_H2 and Hy. The black line represents the decision boundary upon 
which the outcome is predicted. Colours = experimental outcome. 
The x axis in Figure ‎5-21 represents the SM3_H2, a descriptor explaining the size and branching 
of a molecule. The increase in number of solvate with increased SM3_H2 suggests that a large, 
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branched molecule is more likely to form a solvate, probably because it would be difficult for 
such a molecule to optimally fill the three-dimensional space. It is also possible that poor 
packing of molecules in the crystal allows the solvent molecules to diffuse through the 
structure and form a solvate. This idea could be illustrated by a histogram of the SM3_H2 
descriptor in the solvate and the non-solvate groups, as shown in Figure ‎5-22. 
 
Figure ‎5-22. Histograms of the SM3_H2 descriptor distribution from the chloroform data. 
 The y axis in Figure ‎5-21 represents the number of hydrogen bond donors. The increase of 
number of solvents as this value increases suggests that hydrogen bond donors play a role in 
stabilizing the solvent molecules in the crystal voids. This can be supported by the fact that the 
hydrogen bonding related descriptors show a negative sign in the models, therefore 
contributing to solvate formation. The role of hydrogen bonding in solvate formation has been 
previously recognized.20, 21 The improvement in the current findings is the quantification of the 
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relative importance of size, branching and hydrogen bonding. By knowing this information, it 
would be possible to predict the ability of molecules to form solvate based on the molecular 
structure alone.  
In the alcohol containing solvents, the hydrogen bonding related descriptors have shown a 
positive effect on solvate formation. Surprisingly, introduction of the hydrogen bond-related 
descriptors did not improve the predictive ability of the models for hydrate formation. The 
effect of the addition of a hydrogen bond related descriptor to the model is shown in 
Figure ‎5-23. 
 
Figure ‎5-23. An illustration of the change in performance between the alternative water model fitted using piID 
and nH (red) vs the water model fitted using piID, nH and nHDon (blue). The steps in the curve (not smooth) are 
due to the small number of datapoints in the water sample (number of datapoints is 606). 
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In the first instance, it might seem that hydrogen bonding is not important in hydrate 
formation. The role of hydrogen bonding in hydrate formation is a fact that cannot be denied. 
Positive correlations between hydrogen bonding and hydrate formation has been reported.22 
In order to demonstrate the importance of hydrogen bonding, a logistic regression model was 
fitted one variable only, that is the hydrogen bond acceptors (nHAcc). This model resulted in 
an average MSE of 0.237. This proves that hydrogen bonding plays an important role in 
hydrate formation, but it is not the most important discriminating factor according to this 
dataset. Note that all the datapoints provided for the water model were for crystals that were 
successfully grown from aqueous solutions suggests that even the non-hydrate formers among 
them are relatively hydrophilic. 
The solvents that possess similar functional groups had their best models describing the same, 
or closely related structural features, although the datasets for all these solvents were 
completely different. For example, ethanol and methanol are both hydroxyl-containing 
solvents and the hydrogen bonding is essential in their solvate formation, as can be seen by 
the second descriptor in both. This is logical since both solvents are structurally related and 
can involve in similar interactions. Another example is the models of the dichloromethane and 
chloroform where the first descriptor was exactly the same (SM3_H2), chosen from amongst 
about 5000 descriptors. Such similar results agree with the expected outcome of similar 
behaviour of structurally related solvents.  
5.6.5 Cut-off point determination 
 The cut-off point is the numerical probability value which splits the prediction outcomes into 
solvates and non-solvates. In principle, any value between 0 and 1 can be chosen to be the cut-
off value. In order to get an unbiased decision, the convention is to choose a value that 
maximizes the true positive and the true negative predictions.23 An illustration of the 
specificity and the sensitivity curves of the two-variable models is given in Figure ‎5-24. 
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Figure ‎5-24. The sensitivity and specificity curves from the dichloromethane data, sample 1. 
It is not too surprising that the optimal value found by crossing these two curves is close to 0.5, 
due to the fact that equal size samples were used. The value shown in Figure ‎5-24 is for one of 
the 10 samples taken per solvent. To get the best estimation possible for this point, the 
average cut-off point obtained for the 10 samples for each solvent was found. Table 5-12 shows 
the average cut-off point for each solvent. 
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Table ‎5-12. Average cut-off point in each solvent's dataset 
Solvent Average Cut-off point 
Ethanol 0.485 
Methanol 0.485 
Dichloromethane 0.513 
Chloroform 0.514 
Water 0.564 
The average cut-off point was very close to 0.5. The small deviation from 0.5 could be due to 
the sampling error, since this is an average over 10 samples. For this reason, 0.5 was chosen to 
be the cut-off point.  
5.6.6 Residuals 
One of the most important diagnostics of the model performance is the residuals. These are 
the difference between the actual value and the predicted value.24  The importance of this 
diagnostic comes from the fact that the presence of a pattern among the residuals signals that 
the model is modifiable. On the other hand, if the residuals plot was fuzzy and showed no 
trend, then that means the model doesn’t seem to be modifiable despite having prediction 
errors. The distribution around the model should also be symmetrical for a healthy residual 
plot, i.e. the points should be at comparable distances from the line at zero. The residual plot 
of the two-variable ethanol model is shown in Figure ‎5-25. 
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Figure ‎5-25. A residual plot of the ethanol model (from subset data no.1). 
The raw residual plot of a logistic regression model isn’t particularly informative. It cannot be 
estimated by the naked eye how many points fall above or below the curve, making the 
judgment of the presence of a trend or a bias not possible. A suggested way to go around this 
problem is to convert the data into bins (groups), where the average residual value among 
these can be seen. The binned residuals plot for an equal-size sample prediction for each 
model is shown in Figure ‎5-30 (a-e). 
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(a) 
Figure ‎5-26. The binned residual plots from the 2 variable models in each solvent (a): ethanol. Note that each plot 
is based on an equal size sample to show sensible distribution around the zero line. The two grey lines in each 
figure represents the boundaries of 95 % error assuming the model is true. 
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(b) 
Figure ‎5-27. Continued. The binned residual plots from the 2 variable models in each solvent (b): methanol. Note 
that each plot is based on an equal size sample to show sensible distribution around the zero line. The two grey 
lines in each figure represents the boundaries of 95 % error assuming the model is true. 
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(c) 
Figure ‎5-28. Continued. The binned residual plots from the 2 variable models in each solvent (c): 
dichloromethane. Note that each plot is based on an equal size sample to show sensible distribution around the 
zero line. The two grey lines in each figure represents the boundaries of 95 % error assuming the model is true. 
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(d) 
Figure ‎5-29. Continued. The binned residual plots from the 2 variable models in each solvent (d): chloroform. 
Note that each plot is based on an equal size sample to show sensible distribution around the zero line. The two 
grey lines in each figure represents the boundaries of 95 % error assuming the model is true. 
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(e) 
Figure ‎5-30. Continued. The binned residual plots from the 2 variable models in each solvent (e): water. Note that 
each plot is based on an equal size sample to show sensible distribution around the zero line. The two grey lines 
in each figure represents the boundaries of 95 % error assuming the model is true. 
The residual plots for all models look normal, with no patterns observed. Although one sample 
is shown here from each solvent, 10 similar plots were exported for 10 different test sets for 
each solvent’s model, where they showed similar performance. 
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5.6.7 Misclassified data and intercept adjustment 
It was shown earlier that each solvent’s model (the two-variable models in shown in 
section 5.5.1) misclassified between 19 and 26 % of the starting (complete) datasets. But was 
most misclassification attributed to solvate or non-solvate group or was it a 50-50 % split 
between them? Ideally, the misclassification should be a half-split between the solvate and the 
non-solvate groups. This is thought to be due to the fact that the cut-off point was chosen in a 
way to maximize the sensitivity and the specificity of the models, as has been shown in 
section 5.5.5 The percentage of solvates and non-solvates among the misclassified data in each 
solvent dataset was calculated. The results are shown in Figure ‎5-31. 
 
Figure ‎5-31. Percentage of misclassifications in the solvate and the non-solvate groups in each model when the 
complete dataset was predicted using the two-variable models. 
All models have shown a biased behaviour towards the non-solvate group to different extents, 
with the alcohols and water showing the largest bias. This could be surprising in the first 
instance, but bearing in mind that the prior probability of the solvate formation was ignored 
when equal size samples were taken explains this. Although 10 subsets were used to fit each 
model, the fact that equal size sampling was used results in ignoring part of the data. In other 
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words, this error happened due to the sampling error. In a logistic regression model, this error 
could be fixed by adjusting the intercept of the model.25 Therefore, what is required ad this 
stage is eliminating the bias that is present in these models via intercept adjustment. 
In order to know the perfect cut-off point for each model, a loop programmed in R was used to 
make a stepwise change to the intercept in both positive and negative direction until the bias 
in prediction between the solvate and the non-solvate groups is eliminated. This adjustment 
results in an equally distributed error between the solvate and the nonsolvate groups, as 
shown in Figure ‎5-32. 
 
Figure ‎5-32. Percentage of misclassifications in the solvate and the non-solvate groups in each model when the 
complete dataset was predicted using the intercept-adjusted two-variable models. 
Intercept-adjusted models are more fair towards both the solvate and non-solvate groups, 
nevertheless, the overall misprediction and MSE of the models has shown a small increase in 
some solvents. The change in intercept is shown in Table ‎5-13. The details on the change of the 
overall prediction and the MSE per solvent are shown in Figure ‎5-33. 
  
0
5
10
15
20
25
30
Ethanol Methanol Dichloromethane Chloroform Water
Solvate Non-solvate
175 
 
Table ‎5-13. The intercept value in normal and intercept-adjusted models 
 
Original Adjusted 
Ethanol 15.939 15.868 
Methanol 2.8 2.652 
Dichloromethane 15.459 15.357 
Chloroform 14.744 14.688 
Water 4.672 4.558 
 
Figure ‎5-33. The effect of adjusting the intercept on the MSE value of each model. 
5.7 Simple alternatives 
To this point, it is well known that the two-variable models were able to correctly predict the 
behaviour of 74-80 % of the data in any of the five solvents. The descriptors in the models 
shown in section ‎5.6.1 can be instantly calculated by a computer for almost any molecule. 
Nevertheless, it would be impractical to calculate them manually. For example the process of 
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calculating the value of the SM3_H2 descriptor involves working out the third power of a 
matrix. This is a tedious task to be performed manually for almost any molecule. Additionally, 
the descriptor value is not easily estimated by looking at the molecular structure. In order to 
give a more intuitive value, simple alternative models were introduced. 
5.7.1 The alternative descriptors  
The rationale for solving this issue was based on finding simple models that resemble the 
original ones given in section 5.5.1. This could be achieved by considering for simple 
descriptors that are highly correlated with the ones in the original models.  A correlation 
matrix was established for each solvent’s dataset individually and new descriptors were 
selected.  
In the ethanol model, the AVS_H2 descriptor requires a lot of time to be calculated. A 
correlation matrix was calculated and arranged according to the correlations between AVS_H2 
and the rest of descriptors. Part of this correlation matrix is presented in Table ‎5-14. 
Table ‎5-14. Part of the AVS_H2 correlation matrix 
- AVS_H2 
AVS_H2 1 
SpMax_H2 0.981 
SpDiam_H2 0.977 
SM6_H2 0.975 
… … 
nCIC 0.870 
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The top 3 correlated descriptors in this dataset were SpMax_H2, SpDiam_H2 and SM6_H2. 
Although these had the highest correlation, the notation (H2) in their names indicate the need 
to calculate the reciprocal squared topological distance matrix, therefore they are not suitable 
to be manually calculated. The descriptor with 109th highest correlation was the nCIC at a 
correlation value of 0.87. This is a simple count descriptor that counts the number of rings in a 
molecule. The correlation sounds logical as AVS_H2 inherently contains information about the 
size and branching of a molecule; therefore a larger molecule is expected to have a higher 
number of rings. For this reason, the AVS_H2 was replaced with the nCIC and a model was 
fitted. The second descriptor in the ethanol model was already a simple count descriptor, so it 
was not changed. The average MSE of the model that uses nCIC and nHDon over 10 samples 
was 0.157, which is close to 0.148, the average MSE of the original model. 
In the methanol model, the descriptors used were the TRS and nHDon. Both of these are 
simple descriptors that are easy to calculate manually, for this reason the methanol model was 
not adjusted or represented by a simpler model. 
In the dichloromethane model, the SM3_H2 descriptor hard to be estimated using the 
molecular graph. Fortunately, a simple path count descriptor (MPC01) showed to be very 
similar to SM3_H2, with a high correlation (r = 0.983). MPC01 is the count of paths of length 1 
in the H-depleted molecular graph. It could also be seen as the number of bonds between non-
hydrogen atoms in the molecular graph.26, 27  Just like SM3_H2, MPC01 shows large values 
when the molecule size increases so it was subject to logarithmic transformation. 
The second descriptor in the dichloromethane model was the Hy. This descriptor is not very 
complex but may require a considerable amount of time to be calculated. For this reason a 
simpler alternative was looked up. nHDon turned out to have a correlation of more than 0.95 
to Hy, so it was replaced by nHDon. The resulting model still gives similar results. This 
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alternative simple model had an average MSE of 0.150 over 10 samples compared to 0.146 for 
the original model. 
In the chloroform model, the first descriptor (SM3_H2) was shared with dichloromethane. 
Interestingly, chloroform also shares the first alternative descriptor with dichloromethane, 
where the MPC01 descriptor showed a correlation of 0.984 to SM3_H2. The second descriptor 
in the chloroform model was the number of hydrogen atoms attached to a heteroatom (H-
050). This is a simple count descriptor, therefore it was left unchanged. Although the 
chloroform model shows a different second descriptor from the dichloromethane model, the 
correlation between the second descriptors in both is very high (r > 0.95 correlation), 
indicating the similarity in their behaviour. The average MSE of the simpler model, again over 
10 samples, is 0.152, compared to 0.148 of the original model. 
In the water model, the first descriptor was the πID. This descriptor is calculated through the 
formula presented in Equation (‎5-8). Since it is not easy to calculate, it was replaced with the 
nCIC descriptor, which is the number of rings in a molecule. nCIC has a correlation value 
(r= 0.854) of with πID. The second descriptor in the water model was the nH, which is already a 
simple count descriptor. Therefore it was left as it is. A model utilizing the nCIC and nH 
descriptors has an average MSE of 0.161 compared to an average MSE of 0.159 of the original 
hydrate model. The result of these replacement was 5 new models. These five models had 
their intercept adjusted in the same manner shown in section ‎5.6.7. The resulting models are 
illustrated in Equations (‎5-11) to (‎5-15): 
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𝑝𝑒𝑡ℎ𝑎𝑛𝑜𝑙 = 1 −
1
1 + 𝑒−(3.952 −0.766nCIC−0.889nHDon)
 
(‎5-11) 
 
𝑝𝑚𝑒𝑡ℎ𝑎𝑛𝑜𝑙 = 1 −
1
1 + 𝑒−(2.652−0.085TRS−0.612nHDon)
 
(‎5-12) 
 
pdichloromethane = 1 −
1
1 + e−(12.737−3.649MPC01−0.339nHDon)
 
(‎5-13) 
 
pchloroform = 1 −
1
1 + e−(12.336−3.416MPC01−0.358H.050)
 
(‎5-14) 
 
𝑝𝑤𝑎𝑡𝑒𝑟 = 1 −
1
1 + 𝑒−(2.45−0.606nCIC−0.088nH)
 
(‎5-15) 
5.7.2 Performance of the simple models 
The descriptors chosen to simplify the models showed a high correlation to the ones in the 
original models as has been shown in section 5.6.1. This means the simple alternatives are 
ought to have a performance that is comparable to the original ones. The average 
performance of the alternative models (over 10 samples) is shown in Table ‎5-15. A comparison 
of the MSE between the original and the alternative models is shown in Figure ‎5-34. 
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Table ‎5-15. The average performance of the intercept-adjusted alternative models (over 10 samples) in each 
solvent’s dataset. 
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Figure ‎5-34. The increase in the MSE value when alternative models are used. Note that the comparison in shown 
here is between intercept-adjusted two-variable models and intercept-adjusted alternative models. 
The increase in the error values was minimal. This demonstrates that predictions with the 
same success rate can be made without the use of a computer. 
5.8 Practical usage of the models 
The application of the models can be viewed in two ways, these are a visual 
representation and a purely mathematical one, both of which are going to be 
explained in this section. 
5.8.1 Mathematical representation 
After the alternative models were introduced, it is logical to show an example of how these 
could be used to make a prediction. Bearing in mind that most users would not have the 
descriptor calculation software, it was necessary to demonstrate their practical usage. In this 
section, two molecules are going to be predicted for solvate formation using the alternative 
models. The molecules chosen to exemplify the usage of the models were large, branched and 
complex. The reason for these choices is to demonstrate the easiness of using the alternative 
models, regardless of the complexity of the structure. The first example is going to utilize the 
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water alternative model. The example of choice was the azithromycin, an anti-bacterial from 
the macrolides family (CSD reference code: NAVTAF28), which is shown in Figure ‎5-35. 
 
Figure ‎5-35. The structure of azithromycin. Chemical formula C37H67NO13. 
In order to calculate the probability of hydrate formation, two descriptors are required, these 
are the nCIC and nH. The nCIC (number of rings) in the structure can be easily worked out as 3, 
while the nH (number of hydrogen atoms) would take a little longer. The number of H atoms 
sum up to 67. Putting these in the alternative water model gives the Equation (‎5-16): 
 
𝑝𝑤𝑎𝑡𝑒𝑟 = 1 −
1
1 + 𝑒−(2.45−0.606∗3−0.088∗72)
= 0.003 
(‎5-16) 
The prediction is well below the cut-off point for the water model, which indicates this 
molecule is a strong candidate for forming a hydrate. In reality, a dihydrate is recorded in the 
CSD for this entry (GEGJAD), which makes the prediction correct in this case.  
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Another example could be demonstrated via the methanol alternative model. This time, a 
pharmaceutically active statin, known as bryostatin was chosen to predict solvate formation. 
Similar to the previous example, the values of two descriptors have to be worked out in order 
to make the prediction. This time the two descriptors were TRS and nHDon. Considering the 
structure of the molecule, the TRS descriptor can be calculated by counting the number of 
atoms in every ring. This structure show 4 rings, 3 of which are 6-membered rings and one that 
is a 20-membered ring. These rings overlap, but the number of atoms consisting each ring are 
counted individually, leaving the final value of the TRS descriptor to be 38. The nHDon 
descriptor value for this structure is 4. An illustration of the two descriptors on the bryostatin 
structure is shown in Figure ‎5-36. 
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Figure ‎5-36. The chemical structure of bryostatin with the groups contributing to the TRS and nHDon descriptors 
highlighted. 
Feeding these values into the model gives the result shown in Equation (‎5-17): 
 
𝑝𝑚𝑒𝑡ℎ𝑎𝑛𝑜𝑙 =
1
1 + 𝑒−(2.652−0.0847∗38−0.612∗4)
= 0.047 
(‎5-17) 
The low probability value gives the indication of a high likelihood of the methanol solvate 
formation. In fact, this molecule does form a methanol solvate. The form was reported in a 
publication in 1982 (CSD reference code: BOKKIV29). 
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5.8.2 Visual representation 
From a visual perspective, the two-variable models are representing a two-dimensional 
problem, as has been shown in Figure ‎5-21. In this problem, the two descriptors will represent 
the two axes of a plane. For each given molecule, the values of these two descriptors are 
calculated. These two values are used as the coordinates to draw a point on the plane. The 
machine then draws the decision boundary (which is defined by the model) on the same plane. 
The position of the drawn point in relation to the decision boundary decides the prediction 
outcome. The distance from this decision boundary defines the likelihood of hydrate or solvate 
formation. An example is given here using the amoxicillin molecule, which was described back 
in 1971.30 An illustration of the amoxicillin molecule and its classification by the model are 
shown for the amoxicillin molecule in Figure ‎5-37 and Figure ‎5-38, respectively. 
(a) 
Figure ‎5-37. The amoxicillin molecule. 
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Figure ‎5-38. An illustration of the graphical prediction method used by the water model. The point in the plot 
represents the amoxicillin molecule. 
By looking at the water model shown in Equation (‎5-15), it can be anticipated that the region 
for hydrate formation lies to the right of the decision boundary. The amoxicillin did fall into 
this region, with the value of the two descriptors being 3 and 18, respectively. This indicates 
the drug’s ability to form a hydrate according to the model. This is a correct prediction as the 
amoxicillin drug was found to have a trihydrate form that was recognized in the late 1970s.31 
The trihydrate entry is recorded in the CSD under the reference code AMOXCT10. 
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 Discussion of the models Chapter 6:
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The previous chapter has covered the statistical aspects of the models. In this chapter, we 
discuss examples from the dataset, representing the importance of the descriptors that were 
included in the models. Additionally, some descriptors that could be useful for determining 
solvate formation but were not part of the models will be discussed and represented by 
examples form the dataset. Such criticism can help the identification of the strong and weak 
points of the models. An important term to point out before the chapter starts is the short 
contact. In this work, this term is used to describe the distance between two atoms when it is 
at least 0.1 Å shorter than the sum of the van der Waals radii of the atoms in contact. 
6.1 Effects the models take into account 
At this point, it has been shown that the best descriptors to predict solvate formation were 
related to the size and branching of a molecule in addition to its hydrogen bonding ability. The 
relative importance of these two variables will be illustrated via examples from the ethanol 
datasets. 
6.1.1 Size and branching 
This molecular property is the most important in the prediction of the solvate formation 
according to the models. The significance of this property can be illustrated by discussing 
entries that have a small size, low branching and a high ability to form hydrogen bonds and by 
discussing the other extreme case of large molecules with a little ability to form hydrogen 
bonds. A couple of examples representing the former case are 1-((E)-2-
pyridinylmethylidene)semicarbazone, CSD reference code: KUHGEA1 and N-(pyridin-2-
yl)hydrazinecarbothioamide, CSD reference code: XAPTOY.2 These are shown in Figure ‎6-1. 
 
193 
 
(a) (b) 
Figure ‎6-1. Molecular structures of (a) KUHGEA and (b) XAPTOY. 
KUHGEA and XAPTOY possess AVS_H2 values of 2.972 and 2.979 and a number of hydrogen 
bond donors of 3 and 4, respectively. Both of these entries were recrystallized from ethanol. 
The solvent was not incorporated into the crystal structure in either of the cases, despite the 
availability of multiple hydrogen bond donors as well as acceptors. The inability of these 
entries to form an ethanol solvate was correctly predicted by the ethanol model at an x value 
of 0.874 for KUHGEA and 0.741 for XAPTOY. This inability to form a solvate was reasoned by 
not having a size and branching that is large enough to surpass the decision boundary into the 
solvate region. An illustrative example of the case of the molecules that show a large, 
branched structure can be the compound (16S)-(-)-16-ethylrhazilinam ethanol solvate, CSD 
reference code: ECEKON.3 This molecule shows a branched structure (AVS_H2 value is 4.099) 
and has one hydrogen bond donor (nHDon value is 1). The entry is an ethanol solvate, 
nevertheless, no hydrogen bond seems to exist between the molecule and the solvent even in 
the range of the Van der Waals radii + 0.1 Å. This shows that the hydrogen bond is not highly 
involved in the inclusion of the solvent inside the crystal structure. An illustration of the 
ECEKON entry is shown in Figure ‎6-2. Its solvate formation was correctly predicted by the 
ethanol model at x= 0.345. 
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Figure ‎6-2. Molecular structures of ECEKON. 
Multiple examples illustrating solvate formation despite the low count of hydrogen bond 
donors can be seen in all datasets. The CSD reference codes for additional examples from the 
ethanol and methanol datasets are given in Table ‎6-1. 
Table ‎6-1. Additional examples on the importance of size and branching in solvate formation 
From ethanol data 
CSD 
reference 
code 
AVS_H2 nHDon Chemical formula 
Prediction 
value 
MOKVOY4 4.233 0 
 
0.428 
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Table 6-1. Continued 
QEKMEY5 4.201 0 
 
0.458 
QUSWUX6 4.201 0 
 
0.458 
RIBBOU 7 4.213 0 
 
0.447 
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Table 6-1. Continued 
TOYJUM8 4.092 1 
 
 
0.352 
From methanol data 
EREWED9 35 0 
 
0.420 
EMEBUT10 36 0 
 
0.420 
KAQVIJ11 38 0 
 
0.359 
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Table 6-1. Continued 
DADWEM12 39 0 
 
0.340 
ZEBXUZ13 40 0 
 
0.321 
 
6.1.2 Hydrogen bonding 
The importance of hydrogen bonding in different structural formations, including solvate 
structures cannot be denied. Several studies have shown a positive correlation between the 
hydrogen bonding ability and the formation of solvates, especially in alcohol containing 
solvents. Additionally, all the models found agreed that the hydrogen bonding ability of the 
structure is an important factor in the determination of solvate formation. A number of 
examples from the ethanol dataset are used to demonstrate the importance of this type of 
bonding. The molecules that are used to make the demonstration were chosen to have similar 
AVS_H2 values, but differ in the number of hydrogen bond donors as illustrated in Figure ‎6-3 
(a) and (b). 
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(a) (b) 
Figure ‎6-3. Molecular structures of (a) SOYQON and (b) UHUWEA. 
 The first example, shown in Figure ‎6-3(a) is N'-(2,4-dimethoxybenzylidene)-3,4,5-
trihydroxybenzohydrazide ethanol solvate, CSD reference code: SOYQON.14  The other entry 
shown in Figure ‎6-3(b) is N-(2-hydroxyethyl)-6-methoxy-2-oxo-2H-chromene-3-carboxamide, 
CSD reference code: UHUWEA.15 Both compounds were recrystallized from ethanol, but the 
latter has failed to form a solvate. These two entries have close AVS_H2 values of 3.534 and 
3.513, respectively. The larger difference between them lies in the hydrogen bonding ability, 
where the SOYQON entry had 4 hydrogen bond donors, compared to 2 donors in the UHUWEA 
entry. According to the model, this difference in the number hydrogen bond donors is the 
reason for the solvate formation in the first molecule. Both of these entries were correctly 
predicted for solvate formation by the ethanol model, where SOYQON had an x value of 0.256 
and the UHUWEA entry had an x value of 0.676.  
Another example can be shown via ethyl 5-((2-hydroxybenzoyl)carbohydrazonoyl)-3,4-
dimethyl-1H-pyrrole-2-carboxylate ethanol solvate, CSD reference code: EHUKAU,16 and (E)-N'-
(4-(2-chlorobenzyloxy)benzylidene)isonicotinohydrazide, CSD reference code: QERJED,17 both 
of which are illustrated in Figure ‎6-4. 
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(a) (b) 
Figure ‎6-4. The importance of hydrogen bonding in solvate formation shown via the EHUKAU (a) and the QERJED 
(b) entries. 
Both of these entries have an AVS_H2 value of 3.533. The count of the hydrogen bond donors 
is different though. While the EHUKAU entry shows three hydrogen bond donors, the QERJED 
has only one. This causes the model to predict them differently. Both of these entries were 
correctly predicted by the ethanol model, where the EHUKAU entry was predicted to form a 
solvate at x= 0.450 and the QERJED entry was predicted not to form a solvate at x=0.821. A 
large number of examples were available to demonstrate the case. Additional paired examples 
illustrating this case are shown in Table ‎6-2. Note that these examples are from the ethanol and 
the methanol datasets only. This is because the models of these two solvents are the only ones 
that were significantly improved by the addition of the hydrogen bonding factor (see 
section ‎5.5.2 for the addition of the second variable). 
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Table ‎6-2. Additional paired examples indicating the importance of hydrogen bonding ability in solvate 
formation. Each pair of examples has similar background shading 
From ethanol data 
Chemical formula and reference code 
AVS_H2 
value  
nHDon 
value 
Prediction 
value 
NEQDEU18 
 
3.743 1 0.673 
KAYTOU19 
 
 
3.743 4 0.134 
AZUYAV20 
 
 
3.758 0 0.821 
ABEBOZ21 
 
 
3.758 2 0.45 
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Table 6-2. Continued 
IGASOZ22 
 
 
3.76 0 0.812 
SEHSOP23 
 
 
3.76 2 0.449 
From methanol data 
AFETIO24 
 
 
22 0 0.686 
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Table 6-2. Continued 
ANOQOK25 
 
 
22 2 0.391 
CEHCOJ26 
 
 
22 1 0.542 
YUQKAX27 
 
 
22 2 0.391 
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Table 6-2. Continued 
OJOHUQ28 
 
 
25 0 0.629 
QUCSEM29 
 
 
25 2 0.332 
6.2 Effects the models do not take into account 
The previous section has shown examples to prove the usefulness of the descriptors that are 
included in the models. Bearing in mind that 20 % of the data was not correctly predicted by 
the models, there must be factors that account for solvate formation which the models did not 
consider. These factors are going to be shown by examples from the datasets. 
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6.2.1 Hydrogen bond strengths 
The addition of hydrogen bonding to the models has increased their prediction ability, 
especially in the models of the alcohol containing solvents. Nevertheless, the description of 
this property was too simple. The count of the hydrogen bond donors is certainly not the best 
description of the hydrogen bonding ability of a given molecule. This is due to the fact that the 
strength of hydrogen bonds depends on many factors, such as the nature of the hydrogen 
bond donating atom. For instance, a primary amine has a lower affinity than an amide to 
donate a hydrogen bond.30  
An example that can demonstrate this difference in ability to donate hydrogen bonds can be 
seen by comparing 7-hydroxy-1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-
3-carboxamide methanol solvate, CSD reference code: VUQMEA31 and 4-(4-Fluorophenyl)-1-
phenyl-3-(pyridin-4-yl)-1H-pyrazol-5-amine, CSD reference code: LANRUP.32  Both of these 
entries were recrystallized from methanol. Their structures are shown in Figure ‎6-5. 
(a)  (b) 
Figure ‎6-5. Molecular structures of (a) VUQMEA and (b) LANRUP. 
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The values of the descriptors TRS and nHDon are identical for both compounds; these are 23 
and 2, respectively. While the count of hydrogen bond donating groups is the same, the nature 
of these groups is not. The VUQMEA entry shows an amide and a hydroxyl group while the 
LANRUP entry has a primary amine. Amides are known to form stronger hydrogen bonds than 
primary amines; therefore the former is expected to form a stronger interaction than the 
latter.33 In the VUQMEA entry, the hydrogen bond between methanol and the amide group, in 
which the (N–H···O distance is below 2.5 Å) is thought to cause the retention of the solvent in 
the crystal. Despite this difference in hydrogen bond donating ability, the methanol predictive 
model looks at them as identical structures. It predicts both of them to form a solvate at value 
of x=0.373. In fact, it correctly predicts the solvate form of the VUQMEA entry but fails to 
predict the behaviour of the LANRUP entry. 
Another example is 2-((2-Aminophenylimino)(phenyl)methyl)-4-chlorophenol, CSD reference 
code: DEMFUX34 and N'-(2-hydroxynaphthylidene)-3-hydroxybenzohydrazide methanol 
solvate, CSD reference code: LOMLEF.35 These 2 entries are illustrated in Figure ‎6-6. 
 (a)  (b) 
Figure ‎6-6. An illustration of the DEMFUX (a) and the LOMLEF (b) entries. 
From the methanol model perspective, these two entries are identical as they share the same 
values for the descriptors in that model. They both possess a TRS value of 18 and an nHDon 
value of 3. Consequently, they both were predicted to form a solvate at a value of 0.330. By 
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looking at the illustrations of the molecules in Figure ‎6-6, it can be seen that the hydrogen bond 
donor groups are quite different. The DEMFUX entry shows one primary amine and a hydroxyl 
group while the LOMLEF entry shows two hydroxyl and one amide group. The misprediction of 
the DEMFUX is thought to be caused by the inability of the current models to differentiate 
between a strong and a weak hydrogen bonding group. 
6.2.2 Accessibility of hydrogen bonding 
Being one of the main factors involved in the formation of the solvate form, the hydrogen 
bonding ability of the misclassified compounds was investigated more closely. The nature of 
the hydrogen bond donor is not the only factor that influences this type of interaction. It can 
be influenced by other factors, such as the availability of the hydrogen bond donors. In many 
instances, molecules possessing hydrogen bond donor groups have failed to make hydrogen 
bonds with the solvent due to their inaccessibility or involvement in intramolecular bonding. 
An example of that can be seen in the case of tris(2-hydroxy-3-t-butyl-5-methoxybenzyl)amine, 
CSD reference code: RACMEP36 from the methanol dataset. The 3D structure is illustrated in 
Figure ‎6-7.  
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(a)  (b) 
Figure ‎6-7. An illustration of the limited accessibility of the hydrogen bond donors (the oxygen atoms in yellow) in 
the RACMEP entry. Part (a) of the Figure shows the capped sticks model of the entry; part (b) shows the space-
filling model of the same entry. The intramolecular hydrogen bonds are shown in the blue lines between atoms in 
part (a). 
This molecule has failed to form a solvate upon crystallization from methanol. It has a TRS 
value of 18 and possesses 3 hydrogen bond donors. As the capped-stick model in Figure ‎6-7(a) 
shows, the three hydrogen bond donating groups are involved in intramolecular hydrogen 
bonds. Additionally, the space-filling model in Figure ‎6-7(b) shows that these donors are hardly 
accessible for the solvent molecules due to the steric effect, leaving them with a low accessible 
surface area. For these reasons, the methanol model has failed to correctly predict the solvate 
formation of this entry, where it gave an x value of 0.330.  
Another example from the methanol dataset is the case of 5,11,17,23-tetra-t-butyl-25,27-
bis(2-(N-(pyrid-3-ylcarbonyl)amino)ethoxy)-26,28-dihydroxycalix[4]arene, CSD reference code: 
AZOMIL.37 The entry is illustrated in Figure ‎6-8. 
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(a) (b) 
Figure ‎6-8. (a) Capped-stick and (b) space filling representation of the AZOMIL molecule. The inaccessible donors 
(oxygen atoms) are highlighted in yellow. The intramolecular hydrogen bonds are shown in the blue lines 
between atoms in part (a). 
Similar to the previous example, this entry has shown a high TRS (52) value and a large number 
of hydrogen bond donors (nHDon=4). This compound was recrystallized from methanol and 
has failed to form a solvate. The likely reason for the inability of this entry to form a solvate is 
the low availability of the hydrogen bond donors. Three of the four donor groups in this 
structure participate in intramolecular hydrogen bonds. This can be seen by looking at 
Figure ‎6-8(a) where the capped stick model clearly shows it. The other factor is the steric effect 
where other atoms have prevented the solvent from interacting with the donors. This can be 
noticed by looking at Figure ‎6-8(b) which shows the low accessible surface area. The methanol 
model has failed to correctly predict the solvate formation of this entry, where it gave an x 
value of 0.015. This large misprediction is mostly attributed to the reasons mentioned. A large 
number of examples exists in the datasets. The reference codes of these entries are given in   
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Table ‎6-3. Similar to Table ‎6-2, this table shows examples from ethanol and methanol datasets 
because their models were the only two improved by the addition of the hydrogen bond factor 
to the models. 
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Table ‎6-3. Accessibility of hydrogen bond donors 
From ethanol data 
CSD 
reference 
code 
AVS_H2 nHDon Chemical formula 
Prediction 
value 
ICOTIE38  3.938 4 
 
0.069 
QEXYUO39 4.04 3 
 
0.106 
GILZOR40 4.474 4 
 
0.009 
WISTUN41 4.455 3 
 
0.024 
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Table 6-3. Continued 
From methanol data 
CSD 
 reference 
code 
TRS nHDon Chemical formula 
Prediction 
value 
AWITIJ42 52 4 
 
0.015 
TUFSIX43  52 2 
 
0.049 
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Table 6-3. Continued 
QASFUL44 40 4 
 
0.040 
RUWGOF45 40 2 
 
0.123 
6.2.3 Ring interactions  
This type of interaction was widely observed throughout the dataset at short contact distances 
(see the beginning of chapter 6 for the definition of short distances). In order to know if this 
interaction affects solvate formation, a comparison between the short interactions in the 
solvate and the non-solvate groups in each solvent can be conducted. Note that the search 
should cover all three common conformations (parallel, offset parallel and T-shaped) of the 
ring interactions. In addition to the distance, the angle of the interaction and how much it 
deviates from the ideal interaction (90 ᵒ for T-shaped, 0 ᵒ for offset and - stacking) should be 
taken into account. An illustration of the deviation from a perfect interaction is illustrated in 
Figure ‎6-9. 
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Figure ‎6-9. An illustration of the deviation that was allowed for the T-shaped interaction from 90 ᵒ. 
In order to optimize the angle and make it consistent when comparing the distance of 
interactions, the entries of all solvent datasets (~19,000 molecules) were searched for any type 
of ring interaction in the range from 3.2 to 5 Å. This range covers the distance from 0.5 Å 
below to 0.1 Å over the equilibrium distance of the benzene dimer interactions (see 
section ‎2.4.3 for more details). The results of this search are shown via a heat map in 
Figure ‎6-10. 
 
Figure ‎6-10. A heat map showing the number of entries that from a - interaction, where the x-axis shows the 
angle and the y-axis shows the centroid to centroid distance. 
Three regions of high density can be noticed in Figure ‎6-10, two to the left and one to the right 
of the figure. The one to the left high density in the range of 3.5 to 4 Å represents the 
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interactions at an angle near zero. This suggests that entries possessing offset - interactions 
and π-π stacking are in this region. It could be noticed that the interaction is restricted to being 
completely parallel, where a deviation of 5 ᵒ from the perfectly parallel interaction resulted in 
almost no hits. The high density region above that, near 5 Å is not thought to represent any 
binding interactions, as this distance is well above the interaction distance for parallel - 
interactions. The region to the right shows the largest number of interactions around 65 ᵒ 
indicating the entries on this side are the T-shaped (edge-to-face) interactions. More flexibility 
can be noticed in this type of interaction, where the first column with completely navy blue 
boxes can be seen around 40-50 ᵒ. As a result, the search that was conducted to count the 
number of interactions in each solvent allowed for a magnitude of deviation of 10 ᵒ for the 
parallel interactions (sandwich (parallel) and the offset-parallel interactions) from 0 ᵒ, while a 
deviation of 45 ᵒ from the 90 ᵒ ideal interaction was allowed for the T-shaped interactions. The 
results of this search are shown in Figure ‎6-11. The distance on the other hand was restricted to 
the same concept of short interactions defined in at the beginning of chapter 6. 
 
Figure ‎6-11. The percentage of structures with short ring interactions in the solvate and the non-solvate groups 
per solvent. Note that these hits are the ones that followed the restrictions set on the angles of the interaction.   
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Strong ring interactions turned out to be more frequent in solvates. This indicates that ring 
interactions could aid hydrate and solvate formation to different extents among solvents, with 
the chlorinated solvents and water being the most affected type of solvents. 
6.2.4 Halogen bonding 
The chlorinated solvents tested, dichloromethane and chloroform, have drawn attention to 
the halogen bonding role in solvate formation. More than 25 % of the chloroform solvate 
entries have shown halogen bond at short distances between the solvent and the molecules 
(see the beginning of chapter 6 for short distance definition). This could be an evidence of the 
participation of this type of bonding in solvate formation. On the other hand, no entries in this 
dataset showed to have a solvate where the solvent is stabilized through halogen bonding 
alone, which means the chlorinated solvent in any observed crystal always had other 
interactions binding it. This could suggest that halogen bonding is not strong enough to 
stabilize a solvate structure on its own.  
An example of a positive contribution of this bond towards solvate formation can be seen in t-
butyl (1-((4-bromophenyl)sulfonyl)-4-(4-methyl-1H-1,2,3-triazol-1-yl)piperidin-3-yl)carbamate 
chloroform solvate, CSD reference code: KUWWOP.46 An illustration is shown in Figure ‎6-12. 
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Figure ‎6-12. Molecular structure of KUWWOP. 
This entry shows a chlorine atom at a short distance (3.118 Å) from a nitrogen atom 
(C-Cl···N angle=173.8 ᵒ). It has a SM3_H2 value of 4.663 and an H.050 value of 1, both of which 
led to a prediction value of x= 0.520 by the chloroform model (formation of non-solvates). The 
prediction of this chloroform solvate was incorrect where the probability found was 0.020 over 
the cut-off point of the chloroform model. The inclusion of halogen bonding in the model 
could probably shift the predictions of such a case towards the correct prediction region. 
Another example from the chloroform dataset is meso-1,12-dimethylene-2,11-
dithia[3.3]metacyclophane 2,11-dioxide chloroform solvate, CSD reference code: PIGDOZ.47 
The 3D structure of the entry is shown in Figure ‎6-13. 
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Figure ‎6-13. An illustration of the halogen bond in the PIGDOZ entry. It shows the role of this type of bonding in 
the chloroform solvate formation. The bond takes place at a distance 0.1 Å shorter than the sum of the van der 
Waals radii of the two atoms. 
This entry shows a chlorine-oxygen halogen bond at a short distance of 3.027 Å 
(C-Cl…N angle=178.06 ᵒ). The molecule has an SM3_H2 value of 4.339 and a H.050 value of 0. It 
was predicted not to form a solvate at x=0.810. A number of entries in different datasets have 
also shown the effect of this type of interaction. Additional examples from the chloroform 
dataset are given in Table ‎6-4.  
Table ‎6-4. Additional examples of mispredicted data, involving a short halogen bond in the structure. The 
examples are given from the chloroform dataset 
From dichloromethane data 
CSD 
reference 
code 
SM3_H2 Hy Chemical formula 
Prediction 
value 
SUQQEA48 4.560 -0.601 
 
0.656 
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Table 6-4. Continued 
VOHHAC49 4.603 -0.104 
 
0.543 
MOHTOS50  4.741 -0.759 
 
0.537 
YAJCOD 4.742 -0.729 
 
0.531 
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Table 6-4. Continued 
From chloroform data 
CSD 
reference 
code 
SM3_H2 H.050 Chemical formula 
Prediction 
value 
REMDUK51 4.805 0 
 
0.508 
FIJXOM52 4.686 1 
 
0.503 
PASMUS53 4.765 0 
 
0.539 
KAJRUK54 4.747 0 
 
0.552 
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6.2.5 Zwitterions 
Some entries were mispredicted despite the fact that they had a prediction with a high 
confidence. Examples of entries that were predicted with a high confidence for solvate 
formation but failed to form them were given in section ‎6.2.2. This has happened when the 
hydrogen bond donors were not accessible by the solvent molecules, leading to an unexpected 
non-solvate. The opposite case was when some entries having a small size, low branching and 
small number of hydrogen bond donors were able to form a solvate. A closer look on these 
entries have revealed the fact that many of them were zwitterionic, i.e. having a formal 
positive and a formal negative charge on the same molecule. These entries were noticed when 
the data was first investigated in chapter 4 (section ‎4.3.2)  but were not excluded from the 
datasets. An example representing this case is 1-ammoniocyclopropanecarboxylate 
hemihydrate, CSD reference code: FOBJUB55 (Figure ‎6-14). 
 
Figure ‎6-14. Molecular structure of FOBJUB. The heteroatoms are labelled with their formal charge. 
This entry has an nH value of 7 and a ID value of 3.871. These values have led to a probability 
of x=0.905 by the hydrate model, which is far from reality. The entry shows an unusually short 
interaction between a hydrogen bond donating group (ammonium ion (NH3
+)) and the oxygen 
of water at a distance of 1.913Å. The large misprediction associated with this entry is mostly 
related to donor strength where the charged nitrogen is involved. The formal positive charge 
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might have caused it to be more electronegative than usual, leading to a strong interaction 
with the water molecule. This was not the only case witnessed in the datasets. The role of this 
highly polar nitrogen atom in hydrate formation coincides with what has been reported by L. 
Infantes et al. in a CSD investigation of around 35,000 organic molecules in 2006.56 Plenty of 
examples on this type of interaction were seen in each solvent dataset, which gives a warning 
sign to the scientists interested in developing charged organic materials. A list of examples 
illustrating this case from the water data are given in Table ‎6-5. 
Table ‎6-5. Additional examples on mispredictions due to the presence of a zwitterion 
From ethanol data 
CSD 
reference 
code 
AVS_H2 nHDon Chemical formula 
Prediction 
value 
APUNAA57 3.033 3 
 
0.847 
JUQQIV58 3.107 4 
 
0.638 
SUWLOL59 3.097 4 
 
0.646 
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Table 6-5. Continued 
From methanol data 
CSD 
reference 
code 
TRS nHDon Chemical formula 
Prediction 
value 
FEMQEV60 11 0 
 
0.848 
SAWGOM61 0 4 
 
0.551 
AKAWUE62 10 1 
 
0.767 
From dichloromethane data 
CSD 
reference 
code 
SM3_H2 Hy Chemical formula 
Prediction 
value 
EVODAV63 4.151 1.306 
 
0.676 
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Table 6-5. Continued 
ROLDEB64 4.420 -0.778 
 
0.773 
DAHMEE65 4.569 -0.294 
 
0.601 
From chloroform data 
CSD 
reference 
code 
SM3_H2 H.050 Chemical formula 
Prediction 
value 
MIPIMT66 3.886 0 
 
0.945 
TEQTUG67 3.926 3 
 
0.827 
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Table 6-5. Continued 
WAQLAD68 4.019 0 
 
0.919 
From water data 
CSD 
reference 
code 
ID nH Chemical formula 
Prediction 
value 
AHLPRO69 4.477 9 
 
0.860 
CEDJEA70 7.833 9 
 
0.588 
MAPYNM71 7.008 8 
 
0.691 
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6.2.6 Why these factors were not included in the predictive models 
Multiple factors that the models did not account for were mentioned in sections 6.2.1 to 6.2.5. 
A sensible question here would be why the statistical investigation did not identify any of 
these factors. The answer to this question can be one of these cases: 
 The number of examples of a specific factor might not have been large enough to be 
statistically significant. An example of this case can be the zwitterions problem (section 
6.2.5), where about 30 examples representing the case were found in each dataset. 
The fact that the smallest dataset is made of more than 2,500 data points, made these 
entries insignificant. 
 The factor is partially encoded in a descriptor that is already in the model. For 
example, the ring interactions (section 6.2.3) is a factor that was highly involved in the 
solvate formation of the chlorinated solvents. Nevertheless, it was not one of the 
three top descriptors that showed up in the statistical analysis, not even as the third 
most important descriptor. This is because the descriptors found by the logistic 
regression model (spectral moment in the case of chloroform and dichloromethane) 
inherently include information about the number of rings. For example, the correlation 
between the spectral moment descriptor SM3_H2 and the number of rings nCIC in the 
chloroform dataset is larger than 0.75. 
 No descriptor is available to represent that factor. An example of this is the hydrogen 
bond strength, where the descriptors available give either a yes or no, but do not give 
a weighing to the hydrogen bond.  
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6.3 Possible improvements 
At this point, it would be valuable to suggest solutions to improve the predictive ability of the 
models. This section suggests possible improvements that can solve some issues mentioned in 
section 6.2, leading to an effective, simple prediction of the solvate formation. 
6.3.1 Inclusion of a hydrogen bond strength scale 
The hydrogen bond donating ability can vary depending on the donating group and the 
environment surrounding it. Section 6.2.1 has explained this variability with examples. The 
question remains on how could the description of the hydrogen bond donating ability be 
improved? To start with, researchers are aware of this variation as mentioned in several 
publications.72, 73 Different research groups have worked on finding a solution to quantify this 
interaction. In 2001, a study led by Michael H. Abraham from the University College London 
presented empirical hydrogen bond structural constants indicating the relative ability of 
functional groups to donate and accept hydrogen bonds. These constants were obtained based 
on the equilibrium constant of a 1:1 hydrogen bonded complex. They were provided for both 
aromatic and aliphatic functional groups. In 2004, another group, led by Christopher A. Hunter 
was able to provide similar description based on the electrostatic potential surface of 
molecules. Despite the different approaches taken by these two groups, the ranking of 
hydrogen bonding ability between functional groups is analogous. 
Incorporating these findings into the current predictive models can improve their predictive 
ability. To be precise, it could be most beneficial to the predictions that are close to the 
decision boundary of the models, where a small shift towards the correct prediction region can 
influence the outcome. This assumption can be demonstrated by referring to the example in 
Section 6.2.1. The first entry in that example (CSD reference code: VUQMEA), which formed a 
methanol solvate possessed an amide group. The second entry (CSD reference code: LANRUP) 
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which has failed to from a solvate possessed a primary amine group. The empirical scales set 
by Abraham suggests that the hydrogen bond donating constant for the aliphatic amide group 
ranges between 0.40-0.55 compared to 0.08-0.16 for aliphatic amines. The amine in the 
LANRUP structure is connected to a benzene ring, which might mean it is close to being an 
aromatic amine due to the delocalization of the ring. The hydrogen bond donating constant for 
aromatic amines range is 0.17-0.26, which is still significantly lower than the constant of the 
amide. 
Although the hydrogen bond acceptors are not part of the predictive models at this point, an 
illustrative example is essential to prove the usability of these scales. The comparison between 
(3S,6S)-3,6-Diethyl-3,6-dimethyl-1,4-bis(1-phenylethyl)piperazine-2,5-dione methanol solvate, 
CSD reference code: IXAYOW74 and cis-1,4-dicyano-7,7-dimethoxy-6,6-dimethyl-2,3-benzo-cis-
bicyclo[3.3.1]nonane, CSD reference code: QIHFAO75 from the methanol dataset, suggests the 
importance of the hydrogen bond accepting scales. Both of these structures are shown in 
Figure ‎6-15. 
(a)       (b) 
Figure ‎6-15. Molecular structures of IXAYOW and QIHFAO. 
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These two molecules possess hydrogen bond acceptors. These groups are available for 
interaction with methanol. They both had a TRS descriptor value of 18 and an nHDon 
descriptor value of 0. The model does not qualify them to form a methanol solvate, where 
they are predicted at a value of x= 0.755. This means that the model correctly predicts the 
QIHFAO entry but fails to predict IXAYOW. The reason for this misprediction is thought to be 
due to the difference in the hydrogen bond accepting ability. In the paper published by 
Abraham, it is shown that the carbonyl of the amide group acts as a stronger acceptor than the 
ether or cyanide groups. The assigned values for their strengths on the hydrogen bond 
accepting scale is 0.77-0.80 for amide while it ranges between 0.48-0.51 and 0.36-0.44 for 
ether and cyanide groups, respectively.72 
6.3.2 Application of Etter’s rules 
One of the issues that limited the ability of the models to correctly predict the solvate 
formation was the inaccessibility of the strongly-binding functional groups. One reason for this 
inaccessibility was intramolecular hydrogen bonding or involvement of hydrogen bond 
donor/acceptor groups in intramolecular hydrogen bonding (see section 6.2.2). Margaret C. 
Etter has proposed a list of rules regarding hydrogen bonding.76 These rules focus mainly on 
the preferred interactions for strong hydrogen bond donors and acceptors. For example, one 
of the general rules states that “The best proton donors and acceptors remaining after 
intramolecular hydrogen-bond formation form intermolecular hydrogen bonds to one another.”  
The value of this rule can be seen in the cases illustrated and tabulated in section 6.2.2. The 
incorporation of these rules into the models has the potential to improve their predictive 
ability. 
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6.3.3 Inclusion of steric hindrance description 
The application of Etter’s rules can certainly account for a considerable part of the 
mispredictions associated with inaccessibility of the functional groups. Another reason why 
some groups were inaccessible was the steric hindrance around these groups. But how can this 
be studied theoretically? A model of hydrogen bond propensity in organic crystals, known as 
the “logit hydrogen bond propensity” (LHP) was introduced by P. Galek et al. in 2007.77 One of 
the parameters used by this model was called the steric density function. This function 
describes the density of non-hydrogen bonding atoms in the environment around the 
hydrogen bonding functional groups. When there is a high density of non-hydrogen bonding 
atoms, this means the hydrogen bond donor/acceptor is less likely to be accessible by other 
atoms. Such a function could be implemented as part of the predictive models. In more 
technical terms, the knowledge of the chemical structure of a molecule, along with the 
knowledge of the average bond lengths and atomic sizes can help find the density of atoms in 
a specific area, leading to an anticipation of the availability of the hydrogen bond 
donating/accepting groups. 
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 Experimental validation of the models  Chapter 7:
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7.1 Overview 
The predictive models for the five solvents were fitted based on the information available in 
the CSD. The performance of the models was statistically evaluated and the data misclassified 
by the model was analysed in previous chapters. At this point, it was important to check the 
applicability of these models in real-life experiments, representing their use in pharmaceutical 
development. In this chapter, 10 pharmaceutically active candidates will be selected. They will 
be experimentally tested for hydrate and solvate formation with each of the five solvents, in 
order to validate the predictive models obtained. Some of these drugs were part of the 
training data of solvents. Strictly speaking, this could cause preferential prediction for these 
candidates. Nevertheless, due to the large number of molecules in each dataset, the effect of 
these entries on the models is minute, where they constitute less than 1.7 % of the training 
data in the worst case.  
7.2 Selection of drug candidates and their profiles 
The 10 drug candidates that were used for the models validation were chosen to be 
pharmaceutically active and show variability in their molecular structures. The variability 
among these candidates was in terms of the molecular properties that were considered in the 
two-variable models. These are molecular size, different level of branching as well as different 
hydrogen bonding capability. Validating the models based on such different candidates would 
cover a wide range of pharmaceutical applications. The 10 candidates, their structure and 
selection strategy are summarized in Table ‎7-1. 
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Table ‎7-1. The molecular structure, some selected molecular descriptors, application and selection strategy of the 
10 drug candidates 
Drug Candidate Chemical structure 
Theophylline 
anhydrous 
 
 
- Descriptor values 
- AVS_H2 TRS nHDon SM3_H2 Hy H.050 piID nH  
- 3.522 11 1 3.853 0.022 1 6.794 8  
- Pharmaceutical use 
- 
A bronchodilator and an anti-inflammatory that is used in the 
treatment of reversible respiratory airways obstruction.1, 2 
Theophylline is one of the most widely used bronchodilators.1  It 
has been reported3, 4 that low doses of theophylline can reverse 
corticosteroid resistance in chronic asthma and obstructive 
pulmonary disease.  It also exhibits immunomodulatory effect.3-5 
- Selection Philosophy 
- 
Theophylline is a small-sized structure as compared to the 
datasets provided, when the molecular weight is considered (see 
Figure ‎4-11 of chemical space in chapter 4) is considered. The 
structure possesses some short branches. In terms of hydrogen 
bonding, the structure possesses one hydrogen bond donor and 5 
Hydrogen bond acceptors. This candidate was chosen due to the 
mixed properties it possesses where it falls in the middle range of 
most descriptors that are important for solvate formation.  
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Table 7-1. Continued 
Drug Candidate Chemical structure 
Hymecromone 
 
 
- Descriptor values 
- AVS_H2 TRS nHDon SM3_H2 Hy H.050 piID nH  
- 3.443 12 1 3.768 -0.202 1 7.351 8  
- Pharmaceutical use 
- 
A food supplement that is used in bile therapy.6 More recently, it is 
being recognized as a Hyaluronan (HA, Hyaluronanic acid) inhibitor 
therefore capable of preventing chronic inflammation, 
autoimmunity and tumours.7 For example, the inhibitory action of 
4-MU on HA can be beneficial in different malignant diseases such 
as prostate cancer.8 
- Selection Philosophy 
- 
Similar to theophylline, this molecule is small in terms of size, 
possesses two fused rings and shows minimal branching. It also 
contains one hydrogen bond donor and 3 acceptors. It is expected 
to have similar behaviour to theophylline. 
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Table 7-1. Continued 
Drug Candidate Chemical structure 
Isoniazid 
 
 
- Descriptor values 
- AVS_H2 TRS nHDon SM3_H2 Hy H.050 piID nH  
- 2.97 6 3 3.232 1.786 3 5.833 7  
- Pharmaceutical use 
- 
Isoniazid is a first-line anti-tubercular drug also used in 
tuberculosis preventive therapy for HIV positive patients.9, 10 
Isoniazid is mostly used in combination with other anti-tubercular 
drugs (ethambutol, rifampicin, and pyrazinamide) to treat multi-
drug resistant tuberculosis.9, 11  
- Selection Philosophy 
 
- 
Isoniazid possesses an AVS_H2 value which is well below the 
average value in any of the datasets. On the other hand it 
possesses 3 hydrogen bond donors in addition to 4 hydrogen 
bond acceptors, all of which are accessible for interaction. This 
hydrogen bonding ability is also well above the average, 
compared to other entries in any dataset (see Figure ‎4-11 from 
chapter 4 for more details). Such properties make isoniazid an 
excellent candidate that can compare the importance of the size, 
branching and complexity of the structure against the importance 
of hydrogen bonding. 
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Table 7-1. Continued 
Drug Candidate Chemical structure 
Ethenzamide 
 
 
- Descriptor values 
- AVS_H2 TRS nHDon SM3_H2 Hy H.050 piID nH  
- 3.105 6 2 3.477 0.59 2 6.278 11  
- Pharmaceutical use 
- 
Ethenzamide is an anti-inflammatory drug with analgesic, 
antipyretic, and sedative effects.12 It also has anti-convulsive and 
muscle relaxing effects.13 Ethenzamide is used as an active 
ingredient in pain reliving ointments.14 This drug has been 
reported to have ulcerogenic and hypothermic effects.12 
- Selection Philosophy 
- 
Ethenzamide is structurally related to isoniazid. In terms of size 
and branching, it possesses an AVS_H2 value that is slightly 
higher than isoniazid due to the extra branching from the ring. In 
terms of hydrogen bonding, it shows an inferior hydrogen bond 
donating/accepting ability. This candidate was chosen to observe 
if these changes in molecular structure can alter the solvation 
behaviour of the compound. 
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Table 7-1. Continued 
Drug Candidate Chemical structure 
Carbamazepine 
 
 
- Descriptor values 
- AVS_H2 TRS nHDon SM3_H2 Hy H.050 piID nH  
- 3.783 19 2 4.168 0.32 2 9.776 12  
- Pharmaceutical use 
- 
Carbamazepine is an anticonvulsant used to treat epilepsy15, 16 
and trigeminal neuralgia.17 It has been shown to have 
prophylactic and improving effect in manic-depressive illness.18-20 
It has been reported to reduce symptoms of diabetic 
neuropathy21 and post-traumatic stress disorder.22 
- Selection Philosophy 
- 
Carbamazepine’s AVS_H2 value is rather high compared to other 
entries. In terms of hydrogen bonding ability, one primary amide 
is present. It is also important to notice the rigidity of this 
structure, despite it is large size. Carbamazepine was chosen 
after isoniazid and ethezamide, to see the change in behaviour 
as the candidate gains more size, retains rigidity and gets a lower 
hydrogen bonding ability. 
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Table 7-1. Continued 
Drug Candidate Chemical structure 
Diflunisal 
 
 
- Descriptor values 
- AVS_H2 TRS nHDon SM3_H2 Hy H.050 piID nH  
- 3.545 12 2 4.083 0.429 2 8.499 8  
- Pharmaceutical use 
- 
Diflunisal is a nonsteroidal anti-inflammatory analgesic.23 It has 
been shown to be efficient in treatment of postoperative 
pain.24,25,26 
- Selection Philosophy 
- 
In terms of its molecular structure, diflunisal is considerably 
different from the previously described candidates. Firstly, it is a 
flexible compound compared to the previously chosen candidates, 
where the two rings are connected by a rotatable bond. Secondly, 
it possesses two fluorine atoms, which could have significant 
effect on the electrostatic interactions of the molecule. Finally, 
this entry still has two hydrogen bond donors that are completely 
available for interacting with other molecules. This drug is a 
candidate that represents a mildly flexible structure with 
hydrogen donating ability. 
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Table 7-1. Continued 
Drug Candidate Chemical structure 
Fenofibrate 
 
- Descriptor values 
- AVS_H2 TRS nHDon SM3_H2 Hy H.050 piID nH  
- 3.579 12 0 4.381 -0.79 0 8.814 21  
- Pharmaceutical use 
- 
Fenofibrate is used to treat high cholesterol levels.27 It reduces 
the angiographic progression of coronary-artery disease,28,  #873],  
#873],  #873],  #873],  #873] 2001 #873;Simpson, 1990 #867] and 
diabetic retinopathy29 in diabetes patients. 
- Selection Philosophy 
- 
Fenofibrate structure is largely flexible which gives the freedom to 
the molecule to assume a variety of conformations. On the other 
hand, it does not show long branching in any direction. No 
hydrogen bond donors are available in this structure. This could 
be a good candidate to see the effect of having a flexible structure 
with short branches, no hydrogen bond donating ability and a 
larger size compared to other candidates. 
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Table 7-1. Continued 
Drug Candidate Chemical structure 
Felodipine 
 
- Descriptors value 
- AVS_H2 TRS nHDon SM3_H2 Hy H.050 piID nH  
- 3.8 12 1 4.462 -0.277 1 8.66 19  
- Pharmaceutical use 
- 
An antihypertensive agent used in the treatment of high blood 
pressure30 [Comparison of Antihypertensive Effect and 
Pharmacokinetics of Conventional and Extended Release 
Felodipine Tablets in Patients with Arterial Hypertension Drugs]. 
The effect of Felodipine is increased by combining it with other 
agents, such as metoprolol.31 
- Selection Philosophy 
- 
Felodipine has a highly branched structure with a high AVS_H2 
value. It also possesses one hydrogen bond donor and multiple 
hydrogen bond acceptors. The features of this candidate are close 
to fenofibrate, which might cause them to have similar behaviour. 
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Table 7-1. Continued 
Drug Candidate Chemical structure 
Ketoconazole 
 
- Descriptor values 
- AVS_H2 TRS nHDon SM3_H2 Hy H.050 piID nH  
- 3.924 28 0 4.852 -0.717 0 10.425 28  
- Pharmaceutical use 
- 
An antifungal agent32 that is used to treat systematic dermal 
infections.33 It can be administered orally or topically (as cream or 
shampoo).34 The oral form is not preferred due to its high 
hepatotoxicity.34 Higher doses of the drug can cause 
hypoadrenalism.35 
- Selection Philosophy 
- 
Ketoconazole represents the case when the size of a molecule is 
large, branched, possesses multiple hydrogen bond acceptors, but 
no hydrogen bond donors. Screening this structure would give an 
idea on the role of hydrogen donating importance in solvate 
formation. 
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Table 7-1. Continued 
Drug Candidate Chemical structure 
Griseofulvin 
 
 
- Descriptor values 
- AVS_H2 TRS nHDon SM3_H2 Hy H.050 piID nH  
- 3.987 17 0 4.563 -0.699 0 8.93 17  
- Pharmaceutical use 
- 
An antifungal that is mainly used in the treatment of skin 
infections such as trichophyton and microsporum.36-38 It is 
administered orally and known to have multiple side effects.39  
More recently, it has been reported to be a promising anti-cancer 
agent.40, 41 
- Selection Philosophy 
- 
Griseofulvin is very close to ketoconazole in terms of the overall 
size and branching, as indicated by their AVS_H2 values. They also 
have identical nHDon and H-050 values and they both possess 
chlorine atoms. On the other hand griseofulvin is much more rigid 
compared to ketoconazole. This candidate could show the effect 
of rigidity on solvate and hydrate formation. 
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7.3 Sample preparation and characterization 
In this project, it is required to mimic the process under which pharmaceutical materials go 
during processing and manufacturing. These include exposing the candidates to the solvent for 
a long time to allow it to convert to the solvate form in addition to the stirring, which 
resembles the mechanical processing of materials in the industrial process. Therefore, slurries 
of each of the 10 drug candidates, with each of the 5 solvents were prepared, resulting in 50 
slurries. The principal method for hydrate and solvate formation is shown in the materials and 
methods chapter, section ‎3.2.2. 
Characterization of the samples was conducted using TGA. In this work, highly unstable 
solvates that undergo complete desolvation already below 40 °C were considered as non-
solvates. This is because in practice, they are expected to lose the solvent on their own or 
during the drying process. Heating up to 250 ᵒC was reasoned by the fact that all 10 candidates 
melt or decompose before reaching 250 ᵒC.42-52 
A thermogram was obtained for each of the 50 of the slurries prepared according to the 
method in section 3.2.2. Additionally, starting materials (labelled as ‘raw’ in figure) were also 
screened via TGA. Therefore; a set of 6 thermograms per drug candidate was obtained. These 
were then overlaid and analysed. When a new solvate was detected, further analysis took 
place to confirm the presence of this new form. It is important to mention that the TGA results 
shown in the sections of this chapter were normalized. This means that the first data point in 
each plot is considered to be the reference (100 % of weight). The normalization is denoted in 
the legend of the plots as an asterisk “*”. It is also useful to mention that the distance between 
the points on the curves is 5 °C.  
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Theophylline anhydrous 
The thermograms obtained for the theophylline screening products are shown in Figure ‎7-1.
 
Figure ‎7-1. The heating profile for theophylline and its screening products. 
With the exception of water, no weight loss was observed in any TGA profile prior to 
decomposition, which is seen above 170 °C. A theophylline hydrate was detected, with a 
weight loss of ~5.5 % at 60 ᵒC. Nevertheless, the weight loss in this thermogram could be 
misleading, as the desolvation seems to be starting before 40 °C. Therefore, the TG analysis 
was repeated from ambient temperature. The result is shown in Figure ‎7-2. 
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Figure ‎7-2. The TG thermogram of the theophylline hydrate from room temperature. 
The weight loss in Figure ‎7-2 represents the weight loss starting from room temperature. This 
means the weight loss observed here is the total loss in the experiment, which was calculated 
to be 10 % of the total sample weight. Such loss corresponds to a 1:1 stoichiometry of water to 
theophylline (the theoretical weight loss for a 1:1 hydrate is 9.1 %). Therefore, the hydrate 
formed here is most likely to be the same hydrate reported by Sutor et al In 1958.53 (CSD 
reference code THEOPH) 
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Hymecromone 
The thermograms obtained for the hymecromone screening products are shown in Figure ‎7-3. 
 
Figure ‎7-3. TGA profiles of hymecromone and its screening product. 
Ethanol, dichloromethane and chloroform were not able to form a solvate with hymecromone. 
Methanol and water on the other hand have shown a weight drop, attributed to the presence 
of a solvate in the structure. Since the desolvation that was observed for these two solvate 
forms starting around 40 °C, there is a chance there has been a weight loss below 40 ᵒC. For 
this reason, the TGA for these two samples were repeated, with recording the data starting 
from RT. The results are shown in Figure ‎7-4. 
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Figure ‎7-4. TGA profile of hymcromone methanol solvate and hydrate. 
The hydrate form shown in Figure ‎7-4 has reached a plateau of weight loss of 9.2 % at 90 °C, 
while the methanol solvate reached the weight loss plateau at 60 °C, with a weight loss value 
of 14.6 % of the original weight. Both of these correspond to 1:1 solvent:drug solvate (the 
theoretical weight loss is 9.3 % for a 1:1 hydrate and 15.4 % for a 1:1 methanol solvate).  A 
hymercromone hydrate was previously reported in 2002 with the same stoichiometry (1:1) 
(CSD reference code WIKDAV),54 which is likely to be the same hydrate. On the other hand, the 
methanol solvate was not found to be previously reported. For this reason, the PXRD pattern 
for the methanol solvate was obtained and compared to the simulated PXRD patterns of other 
hymercromone forms found in the CSD, as illustrated in Figure ‎7-5.  
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Figure ‎7-5. PXRD patterns of the solvated forms of hymecromone. 
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Isoniazid 
The thermograms obtained for the isoniazid screening products are shown in Figure ‎7-6. 
 
Figure ‎7-6.TGA profiles of isoniazid and its screening products. Note that the heating was up to 155 °C only; this is 
due to the low melting point of this drug candidate. 
Isoniazid was not able to form a solvate with any of the 5 solvents, where no weight loss was 
observed in any of the TG plots.  
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Ethenzamide 
The thermograms obtained for the ethenzamide screening products are shown in Figure ‎7-7. 
 
Figure ‎7-7. TGA profiles of ethenzamide and its screening products. Note that the heating was up to 180 °C only 
due to the low melting point of this drug candidate. 
Similar to isoniazid, ethenzamide did not form a solvate with any of the five solvents. These 
two drug candidates are structurally related and it is expected for them to show similar 
behaviour.  
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Carbamazepine 
The thermograms obtained for the carbamazepine screening products are shown in Figure ‎7-8.
 
Figure ‎7-8. TGA profiles of carbamazepine and its screening products. 
Carbamazepine has failed to form a solvate with any solvent except for water. A hydrate is 
already known to form with carbamazepine as has been reported.55 As the desolvation of the 
carbamazepine hydrate takes place at low temperature, the TGA run was repeated starting 
from RT. The TGA profile obtained is shown in Figure ‎7-9.  
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Figure ‎7-9. TGA profile of carbamazepine hydrate measured from RT. 
The weight loss was 12.6 %, this corresponds to a dihydrate, (theoretical weight loss of a 
dihydrate is 13.3 %) showing that the solvate that was formed here is most likely to be the 
same as the one known before. 
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Diflunisal 
The thermograms obtained for the diflunisal screening products are shown in Figure ‎7-10. 
 
Figure ‎7-10. TGA profiles of diflunisal and its screening products. 
Diflunisal was able to form a solvate with both chlorinated solvents, as can be seen in 
Figure ‎7-10. A 1:1 diflunisal chloroform solvate has been previously reported (CSD refcode: 
RUXRUX 10.1021/cg025589n), while no dichloromethane solvate was found to be reported. 
The stoichiometry obtained by weight analysis shows that the solvent: drug ratio is 0.34 and 
0.38 for dichloromethane and chloroform, respectively. This ratio suggests the chloroform 
solvate is different from the reported one, as shown by the PXRDs in Figure ‎7-11. 
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Figure ‎7-11.  PXRD patterns of diflunisal dichloromethane and chloroform solvate forms. 
The similarity between the PXRD patterns of the dichloromethane and chloroform solvate and 
the non-stoichiometric ratio of the solvate forms could be an indicative of the presence of a 
channel solvate, where the molecules are not in a definite order inside the channels. 
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Fenofibrate 
The thermograms obtained for the fenofibrate screening products are shown in Figure ‎7-12. 
 
Figure ‎7-12. TGA profiles of fenofibrate and its screening products. 
Despite its large size, fenofibrate has failed to form any solvate with the 5 solvents. 
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Felodipine 
The thermograms obtained for the felodipine screening products are shown in Figure ‎7-13. 
 
Figure ‎7-13.TGA profiles of felodipine and its screening products. 
Similar to fenofibrate, felodipine is an example of a large-sized structure in comparison to 
other candidates. Note that felodipine was more likely to form a solvate due to having a 
hydrogen bond donor in its structure, nevertheless both did not form any solvents with the 5 
solvents. 
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Ketoconazole 
The thermograms obtained for the ketoconazole screening products are shown in Figure ‎7-14. 
 
Figure ‎7-14. TGA profiles of felodipine and its screening products. 
Despite its large size, flexibility and multiple hydrogen accepting sites, ketoconazole has failed 
to form a solvate with any of the 5 solvents. The loss of weight in the chloroform sample has 
started after melting, when the sample was visually inspected, it was a yellow/brownish liquid 
in colour, indicating the weight loss seen in the thermogram is due to decomposition. 
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Griseofulvin 
The TGA results for griseofulvin and its screening products are shown in Figure ‎7-15 . 
 
Figure ‎7-15. TGA profiles of griseofulvin and its screening products. 
Griseofulvin was able to form solvates with the chlorinated solvents only. Both a chloroform 
and a dichloromethane solvates were previously reported for griseofulvin.56,57 They show an 
interesting desolvation pattern, where the solvent loss is observed over two steps, one 
happening below 80 °C and the other starting around 80 °C. It is noticeable that the solvent 
loss starts from around room temperature. In order to work out the solvate stoichiometry 
correctly, another experiment was conducted starting from 25 °C, the result of which is show 
in Figure ‎7-16.  
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Figure ‎7-16. TGA profiles of the dichloromethane and chloroform solvate forms of griseofulvin. 
The loss of total weight of the dichloromethane and chloroform solvate upon desolvation was 
(19 %) (25.4 %), respectively. Both solvents in a 1:1 solvate (the theoretical weight loss for 1:1 
dichloromethane solvate is 19.4 % and for 1:1 chloroform solvate – 25.3 %). These results 
match the forms that were previously reported in the literature. 56, 57 The crystal structure of 
the dichloromethane solvate had not been reported. For this reason, a single crystal X-ray 
diffraction experiment was conducted for this solvate. The results and discussion of the 
structure are presented in section 7.5.  
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7.4 Prediction vs results 
After all screening experiments were completed; it was time to compare the experimental 
results with the predictions made via the computer. The predictions made by each model are 
presented separately in Tables 7-2 to 7-6. The highlighted cells in these tables indicate a wrong 
prediction by the models. 
Table ‎7-2. Prediction vs. screening results for the ethanol predictive model 
Drug candidate Prediction value 
Experimental 
solvate 
Carbamazepine 0.427 No 
Felodipine 0.623 No 
Diflunisal 0.649 No 
Griseofulvin 0.657 No 
Ketoconazole 0.709 No 
Theophylline 0.827 No 
Hymecromone 0.866 No 
Izoniazaid 0.875 No 
Fenofibrate 0.901 No 
Ethenzamide 0.908 No 
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Table ‎7-3. Prediction vs. screening results for the methanol predictive model 
Drug candidate Prediction value 
Experimental 
Solvate 
Carbamazepine 0.455 No 
Ketoconazole 0.570 No 
Izoniazaid 0.576 No 
Diflunisal 0.601 No 
Ethenzamide 0.715 No 
Felodipine 0.736 No 
Hymecromone 0.736 Yes 
Theophylline 0.752 No 
Griseofulvin 0.771 No 
Fenofibrate 0.837 No 
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Table ‎7-4. Prediction vs. screening results for the dichloromethane predictive model 
Drug candidate Prediction value 
Experimental 
Solvate 
Ketoconazole 0.439 No 
Griseofulvin 0.668 Yes 
Felodipine 0.680 No 
Carbamazepine 0.791 No 
Fenofibrate 0.796 No 
Diflunisal 0.824 Yes 
Theophylline 0.929 No 
Hymecromone 0.953 No 
Ethenzamide 0.969 No 
Izoniazaid 0.970 No 
  
273 
 
Table ‎7-5. Prediction vs. screening results for the chloroform predictive model 
Drug candidate Prediction value 
Experimental 
Solvate 
Ketoconazole 0.472 No 
Felodipine 0.667 No 
Griseofulvin 0.684 Yes 
Carbamazepine 0.770 No 
Fenofibrate 0.790 No 
Diflunisal 0.813 Yes 
Theophylline 0.928 No 
Hymecromone 0.943 No 
Ethenzamide 0.965 No 
Izoniazaid 0.975 No 
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Table ‎7-6.Prediction vs. screening results for the water predictive model 
Drug candidate Prediction value 
Experimental 
hydrate 
Ketoconazole 0.079 No 
Fenofibrate 0.243 No 
Felodipine 0.291 No 
Griseofulvin 0.304 No 
Carbamazepine 0.320 Yes 
Diflunisal 0.539 No 
Hymecromone 0.658 Yes 
Ethenzamide 0.701 No 
Theophylline 0.710 Yes 
Izoniazaid 0.803 No 
The ethanol model has performed unexpectedly well with 9 correct predictions out of 10. The 
only misprediction by this model was for the carbamazepine molecule. It is worth noting that 
no solvate was formed by the 10 candidates that were tested. This probably shows the ethanol 
model predictive ability towards non-solvate forming molecules only. The methanol model 
followed with a success rate of 8 out of 10. The misprediction was for one solvate 
(hymecromone) and one non-solvate (carbamazepine). The dichloromethane and chloroform 
models have shown a lower predictive ability than the previous models, with 3 mispredictions 
for each model. These wrong predictions were for one non-solvate (ketoconazole) and two 
solvate forms (griseofulvin and diflunisal). The water model has mispredicted the behaviour of 
5 out of 10 compounds. Ketoconazole, felodipine and fenofirate were predicted to form a 
hydrate but didn’t do so. The other two mispredictions, hmyecromone and theophylline were 
predicted not to form a hydrate, yet they were able to form one. 
As the main reasons for solvate formation are not known, the real reasons for the 
mispredictions are not known either. An explanation could be established for each molecule 
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separately, in terms of molecular descriptors and 3D structure; however this would take us out 
of the scope of the research, where we are trying to find a trend for solvate formation. 
Alternatively, some patterns have been noticed in this set of tested molecules. For example, 
isonizaid and ethenzamide had a very small size, resulting in the formation of no solvate with 
any of the 5 solvents, despite their hydrogen bonding ability. Ketoconazole, fenofibrate and 
felodipine were large in size, yet failed to form a solvate with any of the solvent. It can be 
noticed that the first two possess no hydrogen bond donors, which can explain their behaviour 
not to form solvates. Felodipine does possess one hydrogen bond donor, but the ratio of 
hydrogen bond donors to its size is small. Moreover, all three molecules possessed a 
chlorinated ring, which could signal the existence of an electrostatic factor contributing to 
strong intermolecular interactions; therefore, solvent exclusion from the crystal. 
For the molecules that were able to form a solvate despite the model predicting them not to 
form one, it seems like these molecules have the ability to arrange themselves in a low-energy 
solvate form. One trend that was obvious among these was special to the water model, where 
rigid molecules (consisting of connected rings with some degree of branching) were able to 
form a hydrate; these are hymecromone, theophylline anhydrous and carbamazepine. 
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7.5 Griseofulvin dichloromethane solvate 
7.5.1 Overview 
Griseofulvin formed a dichloromethane solvate, as determined from TG results shown in 
Figure ‎7-16. Further investigation regarding this solvate will be carried out in this section. The 
griseofulvin dichloromethane solvate was selected among all other solvates due to the 
interesting properties it showed. For example, colourless single crystals of the solvate were 
formed upon slurrying, yet, the crystal structure of this compound was not known. 
Additionally, the form was stable for more than 24 h at ambient conditions where no changes 
in TGA profiles were observed between a fresh and a stored sample. 
7.5.2 Under the microscope  
An optical refractive microscope and an optical transmittance microscope were used for 
observing the griseofulvin dichlormethane solvate crystals (see section ‎3.2.6 for more details 
about the microscopes). Both of these microscopes were equipped with heating units (hot-
stage microscope). The heating units help studying the morphological changes of the crystals 
over a range of temperature, particularly around the desolvation temperature (80 °C). Since 
the temperature required to achieve the desolvation wasn’t too high, the samples were 
heated under the microscope to 120 °C with a rate of 5 °C min-1. The results are shown in 
Figure ‎7-17. 
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Figure ‎7-17. The first and the last frame of the heating cycles of griseofulvin dichloromethane solvate in the 
reflective (a) and transmittance microscope (b). The first images (left) were taken at ambient room temperature 
while the final images (right) were taken at 120 °C. 
In both techniques, the griseofulvin started as transparent brick/slate-shaped crystals. Upon 
heating, the transparency of these crystals was lost while the morphology of the crystals was 
retained.  
7.5.3 X-ray data and structure solution 
A crystal of suitable size for single crystal X-ray diffraction analysis was obtained from the 
filtered and dried slurry. The cell parameters determined for this crystal in comparison to cell 
parameters for griseofulvin dichlorometane solvate available from literature are given in 
Table ‎7-7. The cell parameters reported previously were determined using a capillary method 
and calculated via least squares approach. The space group was not reported.57 
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Table ‎7-7. Crystallographic parameters of the new dichloromethane solvate (II) versus the reported one (I) 
Parameter  New DCM solvate II Reported DCM solvate I 
Lattice system Monoclinic Triclinic 
Space group I2 Not reported 
a (Å) 11.7585(6) 11.776(5) 
b (Å) 8.5592(4) 11.918(6) 
c (Å) 19.6721(13) 8.640(4) 
α (°) 90.0 111.44(3) 
β (°) 96.817(5) 90.00(3) 
γ (°) 90.0 66.69(3) 
Cell volume 1965.86(19) - 
Density 1.482 - 
Crystal size 
(mm) 
0.4 x 0.04 x 0.02 - 
Z 2 - 
R 0.0592 - 
wR2 0.1542 - 
Temperature 
(K) 
293(2) - 
The cell parameter comparison of the solvate obtained in this work and that reported in 
literature shows considerable differences in the crystallographic data.  The new solvate 
crystallized in the space group I2 (monoclinic) as opposed by the triclinic system reported in 
literature.57 The crystal structure data acquired within this work were used to simulate a 
theoretical powder pattern of griseofulvin dichloromethane solvate. This simulated pattern 
was compared to the pattern acquired from literature in order to identify whether a new 
crystalline form has been obtained, as illustrated in Figure ‎7-18.  
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Figure ‎7-18. Comparison of X-ray diffraction patterns of griseofulvin dichloromethane solvate simulated from 
crystal structure (blue) and reported in literature (orange).  
The comparison of the two X-ray diffraction patterns show some similarity although diffraction 
peak positions are considerably shifted probably due to temperature difference (the single 
crystal data were collected at lower temperature). The apparent similarity between both 
patterns imply that the same crystal form as reported in literature has been obtained in this 
work. However, since crystal structure of the solvate had not been determined previously, it is 
reported in this thesis. The molecular structure of this solvate is shown in Figure ‎7-19.  
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Figure ‎7-19. Molecular structure of griseofulvin showing ellipsoids of thermal displacement parameters. 
Probability of shown ellipsoids is set to 50 %. 
The crystal structure solution of the griseofulvin dichloromethane solvate showed two 
crystallographically independent solvent molecules in the asymmetric unit. The two solvent 
molecules are situated on special positions (i.e. 2 fold symmetry axes), and therefore only half 
of each molecule belongs to the asymmetric unit. Moreover, one of the dichloromethane 
molecules shows a disorder over multiple positions. Several datasets were obtained from 
different crystals and all of them have shown the same trend of one ordered and one 
disordered dichloromethane molecule. The disorder in the solvent molecules has been 
accounted for by refining the occupancies of the corresponding atoms. The chlorine atoms of 
molecule A (see Figure ‎7-19) are symmetry-related and have occupancy of 1. The 
dichloromethane molecule B is disordered over multiple positions. As a result, each of the four 
atom positions can be occupied either by chlorine or by carbon. An illustration of this disorder, 
along with the atom numbering is shown in Figure ‎7-20. 
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Figure ‎7-20. An illustration of the numbering of griseofulvin. 
In the disorder component of the disordered dichloromethane (molecule B) illustrated by black 
lines, the occupancy of the carbon atoms (C27A) should be halved because the carbon atom 
can reside on one of the two symmetrically related positions shown in Figure 7-20 by either 
continuous or dashed lines. The chlorine atoms also should have an occupancy of 0.5, because 
they are on a twofold axis. When the grey illustration of the disordered dichloromethane 
molecule in Figure ‎7-20 is considered, the carbon atoms (C27B, C31B) represent two alternative 
orientations of the molecule. The proportion of former (black) to the latter (grey) part was 
0.21:0.29, leading to a total occupancy of this disordered moiety of 0.5, per asymmetric unit. 
Together with the non-disordered dichloromethane molecule the total stoichiometry of the 
solvate is 1:1, as observed in the TGA thermogram in Figure ‎7-16. 
Previous investigations have reported the crystal structures of griseofulvin polymorphs as well 
as a chloroform solvate. The overlays of the griseofulvin molecule in the newly found solvate 
with the reported griseofulvin structures56, 58-60 and with the known chloroform solvate56 are 
shown in Figure ‎7-21 (a) and (b), respectively.  
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(a) 
(b) 
Figure ‎7-21. (a)An overlay of the griseofulvin molecule in the new DCM solvate (red) with all reported structures 
of grsieofulvin in the CSD. Reference code GRISFL is shown in blue, GRISFL02 is shown in yellow, GRISFL03 is 
shown in orange, GRISFL04 is shown in green. (b) An overlay of the new grisefoulvin dichloromethane solvate 
(red) with the exiting chloroform solvate (grey), CSD reference code MATZEO. 
The overlay in part (a) of the figure shows that the solvate and all polymorphs exhibit a similar 
conformation in the rigid part of the structure (the fused rings and their branches), while they 
show a difference in the direction of the cyclohexane ring and the radicals attached to it. On 
the other hand, part (b) of Figure ‎7-21 shows high similarity between the dichloromethane and 
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chloroform solvate in terms of the molecular structure. Crystal packing similarity function in 
mercury was applied for the dichloromethane and chloroform solvate, the result was 9 out of 
15 molecules in common. 
7.5.4 Interactions and packing 
Before discussing the structure, it is useful to note that in this section, as in chapter 6, any 
interactions with inter-atomic distances shorter than the VDW radii (of interacting atoms) by 
at least 0.1 Å are referred to as “short interactions”. It is also important to note that the 
numbering that is shown in Figure ‎7-20 is going to be used for the discussion of the interactions 
and packing.  
Looking at the interactions of griseofulvin molecules, it can be seen that each molecule forms a 
dimer with an inverted molecule via a pair of C−H···π interactions. Specifically, the interaction 
takes place between H10A and C15 on the chlorinated benzene ring, [d(H···C) =2.787 Å, 
C−H···C = 147.64 °] as illustrated in Figure ‎7-22(a). Note the high contact surface area 
between the molecules in the dimer associated with this interaction, which enforces the 
connection of the molecules in this dimer further. These dimers are connected to other dimers 
along the crystallographic a axis via C−H···O interactions resulting in a ladder-like arrangement, 
as shown in Figure ‎7-22(a). These weak hydrogen bonds take place between O1 and H24A 
[d(H···O) =2.454 Å, C−H···O = 123 °]. The ladder-like motif is connected to other similar motifs 
in horizontal and diagonal directions if the “packing” was viewed along the a axis, as illustrated 
Figure ‎7-22(b). Two interactions linking the dimer motif to another horizontally were noticed, 
these are a short halogen interaction between Cl20 and O23 [d(H···O) =3.137 Å, 
C−H···O = 140.10 °] in addition to a slightly longer C−H···O bond between H24C and O21 
[d(H···O) =2.669 Å, C−H···O = 154.18 °]. These interactions are viewed alone in Figure ‎7-22(c). 
Diagonally, the dimers are held via a two C−H···O bonds between H9C and O19 [d(H···O) 
=2.424 Å, C−H···O = 164.37 °] and O11-H9A [d(H···O) =2.734 Å,  C−H···O = 150.65 °]. Note 
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that the H9C and H9A mentioned here belong to two different molecules. These two bonds 
result in a ring-like 𝑅2
2(13)61 hydrogen bonded dimer, as illustrated in Figure ‎7-22(d).
(a)      (b) 
(c)  (d) 
Figure ‎7-22. The interactions between griseofulvin molecules. Part (a) shows the dimers formed by griseofulvin 
molecules along the B axis. Part (b) shows four pairs of dimers along the a axis. Part (c) shows the horizontal 
interaction between the molecules in part (b), along the C axis. Part (d) shows the ring-like interaction that 
connects the dimers in part (b) diagonally. 
The interactions between the griseofulvin molecules result in a structure with channels, where 
the dichloromethane molecules are positioned. These channels are illustrated in Figure ‎7-23. 
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(a) 
(b) 
(c) 
Figure ‎7-23. The channels of dichloromethane in the griseofulvin dichloromthenae solvate II from. Part (a) shows 
these channels along the a axis, part (b) show the same channels along the b axis and part (c) show the same 
channels along the c axis. 
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It can be noticed that each channel contains a sequence of disordered-ordered 
dichloromethane molecules as can be seen in Figure ‎7-23(c). The non-disordered 
dichloromethane molecules have short interactions with two griseofulvin molecules. These are 
formed through two symmetry-equivalent C–H···O bonds. Specifically, it is between the 
hydrogen atoms in the dichloromethane molecule (H26A, H26B) and the O19 of two 
griseofulvin molecules [d(H···O) =2.586 Å, C−H···O = 142 °]. This dichloromethane molecule 
also forms short interactions with adjacent, disordered dichloromethane molecules through a 
C–H···Cl bond ((d(H···O) =2.52 Å, C−H···O = 121 °]. With exception of the latter weak bond, 
the disordered dichloromethane molecules were not involved in any other short attractive 
interaction, allowing free rotation of these molecules, resulting in the disordered fragment. 
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 Single crystal analysis of the new fenofibrate forms Chapter 8:
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8.1 Overview 
This chapter is dedicated to describing new advances related to the polymorphs of the 
fenofibrate drug. The structural formula of fenofibrate and atom numbering used further is 
shown in Figure ‎8-1. 
 
Figure ‎8-1. The structural formula of fenofibrate showing atom numbering scheme. 
This anti-hyperlipdemic agent shows interesting crystallization properties when crystallized 
from its amorphous form. Homogeneous nucleation and crystallization are slow for 
amorphous fenofibrate.1 Alternatively, heterogeneous crystallization can be initiated by 
addition of an impurity or mechanical stimulation.2 The crystallization of fenofibrate was 
studied with a colleague working in the same suite, Mr Pratchaya Tipduangta. In this chapter, 
the theme of Tipduangta’s work on fenofibrate will be outlined to give a background, but the 
main focus will be the part which I took part in, that is, the determination of the crystal 
structure of two feonfibrate polymorphs, form IIa and form III using single crystal XRD. 
8.2 Fenofibrate polymorphs 
Forms I and II of fenofibrate were reported in the literature.3-6 The literature regarding form I 
was clear, where multiple papers described the same crystalline form. 3-5 On the other hand, 
the literature about form II was not as consistent. Di Martino et al. were the first to report 
form II of fenofibrate in 2000, where they provided PXRD pattern and DSC data of this form. 
More details about the same form was given by Heinz et al. in 2009.3, 4 The latter has 
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confirmed obtaining the same form as Di Martino’s group using DSC data. Another group, 
Balendiran et al. have reported a crystal structure of form II in 2011.5 What is surprising is that 
the simulated PXRD pattern of fenofibrate in the latter work does not match the recorded 
PXRD pattern obtained by the former groups, which signals these are different forms. To avoid 
confusion, Tipduangta has denoted the form discovered by Di Martino et al. as “form IIa” while 
he denoted the form reported by Balendiran et al. as “form IIb”. The PXRD of these forms are 
shown in Figure ‎8-2. 
 
Figure ‎8-2. PXRD patterns of the different fenofibrate polymorphs. 
8.3 Polymorph preparation 
The method that was used to obtain each of the four fenofibrate forms is described in this 
section. Form I of fenofibrate is simply the powder that was obtained from the supplier 
(Sigma-Aldrich). From IIa of fenofibrate was obtained via heterogeneous crystallization of 
amorphous fenofibrate. The preparation started with placing the fenofibrate powder (form I) 
on a microscopic slide, where it was heated to a 100 °C until all fenofibrate was melted. After 
10 15 20 25 30 35 40 45 50
Form I
Form IIa
Form IIb
Form III
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that, the solid on the microscopic slide was left to cool at room temperature to obtain 
amorphous material. Crystallization was initiated by surface disruption; that is, scratching the 
surface of the amorphous film with a stainless steel spatula. The microscopic slide was left to 
crystallize at room temperature, where it yields a mixture of fenodibrate forms I and IIa, with 
from I being dominant. Tipduangta manipulated two factors to get preferential crystallization 
of from IIa.8 The factors changed were the temperature and the free surface available during 
crystallization. The result was the possibility to obtain a pure form IIa by reducing the free 
surface available, i.e. by placing a coverslip on the microscopic slide right after the mechanical 
stimulation of the amorphous film and allowing crystallization to happen in the range from 
room temperature to 40 °C. It was also possible to obtain a mixture of fenofibrate form I and 
IIa, with form IIa being the dominant form by annealing the free-surface microscopic slide at 
40-50 °C. 
Form IIb was reported by Balnderian et al., where they were able to obtain that form by 
recrystallization of fenofibtate from ethanol at room temperature. However, Tipduangta was 
not able to reproduce the form when the same procedure was followed. Alternatively, form I 
of fenofibrate was obtained. A group that worked on fenofibrate in 2014 had the same result 
as Tipguanda,7 where they obtained fenofibrate form I by crystallizing it from an 
undersaturated ethanol solution by slow evaporation. 
From III was obtained via heterogeneous nucleation of amorphous fenofibrate. In order to 
obtain this form, fenofibrate powder (form I) and talc (a pharmaceutical excipient) were 
weighed out in a ratio of 99:1, placed in a glass vial and mixed well with a stainless steel 
spatula. The vial was then heated to 100 °C until all fenofibrate melted. After that, it was 
transferred to a 0 % relative humidity desiccator. After 24 hours, the amorphous fenofibrate in 
the vial crystallized as form III. Obtaining this form was confirmed using microscopy, ATR-FTIR 
and PXRD.8 
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8.4 Single crystal X-ray Diffraction 
8.4.1 Structure solution 
The crystal structures of the forms IIa and III have not been previously determined. In order to 
obtain the crystal structure of these forms, single crystal X-ray diffraction experiments were 
conducted. The crystallographic parameters for these two forms compared to the forms 
mentioned in the literature are shown in Table ‎8-1. 
Table ‎8-1. Crystallographic parameters of fenofibrate polymorphs 
Parameter Form I9 Form IIa8 Form IIb5 Form III 
Lattice system Triclinic Triclinic Monoclinic Triclinic 
Space group P1̅ P1̅ P21/n P1̅ 
a (Å) 8.1325 8.1328(5) 13.619 9.4803(6) 
b (Å) 8.2391 8.7088(6) 7.554 9.7605(6) 
c (Å) 14.399 13.6692(9) 17.88 10.9327(8) 
α (°) 93.978 85.976(6) 90 110.840(6) 
β (°) 105.748 84.815(5) 92.35 90.352(5) 
γ (°) 95.854 74.344(6) 90 99.701(5) 
Cell volume 919.03 927.34(11) 1837.909 929.53(11) 
Density (qcm3) 1.285 1.292 1.304 1.289(2) 
Crystal size (mm) 0.55 x 
0.50 x 
0.44 
0.12 x 0.13 x 
0.46 
0.55 × 0.30 × 
0.25 
0.12 × 0.15 × 
0.34 
Z 2 2 4 2 
R 0.0418 0.0694 0.0355 0.0653 
wR2 0.105 0.1265 0.0897 0.149 
Temperature (K) 193 140(2) 100 140 
Goodness of fit 1.035 1.023 1.026 1.016 
Both forms IIa and III crystallize in the triclinic P1̅ space group with one molecule of fenofibrate 
in the asymmetric unit and two molecules in the unit cell. Structures of forms IIa and III have 
been solved according to the method described in section 8.3. The molecular structures of 
fenofibrate in these new forms are shown in Figure ‎8-3(a) and (b). 
299 
 
(a) 
(b) 
Figure ‎8-3. ORTEP structure of fenofibrate forms IIa (a) and III (b). 
In order to visually compare the conformation of fenofibrate in its polymorphic forms, an 
overlay of the molecular structures in these forms was generated and is shown in Figure ‎8-4. 
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Figure ‎8-4. An overlay of fenofibrate form I (black), form IIa (blue), form IIb (red), form III (green). 
The fenofibrate molecule can be divided into two main parts: a rigid part consisting of the two 
aromatic rings linked by a keto group and a flexible aliphatic tail. The overlay in Figure ‎8-4 
shows that form IIa exhibits the highest proximity in spatial conformation to the most stable 
form I, followed by form III then form IIb. It is noticeable that for the 4 forms shown in the 
figure, the aliphatic chain is not fully extended, but rather folded back towards the aromatic 
part of the structure. This folding seems to be stabilized by an intramolecular C–H···O 
interaction between the middle benzene ring and the ester group in the alkyl chain. An 
overview of the intra-molecular interactions and angles representing the conformation of the 
molecule is given in Table ‎8-2.  
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Table ‎8-2. Intramolecular angles and short contact distances in fenofibrate. The RMSD is a function in mercury 
program that compares structural similarity between molcules/forms 
Form 
Angles 
between the 
two 
aromatic 
rings 
Distance between 
carbonyl O of the 
ester and H of the 
central benzene ring 
Distance between 
ether O and H of 
the benzene ring 
Torsion angle 
(C14-C13-
O16-C17) 
RMSD 
compared to 
form I 
I 48.62(7) ° 2.81 (O24···H14) 2.84 (O21···H14) -23.36 0 
IIa 48.25(10) °  3.04 (O24···H14) 
2.649(16) 
(O21···H14) 
-40.35 
0.189 
IIb  53.73 °  2.90 (O24···H12) 3.00 (O21···H12) 174.98 1.844 
III 45.73(9) °  2.8 (O24···H14) 2.81 (O21···H14) 10.2 0.323 
Table ‎8-2 further confirms the order of conformational similarity to the stable form I among the 
polymorphs to be form IIa > from III > from IIb in both the aromatic and aliphatic parts. The 
easiest way to see this is by comparing the values in the RMSD column. This value is calculated 
through the molecular similarity function in mercury, where the value obtained is based on the 
mean distance between all atoms in the different polymorphs. The values indicate that the 
molecular similarity of these forms is in the sequence mentioned earlier. Other parameters can 
also show the similarity between these molecules. For example, the angle between the planes 
of the two aromatic rings in from IIa deviates from the most stable form by less than 0.5 °, 
compared to a deviation of 3 ° in from III and 5 ° in form IIb. Similar trend was observed in the 
flexible part of the molecule as shown by the torsion angle between the central benzene ring 
and the propanyl-2-methylpropanoate group. The torsion angle between (C14-C13-O16-C17) 
was given in Table ‎8-2 as this is the angle at which the direction of the alkyl chain is defined; 
therefore it signals the similarity between the geneal structures of the different forms.  
From IIb adopts a conformation that is different from other known polymorphs, nonetheless, it 
was found that this molecule in this crystal has a similar conformation to the one observed in 
the fenofibric acid crystal structure.5 In the further discussion only the structures determined 
within this work (forms IIa and III) and the structure of the stable form I will be compared.  
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8.4.2 Main intermolecular interactions 
Fenofibrate form I is the thermodynamically stable form meaning that it has the lowest Gibbs 
energy. For this reason, the interactions in the two newly found structures will be compared to 
it. The main groups that formed strong interactions in the investigated fenofibrate forms were 
the keto group between the two rings, the chlorbenzyl rings and the ester group in the 
aliphatic part. The interactions formed by these three groups will be discussed for each of the 
forms I, IIa and III. 
In form I, the shortest intermolecular interaction was formed between the carbonyl oxygen 
(O24) of the ester group and a hydrogen atom (H12) of the phenyl ring [d(H···O) = (2.49 Å), 
(C-H···O) = 128 °]. The same carbonyl atom forms another short interaction to the H5 atom of 
the chlorophenyl ring [d(H···O) = (2.61 Å), (C–H···O) = 172 °].  , as illustrated in Figure ‎8-5(a). 
Both interactions are more than 0.1 Å shorter than the sum of the atomic van der Waals radii. 
These interactions connect fenofibrate molecules into a layer parallel to the (001) plane. The 
layers are connected to each other through further C–H···O interactions, formed between 
isopropyl methyl groups (H25A) and ketone carbonyl oxygen (O9) atoms [d(H···O) = (2.66 Å), 
(C–H···O) = 156 °] and offset π−π interactions between parallel chlorophenyl rings at an 
interplanar distance of 3.5116(6) Å, as seen in Figure ‎8-5(b). The interlayer C−H···O interactions 
also facilitate the efficient packing of the isopropyl groups with a high surface area, which can 
be seen forming an “embrace” together. 
  
303 
 
(a) 
(b) 
 
Figure ‎8-5. (a) The sheet that is formed parallel to the (001) plane via C–H···O interactions in Form I. (b) The offset 
π−π interactions between parallel chlorophenyl rings in addition to the “embrace” interaction in form I. 
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In form IIa, the carbonyl of the ester group in the aliphatic chain (O24) contributes to the 
formation of a dimer in the unit cell via C14–H14···O24 [d(H···O) = 2.662(11) Å, (C–H···O) = 
129.6(8) °] and C15–H15···O24 [d(H···O) = 2.891(10) Å, (C–H···O) = 120.4(12) °] hydrogen 
bonds. These hydrogen bonds generate a ring motif (Figure ‎8-6(a), between molecules number 
1 and 2). The large contact surface area between the two molecules suggests that van der 
Waals interactions play a significant role in stabilising the dimer. Two principal interactions 
connect adjacent dimers to form layers parallel with the (111) plane. These interactions are: 
C11–H11···O9 hydrogen bonds between the hydrogen donor from the benzene ring and the 
ketone carbonyl acceptor [d(H···O) = 2.570(16) Å, (C–H···O) = 135.2(8) °] and π-π interactions 
between chlorophenyl rings. The former forms a ring motif R2
2(14) between two molecules, as 
seen in Figure ‎8-6(a) (molecules 1 and 3). The offset π-π interaction involves the chlorobenzene 
fragments of two molecules and takes place at an interplanar distance of 3.3029(8) Å between 
the parallel rings, as seen in Figure ‎8-6(a) between molecules 1 and 4. The same stacking 
interaction was observed in form I with an interplanar distance of 3.5116(6) Å. Moreover, the 
layers formed in this form also show the same “embrace” of the alkyl chain seen in form I, 
however at a larger inter molecular distance [Figure ‎8-6(b)]. 
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(a) 
 
(b) 
Figure ‎8-6. (a) The main interactions in fenofibrate form IIa. (b) From IIa pattern that is common with form I. 
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In form III the molecules are linked into layers by two C−H···O bonds parallel to the 
crystallographic (100) plane. Specifically, one interaction takes place between a hydrogen of 
the isopropyl group (H23B) and the ketone carbonyl group of an adjacent molecule, O9 
[d(H···O) = 2.56 Å, C−H···O = 160 °]. The other interaction is between the same keto group 
(O9) and an isopropyl hydrogen (H18), from a different molecule [d(H···O) = 2.67(1) Å, 
C−H···O = 143.6 °]. These interactions are illustrated in Figure ‎8-8(a). In this sheet 
arrangement there is a chain shared between forms I and III, but not present in form IIa 
[Figure ‎8-5(a) and Figure ‎8-8(a)]. Despite the similarity of the layer structures in forms I and III, 
their layers are not superimposable. The relative positions of the molecules perpendicular to 
the (100) plane of form III are different in the two forms. 
The keto group in form III forms a C−H···O interaction with the hydrogen of benzene ring (H14) 
[Figure ‎8-8(b)]. This interaction forms a ring motif, resulting in a dimer. The C–H···O interaction 
takes place between the carbonyl of the keto-group (O9) and (H12) [d(H···O) =2.92 Å, 
C−H···O = 161.8 °]. It can be noticed that a repulsive H-H interaction is seen in this ring motif. 
Such repulsive interactions in the structure are thought to be a reason for the instability of this 
form. Similar interaction between the keto group and a central benzene hydrogen was 
observed in form IIa [Figure ‎8-6(a), molecules 1 and 3], but not in form I. 
Form III shares two other interactions with both forms I and IIa. Firstly, the offset π−π 
interaction of the chlorobenzene rings. In form III, this interaction links pairs of dimers at a 
distance of 3.5719(8) Å. The second shared interaction is the “embrace” type of interaction, 
this seem to be the most essential interaction in all forms, where it maximizes the contact 
surface of molecules in the crystal. The ether atom O(21) has a short contact to H23 (2.78(2) Å) 
and between carbonyl O24 and H atoms of the chlorobenzyl ring (H5 and H6; 2.84 Å and 
2.88 Å). The offset π−π interaction, the “embrace” interaction and the ether C–H···O 
interaction can be seen in Figure ‎8-8(c) and (d). 
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(a) 
(b) 
Figure ‎8-7. (a) The sheet that is formed parallel to the (100) plane via C-H…O interactions in form III. (b)  The keto 
group in C−H···O interaction with the hydrogen of benzene ring in from III. 
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(c) 
(d) 
Figure ‎8-8. Continued. (c) Illustrates the offset π−π interaction, the “embrace” interaction and the ether C–H···O 
interaction in from III. (d) The two molecules on the right side in part (c) from a different angle, showing the 
embrace type of interaction in form III, not short H-H interaction is noticed between the two molecules in part 
(d). 
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8.4.3 Comparison of crystal structures of fenofibrate form I, form IIa and form III  
A summary of the relevant interactions in the three forms of fenofibrate, I, IIa and III, is given 
in Table ‎8-3. 
Table ‎8-3. Relevant short H-acceptor interactions in the crystal structures of fenofibrate forms I, IIa and III. The H 
atoms have the same numbers as C atoms that they attached to. (See Figure ‎8-1 for atom numbering). The 
symbols A, H and D in the table are short of Acceptor, Hydrogen and Donor atoms 
A H  
D A···H 
distance 
D...A 
distance 
D-H Angle vdW 
difference 
Symmetry 
Form I 
O24 H12 C12 2.49 3.156(2) 0.93 128.4 -0.23 x,1+y,z 
O24 H5 C5 2.61 3.534(2) 0.93 171.8 -0.11 1+x,1+y,z 
O24 H11 H11 2.78 3.296(2) 0.93 116.4 0.06 x,1+y,z 
O9 H18A C18 2.62 3.523(2) 0.96 156.3 -0.1 -1+x,-1+y,z   
O9 H19A C19 2.87 3.702(2) 0.960 145.4 0.15 -1+x,-1+y,z   
O9 H2 C2 2.91 3.171(2) 0.930 98.0 0.19 2-x,-y,1-z  
O9 H23A C23 2.67 3.401(3) 0.960 133.8 -0.06 3-x,1-y,2-z   
Cl7 H14 C14 3.10 3.706(2) 0.93 124.4 0.15 2-x,1-y,1-z 
Form IIa 
Cl7 H11 C11 2.895(13) 3.541(2) 0.96(2) 125.8(9) -0.06 1+x,-1+y,z  
Cl7 H6 C6 2.924(18) 3.720(2) 0.96(2) 141(1) -0.03 3-x,1-y,-z  
Cl7 H25A C25 3.062(12) 3.967(3) 0.98(1) 155(1) 0.11 2-x,1-y,1-z    
O9 H11 C11 2.570(16) 3.318(3) 0.96(2) 135.2(9) -0.15 1-x,2-y,-z  
O9 H5 C5 2.874(12) 3.571(3) 0.95(3) 131.2(9) 0.15 2-x,2-y,-z   
O16 H18A C18 2.773(15) 3.734(3) 0.97(2) 170.6(9) 0.05 -x,2-y,1-z  
O24 H14 C14 2.662(11) 3.374(2) 0.98(2) 129.6(9) -0.06 1-x,1-y,1-z  
O24 H18B C18 2.783(10) 3.533(3) 0.97(1) 134.5(8) 0.06 -x,1-y,1-z  
O24 H19A C19 2.913(15) 3.697(3) 0.99(1) 136.9(9) 0.19 -x,1-y,1-z  
O24 H15 C15 2.891(10)  3.485(3) 0.97(2) 120(1) 0.17 1-x,1-y,1-z 
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Table 8-3. Continued 
Form III 
Cl7 H23A C23 3.114(15) 3.915(3) 1.01(2) 141(1) 0.16 1-x,1-y,2-z      
Cl7 H18A C18 2.960(11)  3.781(2) 0.98(1) 141.9(8) 0.01 1+x,1+y,1+z      
Cl7 H25A C25 2.828(14)  3.586(3) 0.98(1) 135.1(8) -0.12 1+x,1+y,1+z      
O9 H18B C18 2.671(12) 3.509(2) 0.98(1) 143.5(8) -0.05 x,1+y,1+z        
O9 H25B C25 2.565(12) 3.498(4) 0.98(1) 159.9(9) -0.15 x,y,1+z 
O9 H12 C12 2.92 3.810(2) 0.93 161.8 0.2 -x,1-y,2-z  
O24 H22 C22 2.91 3.772(2) 0.98 146.9 0.19 1-x,1-y,1-z 
O24 H6 C6 2.88 3.468(2) 0.93 122.2 0.16 x,-1+y,-1+z 
O24 H5 C5 2.84 3.449(2) 0.93 124.4 0.12 x,-1+y,-1+z 
O21 H23C C23 2.775(16) 3.660(3) 1.01(2) 147(1) 0.06 -x,1-y,1-z  
Interestingly, no interactions were observed at a distance less than the Van der Waal radii of 
interacting atoms seem to be shared between the three forms. However, some similarities can 
be identified between forms I and III. For example, the O9 of the ketone group interacts with 
the methyl group (O9 ···H18B) and with isopropyl group (O9 ···H25B). The interaction between 
O24 of the ester carbonyl and H23 of the isopropyl group is also common for both forms I and 
III. Despite these differences in the interactions among the three fenofibrate forms, similar 
packing trends can be identified. Each molecule of the three forms adopts a capital “L” letter 
shape. Two of these “L”s pack inverted to each other to form a near-rectangular shape “L⅂”. 
Rectangular dimers then efficiently fill the space. An illustration of the packing of the three 
forms is shown in Figure ‎8-9. 
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(a) (b) 
(c) (d) 
 
 (e) 
 
(f) 
Figure ‎8-9. The unit cell and packing of fenofibrate form I (a) and (b), form IIa (c) and (d) and form III (e) and (f). 
In order to know how similar these packing patterns are to each other, the “crystal packing 
similarity” function in Mercury was used to compare forms IIa and III to the most stable form I. 
The packing of 15 molecules in each form were compared. Form IIa had 6 out of 15 molecules 
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in common with form I compared to 1 molecule out of 15 in common between form III and 
form I. The observation that the packing is more similar for forms I and IIa could be an 
explanation to the experimentally observed sequence of polymorph transitions: III->IIa->I 
when fenofibrate is left to age at room temperature. In order to assume the conformation and 
arrangement of form I, molecules in form III first need to convert to the other metastable 
polymorph IIa which then can undergo transition to form I.  
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 Summary and conclusions Chapter 9:
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9.1 Summary 
Pharmaceutical companies are always trying to find new solid forms of APIs for different 
reasons. For example new solid forms have the potential to give new forms that give superior 
physicochemical properties to the known forms of a drug such as stability and dissolution (as in 
the case of amoxicillin). Additionally, a newly discovered form is not covered by the patent of 
the parent/innovator company, allowing for large profits of the company discovering the new 
form. One of the strategies to find new solid forms is the use of multicomponent solids. This 
method has gained popularity over the past few years. The forms of cocrystal and solvate have 
received special attention because they are less well explored. The number of marketed 
multicomponent drugs is certainly increasing, showing the larger interest in this area. These 
forms can also have negative effects on pharmaceutical companies, where the unexpected 
formation of a solvate could lead to having remnants of the solvents used during processing of 
the API, causing a danger to the patient as well as a financial loss to the company. 
Until today, the formation of multicomponent solids is not readily predictable, so high-
throughput screening methods are used in order to cover the possible range of solid forms 
(single- and multi-component) that an API can form. Crystal structure prediction is also being 
used alongside experimental work in order to show the possible forms using lattice energy 
calculations.  
In this work, we focused on the solvate forms of organic materials. We tried to relate the 
structural features of organic compounds to their ability to form a solvate using a knowledge-
based approach. Identifying these features resulted in better understanding of the 
crystallization of these forms and provides a quick, easy-to-use tool for scientists, helping them 
in the choice of solvents in early stage development. 
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As a proof of concept, four of the most commonly used recrystallization solvents for organic 
materials were studied. These solvents were ethanol, methanol, dichloromethane, chloroform. 
Additionally, water, being the preferred choice in any experiment, was studied as well. The 
Cambridge Structural Database, is the only database that contains the relevant data. 
For each of the five solvents, two groups of entries were extracted from the CSD; these are a 
solvate-forming and a non-solvate-forming group. For each extracted molecule, thousands of 
molecular descriptors were calculated via the Dragon software. The output of Dragon was 10 
tables; a solvate and a non-solvate forming table per solvent. Each of these tables had a few 
hundreds to a few thousands molecules, which were represented by rows and had thousands 
of descriptors, represented by columns of these tables. All of these descriptors were numerical 
values, which makes them suitable for the application of statistical procedures. 
Statistical significance testing was applied to each solvent’s dataset individually, comparing the 
solvate and non-solvate forming groups. The majority of the descriptors showed significant 
difference between solvate and non-solvate molecules. This implies that most of the structural 
features represented by molecular descriptors have shown the potential to be useful in 
differentiating the solvate and the non-solvate molecules. 
Due to the large number of these useful descriptors, machine learning algorithms were used. 
Initially, an unsupervised machine learning method, PCA, was applied to the data in order to 
reduce the dimensionality. The PCA gave a good separation of the data in space. Nevertheless, 
PCA could not point towards a small number of descriptors that could be used to achieve the 
good separation that was seen by PCA. After that, supervised machine learning was used to 
learn from the available data. A linear and non-linear method were compared, these are 
logistic regression and support vector machine, respectively. The performance of these two 
methods was comparable, with a higher consistency in logistic regression performance, 
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implying that support vector machines could be overfitting to the training data in some cases. 
Therefore logistic regression was used for the rest of the analysis.  
Logistic regression was first used to fit models using the first, first two and first three principal 
components (PCs). It was then used in a systematic approach to descriptor selection, that is, 
models with all possible combinations of one and two descriptors were fitted. When the 
results were compared, the models with one and two variables had comparable results with 
the PCA logistic regression models. This could reflect the high correlation between descriptors, 
where the dimensionality reduction was not of great significance. The variables with two 
descriptors slightly outperformed PCA in the models of all five solvents. Additionally, they 
showed exactly what chemical features are the main contributors for solvate formation, in 
terms of the descriptors available. A third descriptor was added to the models using forward 
selection but it couldn’t improve the performance in any of the five solvents. This again shows 
the high correlation between variables, where among thousands of potentially useful 
descriptors, the predictive ability stopped improving when the third descriptor was added. For 
this reason, the two-variable models were considered to be optimal. The two variables in these 
models were related to the size and branching of molecules in addition to the availability of 
heteroatoms in a molecule. When these models were evaluated, a small bias was noticed, with 
a preferential prediction towards the non-solvate group in all solvents. This was corrected by 
adjusting the intercept of each model, until the bias was not seen any further. The next step 
that was taken was to provide a simpler description than the one given by the two-variable 
models. This could be useful for researches who want to make predictions without using 
computers. The simpler models were obtained based on the correlation of simple descriptors 
to the ones in the two-variable models. As expected, the resulting simple models performed 
very closely to the two-variable models.  
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Analysis of correctly and incorrectly predicted structures revealed that the importance of size 
and branching of the molecule exceeds any other factor, at least among the studied molecular 
descriptors. Factors that seem to be involved in solvate formation but the models did not take 
them into account (e.g. C–H···O hydrogen bonding, steric hindrance and halogen bonding) 
were also identified. These factors are thought to be the reason for misprediction in many 
cases, but were too few in number to be found by the machine learning algorithms. This 
assumption was supported by examples from each data set showing mispredictions caused by 
ignoring at least one of these factors.  
The applicability of the models to pharmaceuticals was tested via experimental validation. Ten 
drug compounds that vary in their properties, especially in the factors that the models take 
into account, were used in this validation. Each of the candidates was tested for its ability to 
form a solvate with each of the five solvents, and the results of the experimental screening 
were compared to the predictions. The success rates for ethanol and methanol were the 
highest (9/10) followed by dichloromethane and chloroform (8/10) then followed by the water 
model (5/10). Multiple reasons could have caused these results. For example the number of 
points in the training data was the smallest in the water data set; therefore it is expected for 
the water model to have the lowest predictability. Additionally, a test set of 10 drug 
candidates is small. Consequently, the test set was probably not representative of the 
population of known crystal structures. Therefore the validation was more of a demonstration 
of how the models work with pharmaceutically active materials and how realistic the results 
are giving probabilities ranging between 0 and 1 depending on the structure given.  
During the screening of the solvate formation, some of these drug candidates formed solvate 
forms that were not previously reported. In this case, the PXRD of the sample was collected. 
Additionally, a new solvate form of griseofulvin dichloromethane solvate was reported via 
SCXRD experiment. A dichloromethane solvate of griseofulvin has previously been reported. 
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Nevertheless, the crystallographic parameters were different from the reported form, showing 
an example of solvate polymorphism. 
Chapter 8 was my contribution to a study conducted by P. Tipduangta, a colleague in the same 
suit who is studying the heterogeneous crystallization of fenofibrate, an anti-hyperlipdemic 
agent. The study focused on the effect of surface annealing and temperature in preferential 
crystallization of different polymorphic forms, where it was possible to obtain polymorph IIa of 
fenofibrate purely by manipulating these factors. It also focused on the role of a commonly 
used additive, talc, in acquiring a new polymorph of fenofibrate that was not previously 
reported, which was denoted as polymorph III. The crystal structures of forms IIa and III had 
not been previously reported. The main scope of this chapter was the determination and 
analysis of the new structures. The structural similarities and differences between the newly 
obtained and the known polymorphic forms were highlighted and discussed in terms of 
possible transition pathways.   
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9.2 Conclusions and future outlook 
9.2.1 Conclusions 
The work produced in this thesis has identified the main structural features that are 
responsible for solvate formation with five solvents in organic compounds using a knowledge-
based approach. These features were used to fit one predictive model per solvent. The models 
can be used to predict the probability of solvate formation of any organic compound with each 
of the five solvents. The factors that were found to influence solvate formation were mainly 
related to size and branching of a molecule, along with its hydrogen bonding ability. The 
success rate obtained ranged between 74-80 % in all 5 solvents. This shows the potential for 
cheminformatic approaches to become one of the fundamental methods in many steps of 
drug discovery and development, providing a simple, quick guide for scientists. 
Implementation of cheminformatics in gaining knowledge and predicting future results can 
save a lot of time and money in the drug development cycle. 
The key points learned from the project will can be summarized in the following points: 
(1) Careful collection and pre-processing of data are important steps, where consideration of 
one phenomenon, such as polymorphism, before analysing the data has resulted in dropping 
more than 30 % of the parent data due to redundancy. Redundancy isn’t a problem with data 
only, but also applies to the description of data, where most of the ~5000 descriptors used 
turned out to have high correlation to each other, resulting in redundant information. 
 (2) A linear, simple algorithm was enough for preliminary classification in this problem. A more 
complex, non-linear method has resulted in overfitting to the training data.  
(3) Principal components have reduced the dimensionality of the data, but failed to add value, 
possibly due to the high correlation between descriptors.  
(4) MSE, AIC and AUC gave very similar results when they were used for model selection in this 
problem, indicating their interchangeability.  
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(5) Complex descriptors are not an essential requirement for models with a good 
predictability, at least for a preliminary description of the data. In this problem complex 
descriptors could be replaced by simple, correlated descriptors, resulting in comparable 
predictive ability.  
(6) Statistical methods are subject to overfitting and underfitting, depending on the sensitivity 
on the method applied. Therefore the consideration of the chemical structure or the opinion 
of an expert is required for a valid prediction.  
(7) The size of a validation set is important to be large enough to represent the data, 10 drug 
candidates per solvent did not provide enough data to confidently judge the experimental 
validity of the predictive models.  
(8) Crystallization conditions, such as exposed surface area and temperature can result in 
different polymorphic forms. Although the last piece of work in this thesis did not explicitly 
concern solvates, crystallization of different forms have the potential to be applied in the field 
of multicomponent solids. 
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9.2.2 Future outlook 
The work presented in this thesis has proven the usefulness of cheminformatics approaches in 
predicting the physicochemical behaviour of organic compounds. While the prediction isn’t 
perfect, improving such a predictive method is possible. One of the main requirements for 
obtaining a better predictive ability is collection of more data. Machine learning is based upon 
using the training data to fit predictive models. The bigger the training data and the more 
diverse it is, the more likely it is to give a realistic model. Another way to improve these 
models would be finding a better description of compounds. This includes a more detailed 
description of hydrogen, halogen and π interactions. It is also possible to add new descriptions, 
encoding new information that is not yet encoded in descriptors such as the accessibility of 
atoms, based on the molecular graph. This could be useful especially when atoms with the 
potential to form strong intermolecular bonds exist.  
The successful application of knowledge-based systems in a complex problem, such as solvate 
formation indicates the possibility to extend their use in other phenomena in the solid state, 
such as cocrystal formation, drug-polymer compatibility and stability of solid dispersions. It is 
important to note here that in order to obtain meaningful results from knowledge-based 
methods, chemical knowledge of a problem is required. Such methods serve as a guide for 
researchers, where it could point towards the factors that need to be considered in their 
research. 
 
